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CHAPTER I 
 
INTRODUCTION 
 
Introduction 
Efficient communication between the cells of the human body is an important 
determinant of human health. Chemical signals in the extracellular milieu encode specific 
messages that instruct individual cells to elicit physiological responses to changes in the 
composition of the extracellular environment. Proteins embedded in the cellular 
membrane sense these signals and relay their “message” to a repertoire of intracellular 
proteins that act in concert to regulate a variety of cellular events such as gene expression, 
cell growth, cell mobility, and even cellular death in response. The integrity of the signal 
relay is essential to maintaining homeostasis, and disruption of the network of cellular 
crosstalk at any given point can result in disease ranging from depression and diabetes to 
heart disease or cancer. One such class of receptor proteins, the G Protein Coupled 
Receptors (GPCRs), forms a highly diverse and ubiquitous group of membrane proteins 
that transduce extracellular messages into intracellular responses via their interactions 
with their signaling partner, the heterotrimeric G protein. The focus of my dissertation 
research has been to better understand the precise mechanisms by which heterotrimeric G 
proteins are activated during GPCR signaling. 
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Historical Perspective 
The discovery of heterotrimeric G proteins was preceded by investigations led by 
Sutherland and colleagues into the biochemical properties of β receptor signaling (17).  
By the late 70’s, it was widely accepted that receptor stimulation by the extracellular 
hormone, epinephrine, was responsible for adenylyl cyclase activity and the production 
of cAMP as a second messenger for eliciting a cellular response. Separation by size 
exclusion chromatography confirmed that the two protein molecules were distinct entities, 
however the underlying mechanism by which activated receptors were able to regulate 
adenylyl cyclase still remained to be understood (18). Experiments conducted by Rodbell 
and colleagues provided a very important clue to this conundrum by showing that, in 
addition to hormone, GTP was a requirement for the activation of adenylyl cyclase during 
glucagon signaling (19,20). Indeed, the addition of a nonhydrolyzeable GTP analog 
(GppNHp) elicited persistent stimulation of adenylyl cyclase (21). Later, it was shown 
that GTP hydrolysis terminated adenylyl cyclase activity, and guanine nucleotides could 
regulate the activation state of the protein (22-24). Thus, a model of signal transduction 
utilizing a GTP-binding protein as the link between hormone-bound receptor and 
adenylyl cyclase was born (21).   
 By the turn of the decade, advances in chromatographic techniques allowed 
Gilman and colleagues to successfully purify what would later be identified as the α, β, 
and γ subunits of the stimulatory G protein, Gs (28). Importantly, reconstitution of 
adenylyl cyclase and Gs with membranes from a cyc- adenylyl cyclase deficient cell line 
was sufficient for cAMP production (30), and so the GTPase hypothesis suggested by 
Rodbell was finally confirmed. Meanwhile, investigations into analogous systems led to 
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the identification of a class of structurally conserved GTPase proteins. The study of 
phototransduction in retina revealed the presence of a light-sensitive GTPase that was 
required for the inactivation of cGMP phosphodiesterase, which hydrolyzes cGMP to 
GMP (31,32). This phenomenon was attributed to the activity of transducin, Gt, the 
cognate heterotrimeric G protein of the visual receptor rhodopsin (33,34). Likewise, 
investigations into the action of the cholera (35-37) and pertussis (38,39) bacterial toxins 
assisted in the identification of the stimulatory (Gs) and inhibitory (Gi) classes of the G 
protein, respectively (41). 
 Since the initial characterizations of GPCRs, and subsequently heterotrimeric G 
proteins, extraordinary progress has been made towards understanding their architecture, 
function, and regulation using a variety of structural and biochemical approaches. 
Rigorous exploration of the relationship between GPCRs and G proteins has implicated a 
highly sophisticated, allosteric mechanism of G protein activation during GPCR signaling. 
Yet, ambiguities still remain. In subsequent sections of this introduction, experimental 
approaches for studying allosteric processes of GPCR and heterotrimeric G protein 
regulation will be reviewed to establish where progress in the field and our understanding 
of these processes currently stands. 
 
Overview of Allostery in GPCRs 
Biological Importance of GPCRs 
 GPCRs are transmembrane proteins that mediate a variety of physiological 
processes. While there is a diverse set of ligands that can activate GPCRs, each receptor 
has incredible fidelity to a small set of cognate ligands that act as agonists, antagonists, or 
 4 
inverse agonists to achieve different receptor activation states. Their specificity for 
regulating a broad number of biological processes has allowed for the development of 
numerous pharmaceutical therapeutics that modulate GPCR signaling. Indeed, GPCRs 
are overrepresented as therapeutic targets as they constitute only 3% of all protein-
encoding genes in humans, but an estimated 50% of all pharmacological targets (44). 
 
Sequence and Structural Determinants of GPCRs. 
Despite the diversity in substrate specificity, GPCRs all share a common 
architecture comprising seven transmembrane helices (45).  They additionally contain six, 
conserved sequence motifs believed to be critical for regulation of receptor activation 
states. These are a disulfide bond, an (E/D)RY motif forming the ionic lock, an 
NPxxY(x)5,6F motif, a Y(x)7K(R) motif, three conserved helix kink-inducing prolines, 
and a CWxP motif comprising the rotamer toggle switch (Figure 1)  (47,48). 
Sequence comparisons of the GPCR superfamily subdivide human GPCRs into 
three main classes (49). Class A, B, and C GPCRs differ in sequence identity, their 
substrate preference, and mechanisms of ligand binding.  Class A, or the Rhodopsin 
family, is by the far the largest: as of 2008, 802 predicted human GPCRs had been 
identified, of which 672 belonged to Class A (44,51). Class A GPCRs do not share a high 
degree of sequence homology and bind diverse ligands, but do contain the conserved 
transmembrane architecture, sequence motifs required for activation, and are defined by a 
short, extracellular N-terminus lacking a common domain (49). Human thrombin 
receptors are an exception and have intrinsic cleavage sites in their N-termini that get 
cleaved to reveal a tethered ligand able to activate the receptor (56). Peptides, small 
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Figure 1: Conserved Structural Motifs of Class A GPCRs. The structure of rhodopsin 
(PDBID: 1U19 (3)) bound to the inverse agonist, 11-cis retinal, represents the prototypical Class 
A GPCR (center). Three intracellular loops (IL) and three extracellular loops (EL) connect seven 
transmembrane (TM) helices arranged in a tight bundle. Ligand entry occurs on the extracellular 
side of the receptor and binds within a central cavity. Retinal binding in rhodopsin is highlighted 
with an orange box.  Details of the conserved structural motifs are shown in the surrounding 
panels and are mapped onto the rhodopsin structure in the same color as the panel outline. A) The 
CWxP motif forms the basis of the toggle switch hypothesis and contributes the proline residue 
that introduces a kink in TM6.  B) Additional conserved prolines, Pro215 and Pro267 in rhodopsin, 
also introduce kinks in TM helices in GPCRs. C) Lys231 and Tyr223 of the Y(x)7K(R) motif form 
interactions in the activated receptor that contribute to the release of the ionic lock formed by 
residues of the D) E(D)RY motif. E) Conserved disulfide helps constrain TM3 and EL2, whereas 
the F) NPxxY(x)5,6F motif  forms the basis of a distinct hydrogen bonding network that is 
comprised of two submotifs: 1) a TM1, TM2, and TM7 linkage and 2) a TM7-cytoplasmic helix 
8 linkage mediated by Asn302 and Tyr306.  
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organic compounds, and nucleotides are a few examples of the many ligands that can 
bind to class A GPCRs. Importantly, until recently, receptors of class A were the only 
GPCRs for which structures had been determined by x-ray crystallography and for which 
the largest number of pharmaceutical drugs have been developed. By comparison to class 
A, much less is known about the allosteric regulation of class B and class C receptors.  
Class B GPCRs are divided into two families, the Secretin and Adhesion families 
(51). Secretin receptors are defined by an extracellular hormone-binding domain. They 
contain conserved cysteine residues in extracellular loops 1 and 2, form a cysteine-bridge 
network in the N-terminus, and bind peptide hormones (58-60). Adhesions receptors are 
defined by long N-termini that are highly glycosylated, protrude from the membrane 
surface, and form a rigid structure containing GPCR proteolytic domains that undergo 
autocatalytic processing to form two non-covalently attached subunits whose features 
vary in different receptor subtypes (61-63). The cleavage site is often found between a 
conserved aliphatic residue such as leucine and small polar residues such as threonine, 
serine, or cysteine (63-65). Despite the diversity in the functional domains formed in 
Adhesion receptor N-termini, these receptors contain conserved cysteine residues in 
extracellular loops 1 and 2 like Secretin receptors and preferentially bind extracellular 
matrix molecules (66). 
Class C GPCRs contain the Glutamate family of receptors and are defined by 
large extracellular N-terminal domains. Crystal structures of the extracellular portions of 
the metabotropic glutamate receptor have been determined and provide insight into the 
topology of Class C ligand binding sites (67). In this receptor, the N-terminus is folded 
into two conserved domains stabilized by three predicted disulphide bridges formed by 
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nine conserved cysteine residues (68,69). Amino acids, cations, carbohydrates, and small 
organic compounds will then bind Class C receptors in structurally similar ligand binding 
domains within the N-terminus. 
 
Mechanisms of Allosteric Regulation in Rhodopsin 
 One of the best-characterized GPCRs, rhodopsin, is a member of class A, and the 
details of rhodopsin activation are generally assumed to apply to the rest of the class. 
Rhodopsin is responsible for perception of light under low light conditions. Numerous 
properties of this photoreceptor have made it amenable to characterization by both in vivo 
and in vitro methods. Rhodopsin is naturally abundant, easily purified, stable in a variety 
of detergents, and has spectroscopic properties that provide a convenient method to 
monitor activation. In addition, ground state rhodopsin covalently ligates an inverse 
agonist, 11-cis-retinal, that locks it into an inactive conformation. This decreases the 
conformational heterogeneity that often limits x-ray crystallographic studies. Accordingly, 
rhodopsin was the first GPCR to be characterized by x-ray crystallography in both active 
and inactive conformations, and eight years elapsed before the structure of any GPCR 
with a diffusible agonist was determined. Very recently, the structures of 14 unique Class 
A receptors (Figure 2) have been added to the repertoire of GPCR crystal structures 
(70,71). These structures verify that the relative arrangement of transmembrane helices in 
the inactive state is largely conserved between rhodopsin and other class A GPCRs. As a 
result, the mechanisms of activation are likely to be shared. 
Rhodopsin is synthesized as an apoprotein called opsin, which lacks the ability to 
detect light. Covalent linkage of 11-cis-retinal to the ε-amino group of Lys296 forms a 
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Schiff base and converts opsin to rhodopsin, conferring light sensitivity. A salt bridge 
between the Schiff base imine on helix VII and the counterion Glu113 on helix III 
stabilizes the covalent linkage by preserving protonation of the Schiff base (72). This 
results in an optical spectrum characteristic of inactive rhodopsin (73,74). The 
protonation state of the Schiff base, among other things, contribute to variations in the 
 
Figure 2: Overview of Class A GPCR Crystal Structures.  Structures are shown bound to their 
ligand (black sticks) and are grouped by the subfamily to which the receptor belongs. Engineered 
extracellular domains and stabilizing binding partners used to aid in the crystallization are 
displayed for the structures where they were employed. 
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absorption spectra of rhodopsin during its reaction cycle (Figure 3) (72). Rhodopsin 
activation is initiated by the absorption of a single photon of light, which induces 
isomerization of 11-cis-retinal to all-trans retinal, catalyzes transfer of the imine proton 
to the Glu113 counterion, breaks the salt bridge, and releases all-trans retinal from a 
covalent linkage with rhodopsin (47).  
 
 
Figure 3: Rhodopsin Cycle of Photointermediate Formation. Opsin covalently bound to 11-
cis retinal forms the inactive photoreceptor, Rhodopsin (red). Upon the absorption of a photon of 
light (hν), the bound 11-cis retinal isomerizes to the all-trans form. Rhodopsin then cycles 
through a series of spectrally unique photointermediates as the chromophore undergoes thermal 
relaxation. Formation of the Meta II state (blue) represents the activated form of the receptor that 
binds to the cognate G protein, transducin, with high affinity. Hydrolysis of the Schiff base 
linkage (N-Lys296) returns the receptor to the Opsin form and liberates all-trans retinal. 
 
EPR, double electron-electron resonance (DEER) spectroscopy, and EM have 
showed that large conformational changes accompany rhodopsin activation (75-78). The 
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most dramatic conformational change is the rigid body movement of helix VI away from 
helix III (Figure 4) (77,78). This conformational change has long been hypothesized to 
be required for the formation of a cytoplasmic G protein-binding site. For rhodopsin, the 
cognate G protein is transducin, Gt. Recent crystal structures of opsin and opsin in 
complex with a high affinity peptide mimicking the C-terminus of the Gαt subunit are 
consistent with the activated conformations of GPCRs indeed exposing a cytoplasmic 
pocket accommodating the C-terminus of Gαt (79,80).  
 
 
Figure 4: Conformational Changes of the Rhodopsin Intracellular Side. Left panel: 
Rhodopsin (PDBID 1U19; (3)) is shown in gray. Middle panel: Meta II (PDBID 3PQR; (81)) is 
shown in blue. Right panel: An overlay of the structures of rhodopsin and opsin highlights the 
differences in these structures. These two structures have a 7Å shift in the position of helix VI 
(arrow) that allows meta II to bind the C-terminus of Gαt in an intracellular binding pocket (82). 
The conformation of opsin is similar to the conformation proposed for rhodopsin upon light 
activation. 
 
Associated with these transmembrane helical rearrangements is exposure of the 
(E/D)RY motif to solvent. In the absence of activation, this motif forms the ionic lock 
believed to stabilize receptors in the ground state (83,84). Salt bridges between Glu134 
and Arg135 of the (E/D)RY motif and Glu247 on helix VII constrain rhodopsin in the 
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inactive conformation in the absence of chromophore isomerization and helical 
reorganization (85,86). Fourier transform infrared (FTIR) spectroscopy showed that 
rhodopsin activation is pH dependent (87,88). Proton uptake by Glu134 in response to the  
reorientation of helices III and VI is associated with metarhodopsin II formation, which is 
characterized by an absorption maximum at 380 nm (89-91). Residues Arg135 and Glu247, 
formerly participating in the ionic lock, can then form hydrogen bonding interactions 
with residues of the Y(x)7K(R) motif on helix V to stabilize the active receptor 
conformation. A broken ionic lock and loss of the agonist were observed in the crystal 
structure of opsin bound to a high affinity peptide (80).  
Taken together, all of these studies point to an active conformation of the receptor 
that allows binding of G proteins to the cytoplasmic surface located over a 25 Å distance 
from the agonist binding site. This interaction between activated receptor and cognate 
heterotrimeric G proteins initiates G protein signaling. 
 
Overview of Allostery in Heterotrimeric G Proteins 
Biological Importance of Heterotrimeric G proteins 
 Heterotrimeric G proteins (Gαβγ) (Figure 5) are activated by GPCRs (Figure 6). 
In the activated state, the heterotrimer dissociates into Gα and Gβγ. These dissociated 
subunits interact with effectors to regulate downstream signaling pathways. For example, 
in rhodopsin signaling, activated Gαt stimulates rod cGMP phosphodiesterase for the 
hydrolysis of cGMP to 5’-GMP. The decrease in cGMP causes cGMP-gated Ca2+ and 
Na+ channels to close and the membrane of the cell to become hyperpolarized. The loss 
of an inward current results in an electrical signal whose outcome is low-light vision (92). 
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Alterations in G protein signaling arising from genetic variation can give rise to severe 
medical conditions. Missense mutations in heterotrimeric G proteins have been shown to 
result in progression of human pituitary and thyroid tumors, congenital night blindness, 
and ocular melanoma (93-96). In one specific example, it was discovered that mutation of 
a highly conserved glycine residue in the GTPase domain found in both heterotrimeric G 
proteins and distantly related Ras proteins resulted in congenital night blindness (95). 
This conserved glycine, residue 38 in Gαt (residue 42 in Gαi1), is situated in a small loop 
that forms essential hydrogen bonds with α and β phosphates on both GDP and GTP in 
the nucleotide-binding pocket of the Gα subunit. A G38D mutation associated with 
 
Figure 5: Overview of the Heterotrimeric G protein Structure. Heterotrimeric G proteins are 
composed of 3 subunits: the nucleotide-binding Gα (blue) subunit and the dimeric Gβ (green) and 
Gγ (gray) subunits. GDP is shown as red spheres in the structure of Gαi1β1γ2 (PDB ID: 1GP2 
(46)). Residues associated with G protein-related diseases are shown as yellow spheres and are 
labeled according to Gαi numbering. The corresponding residue numbering in Gαs is given in 
parentheses. 
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congenital night blindness is thought to disrupt Gαt GTPase activity. Similarly, a more 
severe example of heterotrimeric G protein dysfunction is observed in the transformation 
of growth-hormone secreting human pituitary tumors where a mutation in the Gαs subunit 
of the stimulatory heterotrimeric G protein results in elevated basal adenylate cyclase 
activity and cAMP production in tumorigenic cells (93). G proteins expressed in 
malignant cells contained R201C or R201H and Q227R mutations in the G protein Gαs 
 
Figure 6: Heterotrimeric G protein Signaling Cycle. GPCRs signal through soluble G proteins. 
In State 1, activated receptor binds to the GDP-bound heterotrimeric G protein and promotes 
release of GDP from the Gα subunit to form a nucleotide-free receptor-G protein complex. 
Binding of GTP to the Gα subunit results in dissociation of this high-affinity complex into GTP-
bound Gα, and Gβγ (State 2), each of which are now able to bind to downstream effectors (State 
3) and elicit downstream responses. The Gα subunit has intrinsic GTPase activity which is 
enhanced by Regulators of G protein Signaling. Following hydrolysis of GTP, GDP-bound Gα 
subunits reassociate with Gβγ subunits (State 4) and traffic to the membrane, where they can 
interact with receptors in the next signaling cycle (State 5). 
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subunit. Like G38 in Gαt, Q227 of Gαs is also found in the guanine nucleotide-binding 
pocket (Figure 5). Both R201 and Q227 were shown to be required for maintaining Gαs 
GTPase activity (93). As is the case with these conditions described, G-protein related 
diseases often arise as a consequence of constitutive activation of the catalytic Gα subunit.  
Pathogens can additionally alter G protein signaling and also lead to severe 
physiological consequences. One of the earliest characterized alterations of G protein 
signaling by a pathogen showed that infection by Vibrio cholerae causes cholera toxin to 
ADP-ribosylate R201 in the Gαs subunit of heterotrimeric G proteins (97). This inhibits 
GTP hydrolysis and regulation of adenylate cyclase (24). The resultant increase in cAMP 
levels in intestinal cells causes severe diarrhea and dehydration in the host (98).  
These examples highlight the importance of the G protein-effector interactions in 
maintaining cellular homeostasis. Effector specificity is determined by the GPCR-
activating signal, which then selects the cognate heterotrimeric G protein from a 
conserved family for tissue- or cell-specific regulation of diverse biological responses. 
 
Sequence and Structural Determinants of Heterotrimeric G proteins 
The G protein subtype available for interaction ultimately determines effector 
specificity. Heterotrimeric G proteins are composed of three subunits: Gα, Gβ, and Gγ. In 
humans, there are currently 16 known Gα subtypes belonging to 4 subfamilies, 5 Gβ 
isoforms, and 12 Gγ isoforms, each with differing binding specificities for both effectors 
and GPCRs (99).   
The Gα subunit is the catalytic subunit of the heterotrimeric G protein and is 
composed of two domains. The Ras-like domain adopts a conserved GTPase fold and 
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contains a guanine nucleotide-binding site formed by five flanking loops of the GTPase 
fold (Figure 7). The phosphate (P) loop and the TCAT motif are conserved features of 
the Gα subunit observed through the family. An independently folded, unique helical 
domain caps the nucleotide-binding pocket, which likely prevents spontaneous nucleotide 
 
Figure 7: Conserved Motifs of the G protein α Subunit. The Gα subunit is comprised of two 
domains: the helical domain (gray) and the Ras-like GTPase domain (green) containing elements 
important to the function and regulation of Gα. Conformationally variable Switch regions 
(yellow) converge on the nucleotide-binding site located at the interface of the two domains. The 
α5 helix (blue), the P-loop (purple), and the TCAT motif (orange) flank the Switch regions and 
nucleotide-binding site and facilitate Gα activation. 
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exchange with solvent and possibly increases the affinity for GTP binding within Gα 
(43,100). Important lipid modifications on the Gα N-terminus are implicated in 
heterotrimeric G protein function. Reversible S-palmitoylation of all Gα subtypes except 
Gαt and permanent N-myristoylation of Gαi in the N-terminus assist in plasma membrane 
tethering, G protein activation, and effector regulation (101,102).  
Following heterotrimer dissociation, the Gβγ subunits act as a physiological 
heterodimer and can be separated only under harsh, denaturing conditions (103). Gβγ 
dimerization occurs through the N-terminal helices of both subunits forming a coiled-
coiled domain (104). Following the short N-terminal dimerization domain, the Gβ 
subunit has a C-terminal domain of approximately 300 residues adopting a β-propeller 
fold formed by seven Trp/Asp (WD) repeats. Each repeat contains four antiparallel β-
strands arranged in a circular fashion to form a pseudo-torroid. The Gγ subunit is the 
smallest subunit of the heterotrimeric G protein and is characterized by 2 helices joined 
by a loop. The N-terminal helix participates in the coiled-coiled domain with the Gβ 
subunit, while the C-terminal helix extends over the β-propeller domain. 12 Gγ isoforms 
are C-terminally prenylated by the farnesyl or geranylgeranyl moieties (105-107). Post-
translational modification of Gγ has been shown to be essential for effector regulation 
and in membrane tethering of inactive G proteins (108).  
 
Mechanisms of Allosteric Regulation in Heterotrimeric G proteins 
Although heterotrimeric G proteins can act on a diverse variety of effectors, their 
mechanisms of activation and deactivation are conserved throughout the family (17). 
Numerous x-ray crystal structures of heterologously expressed Gα in various states of 
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activation, Gβγ, and the Gαβγ heterotrimer have revealed how the activation state of the 
protein is encoded into distinct conformations of the Gα subunit (Table 2). Comparisons 
of structures in the GDP, GDP-AlF4-, and GTPγS bound states revealed that three distinct 
sites designated as switches I-III adopt different conformations in the presence of 
different nucleotides (Figure 8). These switch regions undergo conformational changes, 
as much as 8Å for switch II, in response to receptor-mediated G protein activation (109). 
Switches I and II are located at the Gα-Gβ interface, while switch III is near the Gβγ 
coiled-coiled. Disparities observed in switch regions of GDP-bound versus GTPγS-bound 
Gα subunits form the basis for an allosteric mechanism of heterotrimeric G protein 
activation that links receptor interactions at the plasma membrane to GTP binding within 
the Gα nucleotide binding site (42).   
The duration of heterotrimeric G protein activation and interaction with effectors 
is determined by the rate of GTP to GDP hydrolysis. While activated Gα subunits have 
intrinsic GTPase activity, the rate of GTP hydrolysis is dramatically increased, almost 
2000-fold, by interactions with regulators of G protein signaling (RGS) proteins (110). 
This interaction with Gα is necessary for terminating signals in order to avoid 
overstimulation of signaling pathways. In the case of rhodopsin signaling, retinal RGS 
binding to Gαt is necessary for accelerating the termination of photoresponse (111). RGS 
proteins enhance the rate-limiting step in G protein deactivation by driving the formation 
of a Gα-GTP conformation that supports GTP hydrolysis. An x-ray crystal structure 
determined for a RGS4-Gαi1 complex helped establish this mechanism of RGS-mediated 
deactivation of G proteins by defining the interaction surface between the core RGS 
domain and the Gαi1 subunit (112). Absent from the structure was a direction interaction 
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Table 1: Crystal Structures of Gα Proteins 
Family Gα Subtype 
PDB 
ID Variant Ligands 
Space 
Group 
Resolution 
(Å) Ref 
Gi Gαi1 1GDD Wild-type GDP I 4 2.20 (4) 
 Gαi1 1AS3 G42V GDP I 4 2.40 (5) 
 Gαi1 3FFB T329 GDP I 4 2.57 (6) 
 Gαi1 3UMS G202A GDP I 4 2.34 (7) 
 Gαi1 1Y3A Wild-type-KB752 GDP P 1 21 1 2.50 (8) 
 Gαi1 2ZJZ K349P  GDP P 21 21 2 2.60 (10) 
 Gαi1 1GIT G203A GDP-Pi P 43 21 2 2.60 (11) 
 Gαi1 1AS0 G42V GDP-Pi P 32 2 1 2.00 (5) 
 Gαi1 1BOF Wild-type GDP/Mg2+ I 4 2.20 (12) 
 Gαi1 1GFI Wild-type GDP-AlF4-
/Mg2+ 
P 32 2 1 2.20 (13) 
 Gαi1 1SVK K180P GDP-AlF4-
/Mg2+ 
P 32 2 1 2.00 (14) 
 Gαi1 3D7M I56C/Q333C GDP-AlF4-
/Mg2+ 
P 43 2 1 2.90 (15) 
 Gαi1 2G83 Wild-type-KB1753 GDP-AlF4-
/Mg2+ 
P 32 2 1 2.80 (16) 
 Gαi1 2ZJY K349P  GDP-AlF4-
/Mg2+ 
P 32 2 1 2.80 (10) 
 Gαi1 1CIP  Wild-type GppNHp P 32 2 1 1.50 (9) 
 Gαi1 1SVS K180P GppNHp P 32 2 1 1.50 (14) 
 Gαi1 1GIA Wild-type GTPγS/Mg2+ P 32 2 1 2.00 (9) 
 Gαi1 1GIL Q204L GTPγS/Mg2+ P 32 2 1 2.30 (13) 
 Gαi1 1AS2 G42V GTPγS/Mg2+ P 43 21 2 2.80 (5) 
 Gαi1 1BH2 A326S GTPγS/Mg2+ P 32 2 1 2.10 (25) 
 Gαi1 3FFA T329 GTPγS/Mg2+ P 32 2 1 2.30 (6) 
 Gαi 2XTZ Wild-type (A. thal) GTPγS/Mg2+ P 21 21 
21 
2.34 (26) 
 Gαi 3QE0 G42R (E. his) GDP/Mg2+ P 61 2 2 3.00 (27) 
 Gαt 3V00 G56P GDP P 43 21 2 2.90 (29) 
 Gαt 1TAD Wild-type GDP-AlF4-
/Ca2+ 
P 1 21 1 1.70 (40) 
 Gαt 1TAG Wild-type GDP/Mg2+ I 2 2 2 1.80 (42) 
 Gαt 1TND Wild-type GTPγS/Mg2+ P 1 21 1 2.20 (43) 
 Gαi1βγ 1GG2 (G203A Gαi1)(β1)(C68S γ2) GDP P 43 2.40 (46) 
 Gαi1βγ 1GP2 (Wild-type Gαi1)(β1)(C68S γ2) GDP P 43 2.30 (46) 
 Gαiβγ 4FID (Wild-type Gαi)βγ GDP P 21 21 
21 
2.62 (50) 
 Gαtβγ 1GOT (Wild-type Gαt/i1)β1γ1 GDP C 1 2 1 2.00 (2) 
Gq Gαqβγ 3AH8 (Wild-type Gαq/i1)β1γ1-
YM254890 
GDP I 41 2.90 (52) 
 Gαqβγ 2BCJ (Wild-type Gαq)(β1) 
(C68S γ2)(S670A GRK2) 
GDP-AlF4-
/Mg2+ 
P 1 21 1 3.06 (53) 
G12 Gα12 1ZCA Wild-type GDP-AlF4-
/Mg2+ 
P 1 21 1 2.90 (54) 
 Gα13 1ZCB Wild-type GDP P 43 21 2 2.00 (54) 
Gs Gαs 1AZT Wild-type GTPγS/Mg2+ P 21 21 
21 
2.30 (55) 
 Gαo 3C7K Gα0-RGS16 GDP-AlF4-
/Mg2+ 
P 32 2 1 2.90 (57) 
 Gαsβγ 3SN6 (G72S Gαs)(M1Q β1) 
(C54T/C97A/M96T/M98T/ 
N187E-γ2)-(β2AR) 
none P 1 21 1 3.20 (1) 
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between residues of RGS4 and the nucleotide bound to Gαi1. Notably, it was observed 
that RGS4 formed contacts with all three-switch regions in the Gαi1 subunit. Mutagenesis 
confirmed that the residues comprising the RGS-Gα interface did not directly participate 
in GTP hydrolysis, but affected the efficiency of GTPase-promoting activity of RGS. 
Such mutations were found to decrease the binding affinity between RGS and Gα and Gα 
responsiveness, especially when mutations were introduced into the N-terminal helix of 
Gα (113). Mutagenesis of residues in switch II, however, highlighted the importance of a 
conserved glycine, such that its mutation nearly abolished RGS-enhanced hydrolytic 
activity (114). The conformation of switch II in the RGS4-Gαi1 complex structure 
suggests that RGS-binding likely decreases switch II mobility, which contributes to a Gα 
conformation favoring GTP hydrolysis (112). 
Thus, GPCRs act as agonists for G proteins by mediating GTP for GDP exchange 
and G protein activation, while RGS proteins acts as antagonists against G protein-
 
Figure 8: Conformational Diversity in Gα Switch Regions. Conformations of Gαi1 Switch 
regions in the presence of GDP (purple; PDBID: 1GDD (4)), GTPγS (green; PDBID: 1GIA (9)), 
and GDP-AlF4- (yellow; PDBID: 1GFI (9)). In GDP-bound Gαi1, Switch II and III are inherently 
flexible and electron density corresponding to these regions in the crystal structure is disordered. 
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effector interactions by mediating GTP hydrolysis and G protein deactivation. Once GTP 
bound in the nucleotide-binding pocket is returned to GDP to form deactivated Gα, Gβγ 
can then recombine to form the inactive heterotrimer, thus completing the G protein 
signaling cycle. 
 
Overview of Receptor-catalyzed Nucleotide Exchange 
Biological Importance of Receptor-catalyzed Nucleotide Exchange in Gα 
The rate-limiting step in G protein activation is GDP release from the Gα subunit 
of the heterotrimer and is catalyzed by interactions with an activated GPCR. Disruption 
of efficient GPCR-G protein coupling and activation of downstream signaling pathways 
can result in diseases such as diabetes insipidus, Hirschsprung’s disease, and retinitis 
pigmentosa (115,116). In one example of congenital nephrogenic diabetes insipidus 
(CNDI), diagnosed patients cannot concentrate urine and thus present symptoms of 
severe dehydration (116). There are numerous mutations in the vasopressin receptor that 
affect kidney tissue permeability.  This example of CNDI is caused by a mutation in a 
highly conserved arginine residue at position 137 in the vasopressin-activated vasopressin 
type 2 receptor (V2R). It has been demonstrated that the mutation has no effect on 
vasopressin binding affinity, but results in loss of adenylate cyclase stimulation mediated 
by the stimulatory heterotrimeric G protein, Gs (116). R137 is a well-characterized 
residue and an indispensible member of the ionic lock motif found near the cytoplasmic 
G protein binding site of GPCRs. An R137H mutation specifically affects the ability of 
V2R to couple to Gs (116). While the role of this particular mutation provides insight into 
the requirements of GPCR-catalyzed G protein activation, further characterization of 
 21 
structural determinants in GPCR-G protein coupling is needed to understand the basis of 
pathophysiology observed in GPCR-related diseases caused by additional genetic 
variants (117). 
 
Structural Determinants of Receptor-catalyzed Nucleotide Exchange in Gα 
Prior to structural information gleaned from x-ray crystallography, techniques 
such as site-directed mutagenesis, peptide-mapping, and chemical crosslinking were used 
to demonstrate that the α4-β6 loop, α3-β5 loop, αN helix, N-terminus, and C-terminus of 
the Gα subunit as well as the C-terminus of the Gβ subunit all bind to the cytoplasmic 
surface of GPCRs (2,118-126). Once the crystal structure of transducin (Gαtβ1γ1) had 
been determined it became clear that that these structural motifs distantly arranged in the 
primary sequence formed a contiguous surface. While each individual sequence motif 
contributes to the stabilization of activated GPCRs, it is their three-dimensional 
arrangement that forms a stable surface on which the receptor can then bind and promote 
heterotrimeric G protein activation through catalysis of nucleotide exchange in the Gα 
subunit (Figure 9) (117,127). 
Peptide mapping was used to identify the αN helix of the Gαt subunit, the N- and 
C-termini of the Gαt subunit, and the C-terminus of the Gβ1 subunit of the heterotrimeric 
Gt (124,126,128). Peptides corresponding to the C-terminal region of Gαt were 
synthesized and examined for their ability to bind and compete with transducin for 
rhodopsin binding and stabilize activated rhodopsin in the meta II state using an extra 
meta II (128). This peptide corresponding to residues 340-350 of Gαt was shown by a 
spectrophotometric assay measuring metarhodopsin II formation and by a comptetition 
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ELISA assay to compete with transducin for rhodopsin binding (117,122). In the same 
study, a peptide corresponding to residues 8-23 of the N-terminus of Gαt subunit was also 
found to bind rhodopsin (128). 
Chemical crosslinking of a photoactivatable derivative of a peptide (DAP-Q) 
corresponding to intracellular loop III of the α2 adrenergic receptor was used to map 
receptor binding to the N-terminus of the Gα subunit of Go and C-terminus of the Gβ 
subunit of Go (124,126). Chemical crosslinking was also used to confirm the role of the 
αN helix in the Gαt N-terminus and the α4-β6 loop of the Gαt C-terminus specifically in 
rhodopsin interactions (119,125). In these experiments, rhodopsin containing cysteine 
mutations in cytoplasmic loops was first treated with either chemically preactivated 
reagents or photoactivatable reagents and complexed with transducin. Then, trypsin-
digested peptide fragments carrying the crosslinked chemical moieties were analyzed by 
matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass 
 
Figure 9: Receptor-binding Elements of the Heterotrimeric G protein. In the heterotrimer 
(PDBID 1GOT; (2)), the receptor-binding surface (oval) is composed of the N-terminus, C-
terminus, α4-β6 loop, α3-β5 loop of the Gα subunit and the C-terminus of the Gβ and Gγ subunits 
and form a contiguous surface distal to the nucleotide-binding site (box) in the Gα subunit. 
 
 
 23 
spectrometry (119,125). The αN helix, α3-β5 loop, and the α4-β6 loop of Gα subunits 
were additionally confirmed as sites of GPCR-interaction by mutagenesis and alanine-
scanning (118,121,123).  
While Gγ has not been shown to directly interact with the rhodopsin intracellular 
face, farnesylation of a peptide corresponding to 12 residues of the Gγ C-terminus has 
been found to contribute to meta II stabilization, which in turn drives ordering of the 
unstructured peptide upon binding (129,130). 
 
Allosteric Mechanisms of Receptor-catalyzed GDP Release from Heterotrimeric G 
Proteins 
 
All three subunits of the heterotrimeric G protein have been shown to form 
contacts with the cytoplasmic surface of activated GPCRs. While the Gα C-terminus has 
been recognized as a major interaction site, the absence of any one subunit adversely 
affects receptor-catalyzed nucleotide exchange in the heterotrimeric G protein. Therefore, 
when formulating the mechanism of receptor-catalyzed G protein activation, 
contributions from each subunit of the heterotrimer must be considered. 
The α5 helix, found at the C-terminus of the Gα subunit, was previously shown in 
the x-ray crystal structure of the heterotrimeric G protein to form a direct connection 
from the major site of receptor interaction to the nucleotide-binding pocket in Gα (Figure 
7, 9) (2). Mutagenesis to introduce a glycine linker between the α5 helix of Gαi1 and its 
receptor binding C-terminus resulted in uncoupling of receptor binding and nucleotide 
exchange (131). This result led to a proposed mechanism of allosteric activation where 
receptor-induced perturbations of the α5 helix C-terminus destabilize nucleotide binding 
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using a rotation and translation of the α5 helix. Site-directed spin labeling (SDSL) and 
EPR of a recombinant Gαi1 subunit labeled at sites along the α5 helix identified that GDP 
release requires a receptor induced rotation and translation of the α5 helix (131). A 
recombinant Gαi1 double cysteine mutant I56C/Q333C that locks the α5 helix into the 
proposed receptor-bound conformation dramatically elevated nucleotide exchange in the 
absence of receptor and suggested that the α5 helix dipole is responsible for weakening 
stabilizing interactions between the bound nucleotide and the Gα (132).  
While extensive research has allowed description of how activated receptors 
manipulate protein conformations in the Gα subunit to exert allosteric control of their 
preferred nucleotide binding state, much less is understood about how receptor 
interactions with the Gβγ subunit contributes to nucleotide exchange in Gα. Historically, 
two major hypotheses have been proposed: the gear-shift model and the lever-arm model. 
In the gear-shift model, it has been proposed that the Gβ subunit rotates into the GTP-
binding domain of the Gα subunit, closing in on the Gα subunit, and providing the force 
necessary to push the helical domain away from the bound nucleotide, thus allowing 
GDP release. Mutagenesis experiments support this model of receptor-catalyzed 
activation of heterotrimeric G proteins (133,134). In the lever-arm model, nucleotide 
exchange is catalyzed by an activated receptor binding induced tilt of the βγ subunits 
relative to the α subunit (133,135). Specifically, the Gβγ dimer must interact with switch 
II connecting the helical domain of the α subunit to its GTPase domain, forming a lip that 
acts as an exit route for GDP when the tilt motion is induced. This allows the β subunit to 
act as a lever and opens the binding pocket for GDP release (133). This model was 
confirmed by engineering G proteins to mimic the tilted Gβγ conformation and 
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measuring the ability of mutant G proteins to regulate 2nd messenger production. EPR 
data showing flexibility in switch II at the Gα-Gβγ interface provides further support of 
this model (109,133). 
New insights into the mechanism of G protein activation were revealed by two 
recent crystal structures of activated β2-adrenergic receptor (β2AR). The first structure 
was that of the activated form of the receptor stabilized by llama antibodies termed 
nanobodies (52). The second structure was that of the activated receptor stabilized by its 
physiological signaling partner, the Gαsβγ heterotrimer (Gs) (53). Both structures 
exhibited conformational changes in transmembrane helices 5 and 6. The β2AR-Gs 
structure additionally confirmed the stabilizing effects of Gαβγ association on the 
agonist-bound state of the receptor and the presence of a translation of the α5 helix of Gα. 
Unanticipated observations revealed by the β2AR-Gs structure include ordering of 
intracellular loop 2 on β2AR, a lack of extensive contacts between the receptor and the 
Gβγ subunits of Gαsβγ, and a large displacement of the helical domain relative to the 
Ras-like GTPase domain of Gαs (Figure 10). These data, taken together, offer a possible 
mechanism for receptor-catalyzed GDP release from Gαβγ that is largely consistent with 
the models suggested by biochemical and structural data obtained thus far (136,137).  
 
Summary 
 The combined efforts of complementary biochemical, biophysical, and 
crystallographic studies have provided insight into the fundamentals of G protein 
activation. However, many of these findings inform on the endpoints, and much is yet to 
be understood about the transient features of the process.  These include the underlying 
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mechanism of allostery employed in G protein activation, and how the many dynamic 
events that have been described coordinate together to facilitate the process of nucleotide 
exchange. In addition, much is yet to be learned about the determinants of GPCR-G 
protein specificity, the extent of receptor dimerization and its influence on G protein 
activation, the role of post-translational modifications in the regulation of G protein 
signaling, and until very recently, very little was also known about the nucleotide-free 
state of the G protein. The inherently transient nature of GPCR-G protein complexes and 
limitations in in vitro techniques available for studying such systems are the primary 
barriers to studying such aspects of G protein function. However, recent advances in 
 
Figure 10. Overview of the β2-adrenergic-Gαsβγ Complex Structure. The structure of the β2-
adrenergic-Gαsβγ complex (PDBID: 3SN6 (1)) is shown with Gαs-stabilizing nanobody and the 
T4 lysozyme fusion protein removed for clarity. The α5 helix (orange) of the Gαs subunit 
(purple) is shown bound to the receptor (gray) and in close proximity to the receptor intracellular 
loop 2 (yellow). The Gβ (blue) and Gγ (green) subunits of the heterotrimeric G protein form 
expected contacts to Gαs, but lack extensive interaction with the receptor. 
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membrane protein biochemistry and structural biology have led to not only the successful 
determination of GPCR structures from 14 unique families over the last four years, but 
also the first ever structure of the receptor-bound G protein complex between the β2AR 
receptor and the Gs heterotrimer. While these events represent one of the biggest 
accomplishments in the study of receptor-mediated G protein regulation, it is important to 
continue working towards improving membrane protein technology and applying 
techniques that are presently available to the study of additional members of the GPCR 
and G protein superfamilies. In light of these recent advances, it is also important to 
revisit the results from previous studies and consider them in the context of such new 
structural and biophysical information. With this goal in mind, structural and biochemical 
studies such as those presented here attempt to contribute to the overall understanding of 
allostery in G protein function. 
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CHAPTER II 
 
MATERIALS 
 
Buffers and Salts 
ADA (Fluka 00307), Ammonium sulfite monohydrate (Sigma-Aldrich 358983), 
Aluminum chloride (Aldrich 563919), Bis-tris (Sigma B9754), EDTA (Sigma-Aldrich 
E5134), Ferric chloride (Aldrich 451649), HEPES sodium salt (Sigma-Aldrich H7006), 
Magnesium chloride hexahydrate (Sigma-Aldrich M2670), Magnesium sulfate (Sigma-
Aldrich M7506), MOPS (Sigma 69948), Potassium-sodium tartrate tetrahydrate (Sigma-
Aldrich 217255), Sodium chloride (Sigma Aldrich S7653), Sodium fluoride (Sigma 
Aldrich S7920), Sodium succinate dibasic (Sigma-Aldrich 14160), Sodium phosphate 
monobasic (Sigma-Aldrich S0751), Sodium tartrate dihydrate (Sigma-Aldrich 228729), 
Sucrose (Sigma S0389), Tris base (Sigma-Aldrich T4661), Urea (Sigma U5378). 
 
Detergents and Lipids 
The following detergents were purchased from Anatrace: DM (D322) DDM (D310), 
LDAO (D360), MNG-3 (NG310), OG (0311). The follow detergents and phospholipids 
were purchased from Avanti Polar Lipids: DHPC (850345P), DMPA (830845P), DMPC 
(850305P), DMPG (840445P), DMPS (840033P), DOPA (840875P), DOPS, 7.7 MAG 
(850530), 7.8 MAG (850531). Additional detergents and phospholipids: CHAPS (Sigma 
C3023), CHAPSO (Sigma C3649), Monoolein (NuChek Prep M-239).  
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Ligands 
 AMP-PnP (Sigma A2647), GDP (Sigma G7127), GTPγS (MP Biosciences 215903210), 
GTP (Sigma G8877), methyl-α-D-mannopyranoside (Sigma M6882). 
 
Resins and Columns 
Concanavalin A column (GE HealthScience 28-9520-85), HiTrap Blue HP sepharose 
(GE Life Sciences), Poros HQ50 column (Applied Biosystems 16817), Superdex 200 
GL10/300 GL column (GE Life Sciences), TALON Cobalt Resin (Clontech 635502).  
 
Miscellaneous 
Dithiothreitol (DTT) (Sigma 43815), Ethylene glycol (Sigma-Aldrich 32558), Glycerol 
(Sigma 65516), Hexadecyltrimethylammonium chloride (HTAC) (Fluka 52366), 
Isopropyl-β-D-thiogalactoside (IPTG) (Sigma I6758), Kanamycin A (Kan) (Research 
Products Inc K22000), β-mercaptoethanol (β-ME) (Aldrich M6250), Pefabloc 
(Centerchem Inc), PEG2000 (Fluka 81321), Phenylmethanesulfonyl fluoride (PMSF) 
(Sigma 78830).  
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CHAPTER III 
 
COUPLING EFFICIENCY OF RHODOPSIN AND TRANSDUCIN IN BICELLES 
 
Introduction 
Transient complexes between integral membrane receptors and their signaling 
partners mediate cellular responses to disparate signals and are of high biological 
importance. However, these complexes are challenging to study with in vitro biochemical 
methods, since purified receptors in detergent often have both reduced functional 
competence and lower affinity for their binding partners, as compared to receptors in 
native membranes. To help develop tools for the stabilization of membrane proteins with 
soluble signaling partners, we selected the GPCR rhodopsin and cognate G protein Gt as 
a model system. These proteins provide an ideal system for monitoring complex stability, 
since complex formation can be monitored spectrophotometrically.  
Rhodopsin is highly enriched in the rod outer segment (ROS) membranes of the 
retina and is responsible for low-light vision. Rhodopsin itself consists of the apoprotein 
(opsin) and the chromophore, 11-cis-retinal, which binds to Lys296 and acts as an inverse 
agonist (47). Absorption of a single photon photoisomerizes 11-cis-retinal to all trans- 
retinal (ATR), which is an agonist for rhodopsin. Subsequent conformational changes 
within rhodopsin are associated with conversion to the metarhodopsin II (MII) state, 
which is evidenced by a shift in the wavelength of maximum absorbance by rhodopsin 
from 500 nm to 380 nm (138,139). MII binds to the GDP-bound form of cognate 
heterotrimeric G protein, transducin (Gt-GDP), and catalyzes the release of GDP from the 
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Gαt subunit, which is the rate-determining step of the G protein signaling cycle. In this 
high-affinity, rhodopsin-Gt(empty) complex, the activated receptor is thought to stabilize 
the nucleotide-free form of the Gα subunit, which, in turn, stabilizes the agonist-activated, 
MII form of rhodopsin. As a result, spectrophotometric monitoring of the MII signal can 
be used to measure formation of the catalytically competent rhodopsin-Gt(empty) 
complex. 
Previous studies indicated that pH, temperature (140,141), and the presence of 
phospholipids (142-144) all influence the formation of the rhodopsin-Gt complex. 
Despite known dependence upon phospholipids, many biochemical assays investigating 
complex formation and G protein activation are conducted in detergent micelles that are 
relatively poor membrane substitutes for studying receptor signaling. Furthermore, the 
rhodopsin and Gt interaction is significantly disturbed when detergent solubilized 
rhodopsin is used in functional assays (143-145). Detergent micelles and native 
membranes differ in many of their physical properties including packing, curvature and 
charge distribution. Any of these factors may result in the observed decrease in Gt affinity 
for detergent-solubilized rhodopsin as compared to rhodopsin in rod outer segment 
membranes. Interestingly, the addition of phospholipids or fatty acids 
(phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine or docosahexaenoic 
acid) to detergent solubilized rhodopsin has been shown to increase the stability and 
protein-protein interaction capability of rhodopsin (143,146-148). While mixing 
exogenous phospholipids with detergent solubilized rhodopsin has improved protein-
protein interactions, the physical and structural properties of phospholipid-containing 
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micelles are heterogeneous, making the contributions from the above factors difficult to 
interpret. 
A number of artificial membrane models (149-154) might be used to investigate 
the underlying mechanism by which native membranes stabilize the rhodopsin-Gt(empty) 
complex. Bicelles offer distinct advantages over other artificial membrane models since 
they can be easily manipulated in solution and compared to other phospholipid bilayer 
systems such as nanodiscs, bicelles are easily prepared with a high yield. Additionally, 
bicelles do not interfere with the majority of biophysical measurements, and have been 
shown to increase the stability of purified GPCRs as compared to receptors solubilized in 
detergent (149). Furthermore, in the last decade, bicelles have been successfully used in 
crystallization, resulting in structures for bacteriorhodopsin (150), the β2-adrenergic 
receptor (151), xanthorhodopsin (152) and the mouse voltage dependent anion channel 
(153).  
Bicelle morphology (Figure 11) is hallmarked by a disc-like bilayer composed of 
long chain phospholipids that are capped by either short chain phospholipids or 
detergents (155). While bicelle structure is highly dependent on lipid composition, 
temperature, pH and hydration, their biochemical properties can be influenced by 
phospholipid-specific differences in chain lengths, saturation, and head groups (155-158). 
Previous studies have shown that negatively charged phospholipids such as DMPS, 
DMPG or DMPA can be mixed with neutral phospholipids to prepare negatively charged 
bicelles (158-161), which are useful for studying the effect of negatively charged 
phospholipids on the activity of membrane proteins. In this study, we used bicelles to 
investigate the effects of membrane morphology, temperature, pH, and surface charge 
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density on the rhodopsin-Gt(empty) complex. Our results demonstrate that charge density 
of the bilayer is important for the formation and stability of the high affinity complex.  
 
 
Figure 11: Bicelle Morphology and Composition. Bicelles are disc-like membrane structures 
composed of long-chain phospholipids and capped by either detergents or short-chained 
phospholipids. The radius of the disc is dependent on the long-chain phospholipid to detergent or 
short-chain phospholipid molar ratio (q ratio). The width of the bilayer is dependent on the acyl-
chain length of the long-chain phospholipid. In this study, all bicelles compositions were prepared 
in a 2.8:1 phospholipid:detergent molar ratio with 14:0 phospholipids comprising the bilayer. A) 
Neutral bicelles were composed of DMPC bilayers capped with 6:0 DHPC, CHAPS, or CHAPSO. 
B) Negatively charged bicelles were composed of 14:0 phospholipids mixed with DHPC (6:0) in 
a 2.8:1 ratio. The ratio of neutral to negatively charged phospholipids is indicated within the 
parentheses in the graph. Schematic representation of C) DMPS and D) DMPA phospholipids. 
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Methods 
Preparation of Urea Washed ROS Membranes 
Under dim red light conditions, ROS membranes were stripped with 7 M urea as 
described (162). Briefly, ROS membranes were washed twice with EDTA buffer (10 mM 
Tris-HCl, 1 mM EDTA, 1 mM DTT, pH 7.5) and once with urea buffer (10 mM Tris, 1 
mM EDTA, 1 mM DTT, 7 M Urea, pH 7.5). After the final wash, the membranes were 
resuspended in buffer A (10 mM MOPS, 200 mM NaCl, 2 mM MgCl2, 1 mM DTT, 100 
µM PMSF, pH 7.5) and aliquot stored at -80 °C.   
 
Purification of Rhodopsin 
Urea washed ROS membranes were solubilized in 50 mM Tris-HCl (pH 7.5) 
containing 100 mM NaCl and 20 mM DDM or 1% LDAO at 4 °C for 45 min. Insoluble 
material was removed by centrifugation at 20.000 x g for 1 hour at 4 °C. Detergent 
solubilized rhodopsin was purified by using Concanavalin-A chromatography as 
described (163). Briefly, the Concanavalin-A column was equilibrated with binding 
buffer (20 mM Tris-HCl, pH 7.4, 1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2, 250 mM 
NaCl, 1 mM DTT, 0.5 mM DDM) for 48 hours at a flow rate 0.3 ml/min. Detergent 
solubilized rhodopsin was loaded onto the column in a continuous loop for 4 hours. The 
column was then washed with binding buffer (10 column volumes) and bound protein 
was eluted with 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 500 mM methyl α-D-
mannoside and 0.5 mM DDM. Rhodopsin was concentrated using a 10 kDa cutoff 
concentrator and concentration of rhodopsin was determined by measuring the 
absorbance of rhodopsin at 500 nm before and after photo-bleaching. Molar extinction 
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coefficients of detergent solubilized rhodopsin and rhodopsin in ROS membrane were 
taken as 40.600 M−1 cm−1 and 42.000 M−1 cm−1, respectively. 
 
Transducin Purification 
Gt, was prepared as previously described (164). Briefly, ROS membranes were 
washed four times with isotonic buffer (5 mM Tris-HCl, 130 mM KCl, 0.6 mM MgCl2, 
1mM EDTA, 1 mM DTT, pH 8.0) and two times with hypotonic buffer (5 mM Tris-HCl, 
0.6 mM MgCl2 , 1mM EDTA, 1 mM DTT, pH 8.0). Membrane pellets were then washed 
twice with hypotonic buffer containing 0.1 mM GTP to release Gt from the membrane. 
Membranes were pelleted by centrifugation and the supernatant concentrated with a 10 
kDa cutoff concentrator. Protein samples were dialyzed against a 20 mM Tris-HCl, pH 
7.5, buffer containing 0.2 M NaCl, 10 µM GDP, 5 mM β-mercaptoethanol, 10% glycerol. 
Protein purity was assayed by SDS-PAGE, and protein concentration determined by 
Bradford assay (165).  
 
Nucleotide Exchange Assay 
Basal nucleotide exchange was determined by monitoring the intrinsic 
fluorescence (λex: 300nm, λem: 340 nm) of 500 nM Gt in 10 mM MOPS buffer containing 
130 mM NaCl, 1 mM MgCl2 pH 7.2 for 40 min at 15 °C after addition of 10 µM GTPγS 
(166). Receptor mediated nucleotide exchange was determined in the presence of 500 nM 
light activated rhodopsin with and without addition of the indicated bicelle mixture. For 
bicelle experiments, dark rhodopsin was incubated with bicelles in a lipid:protein ratio of 
64000:1 on ice for 45 min. before addition of Gt.  
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Extra Metarhodopsin II Stabilization and Decay Assay 
Stabilization of extra MII was assessed as described (164). Briefly, 10 µM urea 
washed ROS membranes (or detergent solubilized rhodopsin) were incubated on ice for 
15 minutes with 10 µM Gt. For bicelle experiments, detergent solubilized rhodopsin was 
incubated with the indicated bicelles in lipid:protein ratios ranging from 1600:1 to 
12800:1 (1-8% final phospholipid concentrations) on ice for 45 min, followed by addition 
of varying amounts of Gt. Absorbance by rhodopsin-G protein complexes was scanned 
from 350 to 650 nm both before and after light activation in 50 mM HEPES (at the 
indicated pH) containing 0.1 M NaCl, 1mM MgCl2, and 1mM DTT. In this assay, an 
initial dark-adapted spectrum was measured. Rhodopsin was then activated with a flash 
of light (activating only 10-15% of the rhodopsin). One minute after light activation a 
second, light adapted spectrum was collected. Rhodopsin absorption at 390 nm 
normalized to absorption data collected at 440 nm (the isosbestic point) was used to 
quantify MII formation. The extra MII signal was calculated as the difference between 
ΔA390 (light - dark) and ΔA440 (light - dark) (164,167-171). For determination of extra 
MII decay, dark adapted 10 µM rhodopsin was incubated on ice for 15 minutes with 10 
µM Gt (at this concentration over 90% of rhosdopsin was coupled with Gt according to 
our assay system). Then, the protein sample was completely photobleached for 10 
minutes under ambient light. Spectra for the bleached samples were measured every 20 
minutes over a course of 6 hours, and then again after 24 and 48 hours. After 48 hours, 
HCl  was added to a final concentration of 260 mM to protonate the retinal Schiff base in 
rhodopsin and liberate free retinal (164). The half lives of the samples were calculated by 
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fitting data to an exponential decay equation using GraphPad Prism v. 4.03 (GraphPad 
Software, San Diego, California). 
 
Bicelle Preparation 
Bicelles composed of saturated, long-chain (14:0) DMPC, DMPA, DMPG or 
DMPS and the detergents (6:0) DHPC, CHAPS, or CHAPSO were prepared as a 35% 
stock solution with a 2.8:1 lipid to detergent ratio (q ratio) using a procedure modified 
from (172). Neutral bicelles were composed of DMPC and DHPC, CHAPS, or CHAPSO 
to form DMPC:DHPC, DMPC:CHAPS, or DMPC:CHAPSO bicelles. Negatively 
charged bicelles were prepared by substituting a percentage of the total molar lipid 
content of the neutral bicelles with negatively charged DMPA, DMPG, or DMPS, while 
maintaining an overall 2.8:1 phospholipid to detergent ratio. The ratio of neutral to 
negatively charged phospholipids is indicated within the parentheses in Figure 1. A 
custom extrusion apparatus was used for mixing bicelles. The apparatus was constructed 
by connecting two 1 mL glass syringes with tubing capped with luer locks. To prepare a 
1mL, 35% stock of DMPC:DHPC bicelles, 282.50 mg DMPC was added to one syringe. 
337.5 µL of a 20% DHPC solution was mixed with 312.5 µL of water. 200 µL of the 
DHPC solution was then added to the syringe containing DMPC. The remaining DHPC 
solution was added to the other syringe. The bicelle mixtures were cycled through their 
phase transitions 4 times by incubating the entire apparatus at 4 °C and 55 °C. Bicelles 
were homogenized by extrusion after each incubation. Homogeneous bicelles were 
transferred into a microcentrifuge tube and centrifuged at 10.000 x g for 1 minute to 
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remove excess air bubbles. Correctly formed bicelles appeared clear at 4 °C and were 
stored at -20 °C. See Figure 11 for detailed information on the compositions prepared. 
 
Dynamic Light Scattering 
Dynamic light scattering measurements were collected at ambient temperatures 
(18-22 °C) using a DynaPro instrument (Protein Solutions, Inc). DDM detergent micelles, 
neutral bicelles, and negatively charged bicelles were prepared in a buffer containing 50 
mM HEPES pH 8.0, 100 mM NaCl, and 1 mM MgCl2. A 2 mg/mL Conalbumin protein 
standard was prepared in 50 mM HEPES pH 7.4. Scattering data reported are the 
averages of at least 25 scans with 3 independent experiments on 60 µL samples. Data 
were analyzed by Dynamics V5 software (Protein Solutions, Inc) and molecular 
translational diffusion coefficients, DT, were calculated by fitting the data to an 
exponential autocorrelation function generated by Dynamics V5. The hydrodynamic 
radius, Rh, was then calculated as a function of the experimental DT using the equation DT 
= kT/6πηRh, where k is the Boltzmann constant, T is the experimental temperature, and η 
is the solvent viscosity. Rh was calculated under the assumption that scattering particles 
conform to diffusion properties observed for globular proteins undergoing Brownian 
motion in an aqueous saline solution.  
 
Data Analysis 
Graphs and statistical analysis were performed using GraphPad Prism version 
4.03 (GraphPad Software, San Diego, California). 
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Results 
Formation of the Rhodopsin-Gt(empty) Complex in Detergent 
 While the formation of the rhodopsin-Gt(empty) complex in ROS membranes is 
relatively efficient, multiple groups have demonstrated a dramatically decreased yield of 
the complex when Gt is mixed with purified, detergent-solubilized rhodopsin 
(145,149,173). This result was recapitulated here with DDM. In our experimental setup, 
we took advantage of the ability of bound Gt to stabilize the activated MII state of 
rhodopsin, and monitored formation of the high affinity rhodopsin-Gt(empty) complex 
spectrophotometrically using the extra MII assay. As anticipated, we observed that the 
extra MII signal for DDM-solubilized rhodopsin was only 20.7 ± 1.2 % of the maximum 
signal observed for complex formation in ROS membranes (Figure 12), confirming the 
literature reports of inefficient complex formation in detergent (145,149,173).  
 
Formation of the Rhodopsin-Gt(empty) Complex in Bicelles 
Recent evidence supports a chemical role for phospholipids in formation of the 
rhodopsin-Gt(empty) complex (143,145); however, the influence of geometric constraints 
of the membrane bilayer has not previously been addressed. Unlike spherical micelles, 
bicelles mimic the morphology of phospholipid membranes [(Figure 11); (174,175)], and 
thus represent a suitable model system for testing the dependence of rhodopsin-Gt(empty) 
complex formation on membrane structure.  
Our first experiments used well-defined neutral bicelles composed of 
DMPC:DHPC, DMPC:CHAPS, and DMPC:CHAPSO at a final concentration of 8% 
(w/v) (157,160,174,176). In the presence of all three bicelle compositions, the observed 
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extra MII signal from the rhodopsin-Gt(empty) complex was greater than  it was in DDM 
(Figure 12) and reached at least 43.4 ± 7.3 % of the maximum signal observed for 
complex formation in ROS membranes.  
 
 
Figure 12: Neutral Bicelles Support Extra MII Sabilization. Normalized quantitation of extra 
metarhodopsin II in the absence or presence of neutral bicelles. The final concentration of bicelles 
was 8 %. Data were obtained at 4 °C and normalized to the extra-metarhodopsin signal measured 
in ROS membranes under the same conditions. Results are mean ± S.E.M. of three independent 
experiments (* p < 0.05; ** p < 0.01). 
 
ROS membranes contain both phosphatidylcholine (PC) and phosphatidylserine 
(PS) in a concentration of ~45% and ~15%, respectively (177-179). To assess the 
contribution of phosphatidylserine phospholipids to rhodopsin-Gt(empty) complex 
formation, we prepared bicelles doped with DMPS and capped by DHPC. In the initial 
trials, the molar ratio of DMPC to DMPS was fixed at 97:3 (PS (97:3) bicelles). In the 
presence of 8% PS (97:3) bicelles, the extra MII signal was 73.4% ± 15.6% of the extra 
MII signal observed in ROS membranes, essentially the same as that observed in the 
presence of DMPC:DHPC bicelles.    
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To test the effect of phosphatidylserine percentage in the bicelles on rhodopsin-
Gt(empty) complex formation, the ratio of DMPS to DMPC was increased such that the 
DMPC:DMPS ratios were 70:30 (PS (70:30) bicelles) and 50:50 [(PS (50:50) bicelles, 
Figure 11)]. This further increased the yield of extra MII signal (Figure 13A) as 
compared to DDM-solubilized rhodopsin, resulting in 79.5% ± 5.2% of the ROS 
membrane signal in the PS (70:30) bicelles, and 87.4% ± 10.5% of the ROS membrane 
signal in the PS (50:50) bicelles. These data suggest that the concentration of PS indeed 
contributes to formation of functional rhodopsin-Gt(empty) complexes (Figure 13A). 
Phosphatidylserine contains specific fatty acids and a negative charge associated 
with the head group. In GPCR signaling, non-specific electrostatic interactions between 
peripherally bound G proteins and the cell membrane influence the ability of the G 
protein to target to the membrane and guide its orientation on the membrane surface such 
that it is poised to interact with receptor (180-182). To deconvolute the contribution of 
chemical structure and negative charge that PS confers to the stabilization of the 
rhodopsin-Gt(empty) complex, we used bicelles containing negative charges from 
phosphatidic acid (PA). Although PA isn’t an abundant component of ROS membranes, 
it is important for regulation and regeneration of 11-cis retinal (183) and in the photo-
transduction pathway as a precursor in the regulation of diacylglycerol and 
phosphatidylinositol (184,185). The formation of the rhodopsin-Gt(empty) complex in 8% 
PA (97:3) bicelles was similar to that found in the presence of 8% PS (97:3) bicelles, and 
it wasn’t significantly different from that measured in the presence of neutral bicelles. 
Similar to PS (70:30) bicelles, complex formation in the presence of 8% PA (70:30) was 
also improved, increasing complex formation to 85.9% ± 4% of that measured for ROS 
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(Figure 13B). This suggests that the negative charge of the surface of the membrane 
bilayer is of greater importance to the stabilization of rhodopsin-Gt(empty) complex than 
any specific chemical component. The phase transition properties of PA (50:50) and all 
 
 
Figure 13: Anionic Lipid Enhances Extra MII Stabilization. Quantitation of extra-
metarhodopsin II in the presence of different negatively charged bicelles. Extra-metarhodopsin II 
was assessed in the presence of A) DMPS or B) DMPA containing bicelles. The ratio of neutral 
to negatively charged phospholipids, DMPC:DMPS (or DMPA), was 97:3, 70:30 or 50:50 in 
these bicelles. The final concentration of bicelles was 8%. The average lipid:rhodopsin ratio was 
12800:1. Data were collected at 4 °C and normalized to the extra-metarhodopsin signal measured 
in ROS membranes under the same conditions. Results are mean ± S.E.M. values of three 
independent experiments (* p < 0.05; ** p < 0.01; *** p < 0.001; NS, Not Significant). 
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bicelles containing negatively-charged phosphatidylglycerol precluded detection of extra 
MII formation because of difficulties in sample handling.  
Rhodopsin activation is also dependent on the receptor:lipid ratio (186-188). We 
evaluated the limiting concentration of total lipid, as well as the ratio of neutral to 
negatively charged lipids, required to stabilize extra MII formation. We decreased the 
concentrations of PS (70:30), PA (70:30), and PS (50:50) bicelles from 8% to 4%, and 
phospholipids were reduced from 2% to 1%, and we then assessed their ability to 
stabilize extra MII formation. The change in extra MII signal in the presence of 
decreasing total concentrations of PS (70:30), PS (50:50), and PA (70:30) phospholipids 
was not statistically significant between 8% and 1%  (Figure 14A). This suggests that 
total phospholipid concentration is not a determinant of rhodopsin-Gt(empty) complex 
formation in the context of our assay. 
To test the effect of different head groups in the negatively charged bicelle 
preparations on rhodopsin-Gt(empty) complex formation, PA and PS bicelles were mixed 
together to form a composition containing both PA and PS in the bicelle bilayer. The 
final concentration of negatively charged bicelles was 8% (4% PA + 4% PS bicelles). 
The yield of extra MII signal was further increased. We observed 94.3% ± 3.76 % of the 
ROS membrane signal in the presence of PA + PS (70:30) bicelles and 96.4% ± 3.50 % 
of the ROS membrane signal in the presence PA + PS (60:40). While not statistically 
significant, there was nevertheless a trend towards greater extra MII formation using a 
combination of PA and PS in bicelles, compared to bicelle preparations containing either 
PA or PS (Figure 14B).   
 44 
 
Figure 14: Complex Mixtures of Anionic Lipids in Bicelle Preparations. The effect of bicelle 
concentration on rhodopsin-Gt(empty) formation. A) The effect of varying concentrations of PS 
(70:30), PS (50:50) and PA (70:30) bicelles on rhodopsin-Gt(empty) complex formation. Final 
concentration of bicelles was decreased from 8% to 4% and phospholipids concentration 
decreased from 2% to 1% (with lipid:rhodopsin ratios of 12800:1 to 1600:1) as indicated in the 
graph. B) The effect of mixing PA and PS bicelles on rhodopsin-Gt(empty) formation. The final 
concentration of negatively charged bicelles was 8% (4% PA + 4% PS bicelles). The average 
lipid:rhodopsin ratio was 12800:1. The ratio of neutral to negatively charged phospholipids is 
indicated within parentheses in the graph. Data were collected at 4 °C and normalized to the 
extra-metarhodopsin signal measured in ROS membranes under the same conditions. Results are 
mean ± S.E.M. values of three independent experiments.  
 
Characterization of Negatively-charged Bicelles by Dynamic Light Scattering 
Since not much is known regarding the morphology of bicelles containing 
negatively charged lipids, we verified that the addition of the negatively charged lipids 
did not disrupt bicelle formation using dynamic light scattering techniques.  In neutral 
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bicelles, dynamic light scattering experiments (156,189,190), NMR (155,156,174,189) 
and atomic force microscopy (156) have been used to characterize bilayer properties. 
Hydrodynamic radii have been determined for DMPC:DHPC bicelles, and NMR studies 
have confirmed that their morphology exhibits a disc-like planar bilayer at concentrations 
of 3% and higher (174,189,191), while concentrations of DMPC:DHPC below 3% may 
be more indicative of a vesicular morphology (174). The presence of charged 
phospholipids has been shown to directly affect the physical properties of phospholipid 
membranes, but their effects on bicelle morphology and size are largely unknown 
(192,193). Dynamic light scattering (DLS) was performed to determine the homogeneity 
and molecular size of negatively charged bicelles compared to neutral bicelles (Figure 
15). All DLS measurements were performed between 18-22 °C. Although data collection 
at temperatures used in the functional experiments performed in this study (4 °C and 15 
°C) would have been ideal, technical limitations restricted these measurements to ambient 
temperatures. The calculated hydrodynamic radii derived from translational diffusion 
coefficients for scattering detergent micelles (190) and DMPC:DHPC bicelles were 
comparable to those previously reported (Figure 15) (189,191). Compared to neutral 
bicelles, negatively charged bicelles exhibited larger hydrodynamic radii in solution 
(Table 2). The hydrodynamic radii of 8% PA (70:30), PS (70:30), and PS (50:50) 
bicelles were determined to be 5.7 ± 0.1 nm, 5.4 ± 0.1 nm, and 5.4 ± 0.3 nm, respectively 
(Figure 15). Introducing heterogeneity into the negatively charged lipid content did not 
affect the bicelle size; 8% PA+PS (70:30), PA+PS (60:40) bicelles were determined to 
have hydrodynamic radii of 5.4 ± 0.1nm and 5.4 ± 0.1 nm, respectively (Figure 15). 
Consistent with previous studies on DMPC:DHPC bicelles (174), decreasing the bicelle 
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concentration below 3% dramatically affected their size. The hydrodynamic radii in the 
presence of a total lipid concentration of 2% for neutral or negatively charged 
compositions were over 12 nm, a size more typically observed in large vesicles, 
suggesting that the lipids no longer aggregate into disc-like bicelle membranes (Table 2) 
at ambient temperatures required for DLS measurements. While this may not be the case 
at lower temperatures used in our functional studies, we nevertheless chose to focus the 
remainder of our studies on complex formation in the 8% bicelle system, which maintain 
a disk like bicelle structure according to our DLS measurements. 
 
 
Figure 15: Dynamic Light Scattering Measurements on Negatively-charged Bicelles.  Data 
was collected on samples at final phospholipid concentrations of 2%, 4%, and 8% in solution. All 
samples were prepared in extra MII assay buffer (50 mM HEPES pH 8.0, 100 mM NaCl, 1 mM 
MgCl2). 2 mg/mL Conalbumin (75 kDa) and 0.5 mM DDM (70 kDa) were prepared as positive 
controls. Hydrodynamic radii were determined by Dynamics V5 software, with light scattering 
data collected at 18-22°C on a DynaPro detector. The ratio of neutral to negatively charged 
phospholipids is indicated within the parentheses in the graph. Results are are means ± S.E.M. of 
at least 25 scans with two independent experiments (* p < 0.05; ** p < 0.01; *** p < 0.001; NS, 
Not Significant). 
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Affinity of the Rhodopsin-Gt(empty) Complex in Bicelles 
Having identified bicelle compositions that allow the efficiency of rhodopsin-
Gt(empty) complex formation to approach that observed in ROS membranes, we next 
measured the affinity of this complex using the extra MII assay comparing ROS 
membranes, DDM detergent, and various bicelle compositions (Figure 16). Consistent 
with previous studies (164), the EC50 value of Gt for rhodopsin in ROS membranes was 
0.64 ± 0.09 µM (Table 3). As anticipated, DDM-solubilized rhodopsin exhibited a 
significant decrease in the affinity between rhodopsin and Gt, with an increased EC50 
 
Table 2: Dynamic Light Scattering Measurements of Negatively-charged Bicellesa 
Bicelle 
Composition 
DT  
(10-9cm2/s) Rh (nm) MW (kDa) 
PolyD 
(nm) % PolyD 
PolyD 
Index 
Conalbumin 659.9 3.8 74.4 0.8 21.4 0.1 
DDM 737.2 3.5 65.2 1.0 27.6 0.1 
2% DMPC:DHPC 198.6±14.9 10.3±1.1 816.8±207.2 2.6±0.8 25.5±8.0 0.1±0.1 
4% DMPC:DHPC 384.9±104.6 5.8±1.2 232.0±87.4 1.3±0.6 20.6±6.5 0.1±0.1 
8% DMPC:DHPC 641.4±28.3 3.3±0.1 55.6±2.2 0.3±0.1 8.1±4.1 0.0 
2% PS (70:30) 201.5±7.1 11.2±1.3 996.7±265.8 3.4±0.6 29.6±2.1 0.1±0.0 
4% PS (70:30) 307.8±13.9 6.8±0.1 292.3±12.7 1.1±0.1 16.5±2.0 0.0 
8% PS (70:30) 370.6±5.7 5.4±0.1 1721±3.5 0.7±0.2 13.2±2.7 0.0 
2% PA (70:30) 222.2±10.9 9.9±1.6 769.4±292.2 2.7±0.9 26.1±4.6 0.1±0.1 
4% PA (70:30) 327.2±18.2 6.7±0.4 290.6±42.1 1.7±0.1 26.5±3.7 0.1±0.1 
8% PA (70:30) 373.8±4.1 5.7±0.1 194.4±7.9 1.4±0.1 24±1.6 0.1 ± 0.1 
2% PS (50:50) 252.2±33.8 9.8±1.9 794±375.1 2.7±0.5 27.5±1.8 0.1±0.1 
4% PS (50:50) 279.6±21.6 7.4±0.3 369±31.2 1.1±0.3 15±3.4 0.0 
8% PS (50:50) 380±21.5 5.4±0.3 177.8±22.4 1.2±0.1 22.8±2.7 0.1±0.1 
2% PS+PA(70:30) 230.4±21.1 9.7±1.4 742.4±244. 2.7±0.6 26.5±2.6 0.1±0.1 
4% PS+PA(70:30) 297.0±15.9 7.3±0.3 350.2±31.0 1.6±0.1 21.6±0.7 0.1±0.1 
8% PS+PA(70:30) 387.5±6.1 5.4±0.1 171.7±5.9 1.4± 0.1 26.4±1.5 0.1±0.1 
2% PS+PA(60:40) 197.5±24.2 11.6±2.4 1188±574.7 3.0±1.0 24.2±3.5 0.1±0.1 
4% PS+PA(60:40) 309.9±17.6 6.8±0.3 300.5±33.9 1.6±0.2 23.6±3.9 0.1±0.1 
8% PS+PA(60:40) 386±3.4 5.4±0.1 171.4±1.7 1.5±0.1 28.7±1.3 0.1±0.1 
aAll bicelle samples were prepared in extra MII assay buffer (50 mM HEPES pH 8.0, 100 mM 
NaCl, 1 mM MgCl2). 2 mg/mL Conalbumin (75 kDa) and 0.5 mM DDM (70 kDa) were prepared 
as positive controls. Hydrodynamic radii were determined by Dynamics V5 software with light 
scattering data collected at 18-22 °C on a DynaPro detector. The final concentration of 
phospholipids was 2%, bicelles was 4 or 8%. The ratio of neutral to negatively charged 
phospholipids is indicated within the parentheses in the table. Results are means ± S.E.M. of at 
least 25 scans with three independent experiments. 
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value of 3.14 ± 0.05 µM (Table 3). Bicelle-solubilized rhodopsin exhibited an 
intermediate affinity for Gt. In the presence of either PA (70:30) or PS (70:30) bicelles, 
Gt had an EC50 value for rhodopsin of 1.08 ± 0.12 µM and 1.08 ± 0.09 µM, respectively. 
Increasing the negative charge density by using PS (50:50) bicelles did not alter this 
affinity (EC50 of 1.07 ± 0.07 µM). Heterogeneity of the negatively charged lipid content 
improved the affinity of Gt for rhodopsin, and the EC50 value decreased to 0.94 ± 0.05 
µM in the presence of PA+PS (70:30) bicelles. However, the affinity of Gt for rhodopsin 
was most comparable to that measured in ROS membranes in the presence of 
heterogeneous PA+PS (60:40) bicelles, where the EC50 value was 0.79 ± 0.05 µM. This  
suggests that variations in both phospholipid head group and charged density of bicelles 
affect the affinity between rhodopsin and Gt. 
 
 
Figure 16: Effect of Negatively-charged Bicelles on the Affinity of Gt for Rhodopsin. 
Concentration-response curves of MII signal stabilized by Gt in the presence of different mixtures 
of bicelles at a final concentration of 8 % (lipid:rhodopsin ratio of approximately 12800:1). The 
concentration-response curves were measured at 4 °C and curves are presented for (red) ROS, 
(empty red circle) ROS + 150 µM GTPγS, (grey) soluble rhodopsin (DDM), (light green) PS 
(70:30), (green) PS (50:50), (orange) PA (70:30), (light blue) PA+PS (70:30), (dark blue) PA+PS 
(60:40), (empty dark blue circle) PA+PS (60:40) + 150 µM GTPγS. Solid curves are best fits 
from a four parameter logistic equation. See Table 3 for estimated EC50 values. Results are mean 
± S.E.M. from of at least three independent experiments. 
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The rhodopsin-Gt(empty) complex rapidly disassociates when GTP binds to the 
empty nucleotide binding pocket, which is observed as a decrease in the extra MII signal. 
As a control for formation of functional complexes in bicelles, rhodopsin-Gt(empty) 
complexes from the previous experiment were incubated with excess GTPγS. As 
expected, a loss in the extra MII signal was observed (Figure 16, open circles), 
confirming that the rhodopsin-Gt complex was functional.  
 
Half-life of the Rhodopsin-Gt(empty) Complex in Bicelles 
 The half-life of rhodopsin-Gt(empty) in the presence of negatively charged 
bicelles was next measured as a function of extra MII decay over time and compared to 
the half-life of the complex in ROS membranes and DDM. The half-life of rhodopsin-
Gt(empty) was 0.63 ± 0.01 days in ROS membranes versus 0.07 ± 0.01 day in DDM 
Table 3. The affinity of Gt for Rhodopsin in the Presence or Absence of Bicellesa
 
aThe concentration response curves were measured at 4 °C in the presence of different amount of 
Gt. Final concentration of bicelle was 8% (lipid:rhodopsin ratio of approximately 12800:1). The 
ratio of neutral to negatively charged phospholipids is indicated with parenthesis in the table. The 
concentration-response curves were analyzed using a four parameter logistic equation. Results are 
mean ± S.E.M. values from at least three independent experiments. 
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micelles at pH 8.2 and 4°C. This confirms that detergent solubilization not only affects 
the formation efficiency of rhodopsin-Gt complexes, but also their stability. A remarkable 
increase in the half-life of rhodopsin-Gt(empty) complexes was observed in the presence 
of several bicelle compositions at pH 8.2 and 4°C (Figure 17A, Table 4). PA (70:30), PS 
(70:30), and PS (50:50) bicelles extended the half-life to 5.4 ± 0.2, 5.8 ± 0.3 and 5.8 ± 0.3 
 
 
 
Figure 17: Stability of Rhodopsin-Gt(empty) Complex in the Presence of Negatively-charged 
Bicelles. The effect of negatively charged bicelles on complex stability was evaluated at A) 4 °C 
and B) 15 °C. C) The effect of pH on complex stability at 4 °C (black bars) and at 15 °C (grey 
bars) in the presence of PA+PS (70:30) bicelles. Final concentrations of PA+PS (70:30) bicelles 
were held constant at 8% (lipid:rhodopsin ratio of approximately 12800:1). The ratio of neutral to 
negatively charged phospholipids is indicated within the parentheses in the graph. The half-life of 
extra MII signal was calculated by using an exponential decay equation. Results are mean ± 
S.E.M. values from at least three independent experiments (* p < 0.05; ** p < 0.01; *** p < 
0.001; NS, Not Significant). 
 
 
 
 51 
days, respectively. The half-life of the rhodopsin-Gt(empty) complex increased further to 
6.8 ± 0.3 days in PA+PS (70:30) bicelles and 7.0 ± 0.3 days for PA+PS (60:40) bicelles. 
This result was not surprising, because while not statistically significant, we did observe 
a trend towards greater extra MII formation using the mixture of negatively charged 
lipids, and over the time span of decay experiments, the mixture of negatively charged 
lipids were found to be significantly enhanced over that seen using either negatively 
charged lipid alone. As a control, we incubated the samples at the end of the decay 
experiments in GTPγS (Figure 18), confirming that rhodopsin and Gt are both functional 
and form a reversible complex within these bicelles. The differences observed in the 
affinity and stability experiments reflect differences between how these experiments are 
 
Table 4: The Rate of Extra MII Decay in the Presence of Negatively-charged 
Bicellesa 
 
aThe extra-metarhodopsin II decay was measured at 4 °C and 15 °C. The final concentration of 
each bicelle mixture is 8% (lipid:rhodopsin ratio of approximately 12800:1).  The ratio of neutral 
to negatively charged phospholipids is indicated within parentheses. The half life of extra MII 
signal was calculated using an exponential decay equation. Results are mean ± S.E.M. values 
from at least three independent experiments. 
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performed; while affinity assays roughly reflect EC50 values, stability assays are 
conducted using greater than EC90 values of Gt. Furthermore, affinity assays employ 
rhodopsin that is 10-15% bleached, versus 100% bleached rhodopsin used in decay 
assays. Nevertheless, both experiments provide important information regarding the 
affinity and stability of the rhodopsin-Gt(empty)complex.  
Since the MII state of rhodopsin is the physiologically relevant binding partner of 
Gt (141), stabilization of MII is likely to improve the half-life of the rhodopsin-Gt(empty) 
complex. Previous studies have demonstrated that temperature and pH influence the half-
 
 
Figure 18: Extra MII Decay Measured at 4 °C and pH 8.2.  To test Receptor-G protein 
coupling, we added excess GTPγS which terminates receptor-G protein interaction, and we 
measured this loss of coupling as the loss of the extra-MII signal. We added 150 µM GTPγS 48 
hours after starting from the decay experiment. Then, after 5 min. incubation with GTPγS, we 
measured extra-metarhodopsin signal again. The final bicelle concentration is 8%. Results are 
mean ± S.E.M. values of at least three independent experiments. 
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life of the rhodopsin-Gt complex (140,141,194), perhaps reflecting changes in stability of 
MII and/or changes in membrane fluidity and protein dynamics. Increasing the 
temperature decreased the half-life of the rhodopsin-Gt(empty) complexes formed in the 
presence of all compositions of bicelles tested by at least 1.5-fold, as compared to results 
obtained at 4 °C (Figure 17B, Table 4).  
The effect of bicelle concentration on the stability of rhodopsin-Gt(empty) 
complex was tested in the presence of both 2% phospholipids and 8% negatively charged 
bicelles at different temperatures. The half life of the rhodopsin-Gt(empty) complex was 
decreased when the concentration of phospholipids decreased from 8% to 2% (Figure 
19). This result, taken together with the DLS data, suggests that that membrane structure 
is an important factor for rhodopsin-Gt(empty) complex stability. 
 
 
Figure 19: Stability of Rhodopsin-Gt(empty) Complex in the Presence of Negatively-charged 
Bicelles. The effect of negatively charged bicelles on complex stability was evaluated at a) 4 °C 
and b) 15 °C. The final concentration of phospholipids was 2% (grey bars), bicelles was 8% 
(black bars). The lipid:rhodopsin ratio was approximately 12800:1. The ratio of neutral to 
negatively charged phospholipids is indicated within the parentheses in the graphs. The half-life 
of the extra MII signal was calculated by using an exponential decay equation. Results are mean 
± S.E.M. values from at least three independent experiments (* p < 0.05; ** p < 0.005). 
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The stability of rhodopsin-Gt(empty) complexes in PA+PS (70:30) bicelles was 
additionally tested for pH-dependence (Figure 7C). A decrease in pH from 8.2 to 6.5 at 4 
°C resulted in a 1.5 fold decrease in the complex half-life. This was much longer than the 
half-life of the complex in ROS membranes (164), suggesting that extra MII instability at 
pH 6.5 is not a property of extra MII only but of the native membrane environment. 
While increasing the pH from 8.2 to 9.0 at 4 °C had a negligible effect on stability 
(Figure 17C, black bars), increasing the temperature had a more pronounced effect. 
Increasing the temperature from 4 to 15 °C resulted in a nearly 1.5 fold decrease in the 
half-life of the complex, regardless of pH value tested (Figure 17C, grey bars).  
It is well established that the addition of excess ATR to rhodopsin can activate 
rhodopsin and stabilize the MII state (195,196). Accordingly, we measured the half-life 
of rhodopsin-Gt(empty) complex in the presence of 1.5 fold molar excess of ATR in both 
ROS and in a negatively charged phospholipid preparation. Not surprisingly, the half life 
of complex increased from 0.62 ± 0.01 to 0.97 ± 0.03 days at 4 °C in presence of ROS 
membranes, and in our 2% PA+PS (60:40) phospholipid preparation, addition of ATR 
increased the half life of the complexes to 4.0 ± 0.5 days at 15 °C. Lowering the 
temperature to 4 °C further extended the half life to 7.2 ± 0.2 days in this lipid 
preparation. These data are consistent with ATR’s ability to stabilize the rhodopsin-
Gt(empty) complex, similar to reported effects of ATR on MII stability.   
 
Receptor-catalyzed Nucleotide Exchange in the Presence of Bicelles 
 Previous studies have shown that the addition of phosphatidylcholine, 
phosphatidylserine or phosphatidylethanolamine exerts differential effects on receptor-
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catalyzed nucleotide exchange in the Gα subunit of the G protein, with Gt activation rates 
altered specifically by the presence of phosphatidylserine (145). To evaluate the effect of 
our optimized bicelle compositions on Gt function, the receptor-catalyzed nucleotide 
exchange rate was determined using an intrinsic tryptophan fluorescence assay (Figure 
20), which reflects the ability of an activated receptor to stimulate GDP-GTP exchange 
on the G protein. The nucleotide exchange rates in PA (70:30), PS (70:30), or PS (50:50) 
bicelles were similar to those observed in ROS membranes (Table 5). Additionally, 
heterogeneity of negatively charged bicelles enhanced rates of G protein activation. The 
nucleotide exchange rate in the presence of PA+PS (70:30) and PA+PS (60:40) were 
measured 4.62 ± 0.30 and 4.48 ± 0.51 (1/sec x 10-2), respectively (Figure 20, Table 5). 
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Figure 20: Intrinsic Fluorescence Changes in Gt. Basal or receptor mediated nucleotide 
exchange in Gt was measured in the presence or absence of different bicelles as described in the 
materials and methods section. Final bicelle concentration in each sample is 8% (lipid:rhodopsin 
ratio of approximately 12800:1). A) Basal or receptor mediated Trp211 fluorescence change of Gt. 
Fluorescence curves are presented for Gt in the presence of ROS (red), detergent solubilized 
rhodopsin (DDM) (teal), Gt alone (black), PS (70:30) (green dash), PS (50:50) (green), PA 
(70:30) (yellow), PA+PS (70:30) (orange), PA+PS (60:40) (blue). Data were collected at 21 °C 
for 40 min. B) Quantitation of the initial rates of basal or rhodopsin-catalyzed nucleotide 
exchange for Gt. The ratio of neutral to negatively charged phospholipids is indicated within the 
parentheses in the graph. Results are mean ± S.E.M. values of at least three independent 
experiments (* p < 0.05; ** p < 0.01; NS, Not Significant). 
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Table 5: Basal and Receptor-mediated Nucleotide Exchange Rates of Gt in the 
Presence of Different Bicellesa 
 
 aFinal concentration of bicelles was 8% (lipid:rhodopsin ratio of approximately 12800:1). The 
ratio of neutral to negatively charged phospholipids is indicated within parentheses.  The initial 
nucleotide exchange rates are shown in sec-1 x 10-2 for Gt. The exchange rate was determined by 
fitting the data to an exponential association equation Fλ = Fλmax(1-e-kt). Results are mean ± 
S.E.M. values from at least three independent experiments. 
 
 
Discussion 
Early studies on receptor-G protein coupling indicate that temperature, pH, and 
the presence of lipids each influence complex formation (140,141,143,194), but our 
understanding of the contribution of membrane lipids to complex stabilization has been 
limited to experiments performed in detergent micelles, mixed micelles, and other 
undefined lipid preparations. Findings in recent years have increased our appreciation of 
the importance of membrane morphology and composition on receptor structure and 
function. Unlike spherical detergent micelles, bicelles usually adopt a disk-like shape, 
which NMR studies indicate are similar in morphology to native membranes (155,174). 
Bicelles have also previously demonstrated an ability to support folding and thermal 
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stability of rhodopsin and opsin (149). Here, we investigated the formation and 
stabilization of a receptor-G protein complex by incorporating negatively charged 
phospholipids into a neutral bicelle preparation.  
Biochemical and biophysical studies have demonstrated that the lipid bilayer is 
important for the assembly, stability, and function of membrane proteins (197-199). In 
ROS membranes, rhodopsin is also surrounded by a specific phospholipid composition 
that likely facilitates visual transduction processes, and contain roughly ~2.5 % 
phosphatidylinositol, ~13% phosphatidylserine, ~41% phosphatidylethanolamine, ~45 % 
phosphatidylcholine (177-179). Since rhodopsin-Gt coupling is significantly less efficient 
in detergent micelles than in ROS membranes or neutral or negatively-charged bicelles, 
this specific lipid environment may contribute to visual signaling by optimizing the 
stability of this complex. Our studies confirm the previously observation that negatively 
charged lipids improve the efficiency of rhodopsin activation and G protein interaction 
(145,200-203). We have found that the overall charge of the specific bicelles influenced 
formation and stability of the high affinity receptor-G protein complex, likely through a 
combination of electrostatic and physical effects, as electrostatics are known to play a 
role in receptor-G protein interaction (180,181). In our experiments, increasing the 
density of negatively charged phospholipids in bicelles enhanced the complex formation, 
stability, and rates of receptor-mediated G protein activation, supporting a role for 
electrostatics in stabilizing optimal receptor-G protein coupling (180). The physical 
properties of bicelles most likely stabilize the receptor-G protein complex structure better 
than ROS membranes through enhanced G protein docking and membrane anchoring 
than what is available in the native lipid environment. Here we present evidence of 
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functional rhodopsin-Gt complexes in an artificial membrane environment that 
incorporates negatively charged phospholipids into a neutral bicelle.  
Bicelle morphology and phase properties are extremely sensitive to changes in 
temperature, phospholipid concentration in solution, and q ratio. In the case of neutral 
bicelles, decreasing the total concentration below a critical percentage results in 
formation of large unilamellar vesicles (174). In terms of neutral bicelles, decreasing final 
concentration of bicelles or increasing q ratios and temperatures is known to induce a 
phase transition from disc-like bicelles to an extended network of interconnected lipids 
called the perforated lamellar phase, or “swiss cheese”-like phase, characterized by high 
sample viscosity (157,174). Here we observed similar effects on bicelle morphology and 
phase properties. Hydrodynamic radii dramatically increased when the total phospholipid 
concentration was decreased to 2% at ambient temperatures, which suggests formation of 
large vesicles (174) at temperatures above those used in our functional studies. All 
compositions of negatively charged bicelles were temperature sensitive, and became 
highly viscous above 24°C, which is the phase transition temperature for DMPC (174). 
Interestingly, the stability of negatively charged bicelle phase, as assessed by color and 
fluidity, appeared to be the greatest at below 20°C.  
Lipids are known to be important for optimal function of many trans-membrane 
proteins. Disruption of the membrane phospholipid composition during protein 
purification can affect the folding of membrane proteins, and consequently, signaling 
capabilities. For example, changes in temperature can lead to increased phospholipid 
dynamics and membrane fluidity, which contribute to receptor destabilization. 
Temperature also has observable effects on bicelle properties, as changes in temperature 
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result in phase transitions. When the temperature is increased from 4 to 15 °C, we noted a 
decrease in the decay half-life of the complex in bicelles, consistent with results in other 
systems (140,204). Taken together, we suggest that bicelle preparations containing 
negatively charged phospholipids facilitate stabilization of receptor-G protein complexes, 
and this effect is most evident at lower temperatures, compatible with temperatures used 
in most functional studies.  
The metarhodopsin I/metarhodopsin II, (MI/MII) equilibrium of rhodopsin 
governs the productive coupling of receptor with G proteins, with coupling to MII being 
substantially more efficient (141). Knierim et al. showed that more than one proton is 
released from the MII state when rhodopsin binds to the C-terminal peptide of Gα (91). 
Sato et al. reached a similar conclusion using a computational approach, wherein an 
initial decrease in extra MII was predicted as the pH was raised, followed by an increase 
in extra MII at even higher pH’s. Similarly, we observe that increasing the pH from 6.2 to 
8.5 in the presence of negatively charged phospholipid compositions enhances the half-
life of the high affinity complex. These results suggest that negatively charged bicelles 
contribute to the stability of the complex by both enhancing MII formation, as well as 
facilitating the G protein orientation at the membrane necessary for productive 
interactions with receptors.  
Further studies are planned to determine the effect of bicelles containing other 
negatively charged phospholipids commonly found in membranes, such as 
phosphatidylinositols, on stability of the receptor-G protein complex. This study will 
include effects of varying acyl chain length and saturation of the phospholipids, which 
can have effects on both receptor activation and receptor-G protein coupling (146-
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148,205). While 14:0 fatty acids are not a major acyl chain constituent of lipids in ROS 
membranes, 14:0 lipids have been used successfully in other bicelle systems to stabilize 
receptor structure (150,151,153). The addition of cholesterol, as well as phospholipids 
which vary in head group size and charge, have also been shown to have effects on 
receptor-G protein interaction and G protein activation (143,145,206), suggesting this 
may be another factor requiring further study. 
 
Summary and Conclusions 
A highly complex lipid environment allows the adaptability and flexibility in 
membrane structure required for the cellular signaling. Our data demonstrate that 
rhodopsin-Gt interactions and G protein activation is strongly dependent on phospholipid 
composition and charge density. We developed an optimized system that included 
PA+PS (60:40) bicelles, which increased the half-life of the rhodopsin-Gt(empty) 
complex to one week. This system provides a powerful tool for the study of GPCR-G 
protein complexes, and the fundamental approaches described here may be applicable to 
other complexes between membrane proteins and their soluble signaling partners. 
 
 
This work was has been reprinted with permission from: 
Kaya, A.I., Thaker, T.M., Preininger, A.M., Iverson, T.M., and Hamm, H.E. (2011) 
Coupling Efficiency of Rhodopsin and Transducin in Bicelles. Biochemistry. 50(15): 
3193-3203. Copyright 2011 American Chemical Society. 
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CHAPTER IV 
 
CRYSTALLIZATION OF THE RHODOPSIN-TRANSDUCIN COMPLEX 
 
Introduction 
Rhodopsin represents a unique member of the GPCR superfamily of signaling 
proteins that has proven to be quite ideal for structural studies. Unlike many of the 800 or 
so additional receptors of the superfamily that exhibit basal activity related to multiple, 
conformationally diverse signaling states capable of engaging G proteins in the absence 
of receptor stimulation, the activation of rhodopsin is tightly regulated by its covalent 
ligand (70,71). In the absence of light, the inverse agonist, 11-cis retinal, locks rhodopsin 
into its inactive conformation.  Only when light is sensed and a photon is absorbed does 
rhodopsin transition to the activated state competent for binding intracellular 
heterotrimeric G proteins (92). This structural rigidity and specificity of interaction is a 
highly desirable feature for crystallization experiments that depend on conformational 
homogeneity to produce high-quality, isotropic crystals.  Indeed, this system was the first 
GPCR to have had its structure determined, and thus represents one of the best-
characterized receptors to date (207). Despite the amenability of the receptor and its 
cognate signaling partner, the heterotrimeric G protein transducin, to structural studies, 
there exists one last structural frontier in the rhodopsin-transducin system remaining to be 
explored: the nucleotide-free, high-affinity GCPR-G protein complex.  Successful 
determination of such a complex would provide critical insight into the specific 
mechanism of receptor-mediated allosteric G protein activation. 
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Recent advances in technology available for studying structure-function 
relationships in membrane proteins have paved the way for the successful crystallization 
of a number of GPCR structures, including the β2AR-Gs structure (70). While this latest 
structure has illuminated a number of interesting and surprising details of the receptor-G 
protein interaction, work on the nucleotide-free G protein state is not yet done.  Many 
questions still exist regarding the GPCR-G protein interaction. For example, determinants 
of GPCR-G protein specificity and the structural and sequence elements that contribute to 
the diverse range in nucleotide exchange rates observed in G proteins have yet to be fully 
understood (2,46,52,208). Related to these is also the question of how the allosteric 
mechanism of G protein activation differs among the various combinations of GPCR-G 
protein pairs. These questions can be answered by structural studies on additional 
nucleotide free states of receptor-bound G protein subtypes. Comparative analysis is a 
powerful tool for understanding how related proteins evolve to become unique entities. In 
GPCRs, the diversity of the receptor-G protein interaction necessitates multiple, separate 
studies investigating additional structure-function relationships. Given its homology to 
the Gi family of signaling G proteins, investigations into the transducin G protein system 
and its interactions with rhodopsin will provide further insights into general mechanisms 
of allosteric receptor-mediated G protein activation. 
As evidenced by the wealth of structural information available, rhodopsin is an 
excellent model system for investigations into the complexed state of GPCRs and G 
proteins. The rod cells of mammalian retina are highly enriched in the visual receptor.  In 
fact, purification of the receptor from an endogenous source such as bovine eyeballs can 
yield up to 80 mg of rhodopsin per every 200 retinas harvested.  Often bovine retinas can 
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be obtained for mere dollars from local slaughterhouses, whereas the expression systems 
employed for recombinant GPCR and G protein expression can cost upwards of 
thousands of dollars per mg of protein. Similarly, abundant amounts of transducin in its 
fully functional form can also be purified from the same source as rhodopsin. Thus, an 
optimized “expression system” is readily available for the visual transduction receptor-G 
protein pair. 
 A variety of technical approaches for determining membrane protein structures 
presently exist. Solubilization and structure determination of membrane proteins in 
detergent micelles predates all of the other techniques, and over 300 membrane protein 
structures have been determined using this approach. More recently, phospholipids and 
the in meso method of membrane protein crystallization have come into popularity. The 
utility of bicelles as a model membrane for structural work on membrane proteins was 
first made popular nearly two decades ago when it was discovered that they had the 
ability to magnetically align for solid and solution state NMR (155,209). The morphology 
of bicelles is disc-like, much like native membranes (Figure 11A, B), and spontaneously 
form in the presence of phospholipids mixed with amphiphiles or detergent (210).  Based 
on the ratio between phospholipid and detergent (q ratio), bicelles dimensions can be 
tightly controlled, thus rendering them an extremely versatile tool for studying dissimilar 
membrane proteins of all types. Perhaps the most impressive feature is the ability of 
membrane proteins to retain their native functions in phospholipid bicelles, whereas 
detergent micelles often cause proteins to lose their functionality (211,212). Crystal 
structures of the proton pump bacteriorhodopsin (172), xanthorhodopsin (152), the 
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voltage-dependent anion channel 1(153), rhomboid protease (213), and the GPCR β2-
adrenergic receptor (151) have all been determined in phospholipid bicelles. 
 Crystallization of membrane proteins in lipidic mesophases, or the lipidic cubic 
phase (LCP), was first introduced by Landau and Rosenbusch who demonstrated the 
ability of such a matrix to facilitate the formation of crystals of bacteriorhodopsin (214). 
Like bicelles, the cubic phase is marked by a native membrane-like morphology. This 
morphology is referred to as a lyotropic liquid crystal, and it consists of a curved lipid 
bilayer with a midplane that adopts cubic symmetry (215). In its crystalline form, the 
cubic mesophase forms aqueous and bilayer segments that are continuous in all three 
dimensions (Figure 21).  This bicontinous property has been found to promote type I 
crystal packing, which is marked by the formation of crystal contacts between both the 
polar and non-polar regions of membrane proteins, versus the singular polar contacts 
observed in type II crystal packing (216). Type I packing results in improved crystal 
order, and thus diffraction quality.  Caveats of membrane protein crystallization by the in 
meso method utilizing lipidic mesophases are the apparent curvature of the bilayer, which, 
like detergent micelles, can be deleterious to protein stability and the limitations, and the 
limited size of solvent channels permeating the bilayer which can make the crystallization 
of larger complexes difficult (217). However, extensive characterization and 
investigations into the physical properties of cubic phase lipids (218,219) have revealed a 
battery of reagents and precipitants, such as low molecular weight PEGS and non-volatile 
alcohols, that alleviate some of the membrane curvature and swell the solvent channels to 
produce a sponge phase for accommodating larger soluble domains such as the one 
associated with a GPCR-G protein complex. Notably, the field of GPCR structural 
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biology has had incredible success in determining structures from crystals grown in the 
lipidic cubic and sponge phases. Of the 119 structures determined by this method, 38 of 
these are of unique membrane proteins, and 17 are of GPCRs (Cherezov Group website). 
Using both phospholipid bicelles and the rapidly advancing LCP technology, 
structural studies on the rhodopsin-transducin complex were pursued.  The results from 
the preliminary characterizations presented in this chapter offer insights into determinants 
of not only GPCR-G protein stability, but also instability. This data hopefully forms the 
basis from which future structural studies on the rhodopsin-transducin system will be 
continued. 
 
 
Figure 21. Cartoon Representation of a Bicontinuous Lipidic Cubic Mesophase. Figure 
adapted from (215). 
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Methods 
Preparation of ROS Membranes 
All steps of the purification were performed on ice or at 4 °C. For preparation of 
dark-adapted ROS membranes, all steps were additionally performed under dim red light.  
Bovine retinas obtained from 200 bovine eyes were used for each purification batch. 
Retinas were thawed on ice and diluted to a final volume of 200 mL in a 30% Sucrose 
Solution (30% w/v sucrose, 90 mM KCl, 30 mM NaCl, 2 mM MgCl2, 10 mM MOPS, 0.1 
mM EDTA, pH 8.0, 1 mM DTT, 50 µM PMSF). The retina slurry was stirred for 1 hr at 
4 °C to separate the outer segments from the rod cell inner segments and basolateral 
membrane.  The retina slurry was then evenly distributed into eight Oak Ridge centrifuge 
tubes and centrifuged for 4 minutes at 4°C in a Sorvall SS-34 rotor at 4,000 rpm. The 
supernatant from the spin step was set aside on ice while the cell pellet was resuspended 
with a small volume of 30% Sucrose Solution. The centrifugation step was then repeated 
for the resuspended pellets by centrifugating at 4°C for 4 minutes in a Sorvall SS-34 rotor 
at 6,000 rpm. The supernatants from both centrifugation cycles were pooled and the cell 
pellets discarded. The pooled supernatant was evenly distributed into Oak Ridge 
centrifuge tubes and centrifuged for 20 minutes at 4°C in a Sorvall SS-34 rotor at 19,000 
rpm. The supernatant was then discarded and the cell pellets resuspended with 1 mL of 
26% Sucrose Solution (26% w/v sucrose, 90 mM KCl, 30 mM NaCl, 2 mM MgCl2, 10 
mM MOPS, 0.1 mM EDTA, pH 8.0, 1 mM DTT, 50 µM PMSF) for every two pellets.  
The resuspended pellet slurry was pooled and set aside on ice while sucrose gradients 
were prepared.   
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 The sucrose gradients consisted of three separate solutions: Gradient Solution 1 
(0.84 M sucrose, 10 mM MOPS, 60 mM KCl, 30 mM NaCl, and 2 mM MgCl2), Gradient 
Solution 2 (1.0 M sucrose, 10 mM MOPS, 60 mM KCl, 30 mM NaCl, and 2 mM MgCl2), 
and Gradient Solution 3 (1.14 M sucrose, 10 mM MOPS, 60 mM KCl, 30 mM NaCl, and 
2 mM MgCl2).  Each gradient was prepared by layering 7 mL each of the Sucrose 
Gradient Solutions in six 36 mL Sorvall AH629 swinging bucket centrifuge tubes (or 
similar). A large needle or pipette was used to carefully layer Sucrose Solution 1 on the 
bottom of each centrifuge tube.  Sucrose Solution 2 was dispended into the tubes by 
inserting the pipette tip containing the solution through Sucrose Solution 1 and touching 
the bottom of the centrifuge tube. Dispensing Sucrose Solution 2 in this manner will 
cause Sucrose Solution 1 to rise. Using the same technique, Sucrose Solution 3 was 
dispensed below Sucrose Solution 2. Dispensing Sucrose Solution 3 will cause Sucrose 
Solutions 1 and 2 to rise. The final order of the solutions was Sucrose Solution 3 on the 
bottom, Sucrose Solution 2 in the middle, and Sucrose Solution 1 on top.  
Once the sucrose gradients were prepared, the pellet slurry was carefully layered 
on top of each tube, balanced with 26% Sucrose Solution, and centrifuged at 4°C for 30 
minutes in a Sorvall AH-629 swinging bucket rotor at 25,000 rpm. This step of the 
protocol resulted in a gradient separation of the slurry components with each gradient 
adopting various degrees of opacity. The bottom layer was somewhat clear, the next layer 
was orange, and the top layer, again, was clear. The orange layer in the center contained 
the ROS membranes and was carefully recovered.  The pooled ROS membrane layers 
were distributed evenly into Oak Ridge centrifuge tubes and centrifuged for 20 minutes at 
4 °C in a Sorvall SS-34 rotor at 19,000 to pellet the ROS membranes. The supernatant 
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from this spin step was discarded and each membrane pellet washed with 1 mL of freshly 
prepared Isolation Buffer (90 mM KCl, 30 mM NaCl, 2 mM MgCl2, 10 mM MOPS, 0.1 
mM EDTA, pH 8.0) containing 2.5 µg/mL Pepstatin, 10 µg/mL Aprotinin, and 10 µg/mL 
Leupeptin. Resuspended membranes were thoroughly homogenized by vigorously 
pipetting and transferred to a 15 mL conical tube. The final volume of the ROS 
membrane homogenate was adjusted to 15 mL with Isolation Buffer and the conical tube 
carefully wrapped in aluminum foil for storage at -80 °C. 
 
Preparation of Urea-washed ROS Membranes 
All steps were performed under dim red light and on ice or at 4°C. Dark-adapted 
ROS membranes prepared as previously described were thawed and transferred to a glass 
dounce homogenizer embedded in ice. The homogenizer was then partially filled with 
EDTA Buffer (10 mM Tris-Cl, 1 mM EDTA, 1 mM DTT, pH 7.5) and the ROS 
membranes gently homogenized to facilitate separation of peripheral proteins from the 
rhodopsin-enriched membranes. The homogenate was then transferred to Oak Ridge 
tubes and centrifuged for 30 minutes in a Ti-70 rotor at 30,000 rpm. Supernatant from the 
centrifugation step was then discarded and each pellet resuspended with 1 mL EDTA 
Buffer. The resuspended pellets were pooled and homogenized again in EDTA Buffer to 
further wash the membranes. The homogenate was then transferred into ultracentrifuge 
tubes and centrifuged again for 30 minutes in a Ti-70 rotor at 30,000 rpm. Following the 
second centrifugation step, the supernatant was discarded and each cell pellet 
resuspended with 1 mL of Urea Buffer (10 mM Tris-Cl, 1 mM EDTA, 1 mM DTT, 6 M 
urea, pH 7.5). The pellet resuspension was then homogenized in Urea Buffer. Membranes 
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were pelleted by centrifugation for 30 minutes in a Ti-70 rotor at 45,000. To remove 
excess urea, the membrane pellets were resuspended with Buffer A (10 mM MOPS pH 
7.5, 2 mM MgCl2, 200 mM NaCl, 1 mM DTT, 0.1 mM PMSF) and further homogenized. 
The homogenate was then centrifuged for 30 minutes in a Ti-70 rotor at 30,000 rpm to 
again pellet the membranes.  Following this final spin step, the supernatant was discarded 
and each pellet resuspended with 1 mL of Buffer A. The concentration of rhodopsin was 
determined by measuring the absorbance of an aliquot of membranes diluted 25-fold with 
20 mM HTAC at 500 nm before and after photobleaching. The difference in the 
absorbance and a molar extinction coefficient of 42,000 M-1cm-1 were then used to 
calculate the rhodopsin concentration using Beer’s Law (220). The dark-adapted, urea-
washed ROS membranes were stored at -80°C as 100 µL aliquots in black opaque 
microcentrifuge tubes or wrapped in foil. 
 
Purification of Rhodopsin by Concanavalin A Affinity Chromatography 
All steps were performed under dim red light and on ice or at 4°C. Approximately 
400 µL of dark-adapted ROS membranes were thawed and resuspended with an equal 
volume of ConA Binding Buffer (20 mM Tris-Cl pH 7.4, 250 mM NaCl, 1 mM MgCl2, 1 
mM CaCl2, 1 mM MnCl2). The membranes were then pelleted by centrifugation for 25 
minutes at top speed (20,000×g) in a benchtop Eppendorf Centrifuge. The supernatant 
was discarded and the membrane pellet resuspended with 400 µL Rhodopsin 
Solubilization Buffer (20 mM Tris-Cl pH 7.4, 250 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 
1 mM MnCl2, 80 mM DDM (SOL-grade)). The resuspension was mixed by pipetting 
until no longer cloudy. The membranes were then incubated on ice and mixed by 
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pipetting every 15 minutes for 45 minutes to fully extract rhodopsin from the native ROS 
membranes and solubilize into DDM detergent micelles. After 45 minutes, the 
solubilized protein was again centrifuged for 25 minutes at top speed in a benchtop 
Eppendorf Centrifuge. The supernatant was then carefully collected and remaining pellet 
discarded. 
To further purify detergent-solubilized rhodopsin, a light-protected “ConA 
Purification Hutch” was first assembled in a 4°C environment to protect the purification 
apparatus from light. The hutch contained a clamp stand for securing a ConA Sepharose 
column, a peristaltic pump, and a tube rack for holding samples (see Figure 22). A 30 
mL syringe was carefully attached to the top of a 1 mL ConA column and 10 mL of 
Wash Buffer 1 (20 mM Tris-Cl pH 7.4, 250 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 
mM MnCl2, 0.5 mM DDM (Anagrade)) eluted over the column to wash off the ethanol-
containing storage buffer in which the column was packed. The column was then 
equilibrated with 30 mL of Wash Buffer 1 in a continuous loop using a peristaltic pump 
flowing at 0.3 mL/min for at least 48 hours.  
Once the ConA column had been sufficiently equilibrated, the detergent-extracted 
rhodopsin was diluted to 10 mL with ConA Binding Buffer (20 mM Tris-Cl pH 7.4, 250 
mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2) and loaded onto the equilibrated 
ConA column. The protein load fraction was flowed over the column in a continuous 
loop 0.3 mL/min for at least 4 hours.  The load fraction was then eluted and the column 
washed with 10 mL of Wash Buffer 1, 5 mL of Wash Buffer 2 (20 mM Tris-Cl pH 7.4, 
100 mM NaCl, 0.5 mM DDM (Anagrade), pH 7.4), 50 mL of Elution Buffer 1 (20 mM 
Tris-Cl pH 7.4, 100 mM NaCl, 0.5 mM DDM (Anagrade), 400 mM α-DM, pH 7.4), and 
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5 mL of Elution Buffer 2 (20 mM Tris-Cl pH 7.4, 100 mM NaCl, 0.5 mM DDM 
(Anagrade), 500 mM sucrose, pH 7.4).  Fractions from the Elution Buffer 1 and Elution 
Buffer 2 wash steps contained rhodopsin and were pooled. The pooled eluent was 
concentrated by centrifugation in a dark-adapted 10 kDa molecular weight cutoff Amicon 
concentrator at 4°C at 1,600 rcf(max) in 20 minute intervals until the total volume 
reached approximately 2 mL. The concentrated sample was then diluted to 50 mL with 
Extra Meta II Exchange Buffer and subject to rounds of serial centrifugation at 4°C and 
 
Figure 22: Concanavalin A Affinity Purification Hutch. A simple cardboard box lined with 
aluminum foil and sealable flaps is sufficient for creating a dark-adapted environment for conA 
purification of rhodopsin. Box 1 highlights the 1 mL ConA Sepharose Column (GE Healthcare) 
attached to a 30 mL syringe. Both are held to a ring stand with a standard clamp. Box 2 shows the 
peristaltic pump with two leads, one of which remains connected to the bottom end of the ConA 
Sepharose Column. Depending on the requirement of the protocol, the second lead can either rest 
in a collection tube (Box 3) or can be secured in place inside of the syringe (Box 1) for flowing 
solutions over the column in a continuous loop (i.e. while loading the column with rhodopsin or 
while pre-equilibrating the column with detergent). A photograph of the hutch and appartus 
shown as a schematic in A) is shown in B). 
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1,600 rcf(max) in 20 minute intervals. The protein sample was concentrated to a final 
volume of  ~200-500 µL and stored on ice until further use. The rhodopsin concentration 
was again determined by measuring the absorbance at 500 nm as previously described 
(220). For detergent-solubilized rhodopsin, however, the molecular extinction coefficient 
used was 40,600 M-1cm-1. 
 
Preparation of Transducin 
The rhodopsin-transducin complex was purified from light-adapted bovine ROS 
membranes prepared as previously described. Membranes were then washed four times 
with Isotonic Buffer (5 mM Tris-Cl, 130 mM KCl, 0.6 mM MgCl2, 1 mM EDTA, 1 mM 
DTT, pH 8.0) and two times with Hypotonic Buffer (5 mM Tris-Cl, 0.6 mM MgCl2, 1 
mM EDTA, 1 mM DTT, pH 8.0). Transducin was released into the supernatant by 
resuspending ROS membrane pellets with Hypotonic Buffer containing 0.1 mM GTP. 
The membranes were pelleted by centrifugation and the supernatant containing 
transducin was dialyzed against Transducin Storage Buffer (20 mM Tris-Cl, 200 mM 
NaCl, 10 µM GDP, 5 mM β-ME, 10% glycerol, pH 7.5).  Purified transducin was stored 
at -80°C. 
 
Preparation of Gβγ 
Gβγ was purified as previously described with slight modification (221). Purified 
transducin was first incubated with 40 mM MgSO4 to dissociate the Gαt and Gβ1γ1 
subunits. The protein was then loaded onto a HiTrap Blue HP sepharose column and the 
Gβγ fraction eluted in the flow-through in Buffer C (10 mM Tris-Cl pH 7.5, 150 mM 
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NaCl, 20 mM MgSO4, 1 mM EDTA, 10% glycerol, 5 mM βME). Eluted protein was 
concentrated in a 10 kDa Amicon concentration at 4 °C at 1,600 rcf(max) and buffer 
exchanged into  Gβγ Storage Buffer (10 mM Tris-Cl pH 7.5, 100 mM NaCl, 5 mM βME, 
10% glycerol). Purified protein was stored at -80°C.   
 
Extra Meta II Assay 
The formation of extra metarhodopsin II (meta II) in ROS membranes was 
measured on an Aminco DW2000 spectrophotometer in the presence of increasing 
concentrations of G protein. Heterotrimeric G protein was reconstituted from purified 
wild-type or K345L Gαi1 in the same manner as used for receptor-mediated nucleotide 
exchange measurements. 2 μM of rhodopsin in dark-adapted urea-washed ROS 
membranes were incubated with varying concentrations of wild-type or K345L Gαi1β1γ1 
in meta II buffer (50 mM HEPES, 100 mM NaCl, 1 mM MgCl2, 1 mM DTT, pH 8.0) on 
ice for approximately 10 min. Absorption spectra for both dark and light-adapted samples 
were then collected at 4°C. Following collection of a dark-adapted spectrum, samples 
were exposed to 2 quick flashes of light approximately 30 s apart. The light-adapted 
spectrum was then immediately collected. The extra meta II signal was calculated as the 
change in meta II formation (difference between absorption at 390 nm and 440 nm) upon 
light activation. Dose response curves were generated by nonlinear regression using a 
sigmoidal dose-response (variable slope) equation as previously described (222). 
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Preparation of Phospholipid Bicelles 
Bicelles composed of saturated, long-chain (14:0) DMPC, DMPA, DMPG or 
DMPS and the detergents (6:0) DHPC, CHAPS, or CHAPSO were prepared as a 35% 
stock solution with a 2.8:1 lipid to detergent ratio (q ratio) using a procedure modified 
from (172). Neutral bicelles were composed of DMPC and DHPC, CHAPS, or CHAPSO 
to form DMPC:DHPC, DMPC:CHAPS, or DMPC:CHAPSO bicelles. Negatively 
charged bicelles were prepared by substituting a percentage of the total molar lipid 
content of the neutral bicelles with negatively charged DMPA, DMPG, or DMPS, while 
maintaining an overall 2.8:1 phospholipid to detergent ratio. The ratio of neutral to 
negatively charged phospholipids is indicated within the parentheses in Figure 11B. A 
custom extrusion apparatus was used for mixing bicelles. The apparatus was constructed 
by connecting two 1 mL glass syringes with tubing capped with luer locks. To prepare a 
1mL, 35% stock of DMPC:DHPC bicelles, 282.50 mg DMPC was added to one syringe. 
337.5 µL of a 20% DHPC solution was mixed with 312.5 µL of water. 200 µL of the 
DHPC solution was then added to the syringe containing DMPC. The remaining DHPC 
solution was added to the other syringe. The bicelle mixtures were cycled through their 
phase transitions 4 times by incubating the entire apparatus at 4 °C and 55 °C. Bicelles 
were homogenized by extrusion after each incubation. Homogeneous bicelles were 
transferred into a microcentrifuge tube and centrifuged at 10,000 x g for 1 minute to 
remove excess air bubbles. Correctly formed bicelles appeared clear at 4 °C and were 
stored at -20 °C. 
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Preparation of Negatively-charged Cubic Lipids 
The majority of in meso crystallization experiments utilize cis-monounsaturated 
fatty acids. The most commonly used lipid is the monoacylglycerol, monoolein (MO), 
also known as 9.9 MAG. A simplistic view of MAGs can be described as a head attached 
to a neck separated from its tail by a cis double bond. The glycerol head group forms the 
head connected by an ester linkage to the region of the following acyl chain forming the 
neck.  The remaining portion of the acyl chain extending beyond the cis double bond is 
the tail. The total number of carbons in the neck and tail are denoted in the MAG notation. 
Thus, 9.9 MAG consists of an 18-carbon acyl chain where 9 carbons belong to the neck 
and 9 carbons belong to the tail. Additional MAGs screened in the crystallization of 
RhoGt included 7.7 MAG and 7.8 MAG consisting of 14 and 15 carbon acyl chains 
(Table 6), respectively.  These cubic lipids were purchased from NuCheck prep 
(monoolein) or Avanti Polar Lipids (7.7 MAG and 7.8 MAG). The latter was received as 
a powder, thus the protocol for preparing LCP host lipids supplemented with DOPS 
negatively charged phosopholipid was slightly different for the two sets of MAG. 
 
Table 6: LCP Host Lipid Compositions Screened for RhoGt Crystallization 
Host Lipid % Hydration Temperature (°C) Drop Size (nL) 
Monoolein 40% 20 50 + 800 
Monoolein + 5% DOPS 40% 20 50 + 800 
7.7 MAG 50% 20 50 + 800 
7.7 MAG + 5% DOPS 50% 20 50 + 800 
7.8 MAG + 5% DOPS 40% 20 50 + 800 
 
DOPS at a final concentration of 5 mol% was selected based on findings that this 
concentration was sufficient to stabilize the appropriate cubic phase for in meso 
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crystallization (223). For MO containing 5 mol% DOPS we first melted the frozen MO at 
55°C to return the lipid to its viscous, molten phase.  While MO was melting, the 
appropriate amount of DOPS needed for a stock containing 5 mol% DOPS was measured.  
Using the density of MO (0.895 g/mL), the volume of MO required for a stock containing 
95 mol% MO was calculated and mixed with the DOPS in an opaque glass vial.  For the 
powder MAGs, the amount of lipid needed for 95 mol% stocks was determined using the 
molecular weight and the necessary amounted needed weighed with an analytical balance.  
Both the MAG and DOPS were then mixed together in a sample vial. Methanol was then 
added to the mixtures to fully dissolve the lipids in one another and dried in a vacuum 
desiccator or by vacufuge to evaporate the excess methanol. If dried in a vacuum 
dessicator, leave the sample tube covered in a thin foil punctured with three or 4 holes to 
allow the methanol to evaporate.  The incubation time for methanol evaporation by 
vacufuge depends on the speed and model of the instrument, and should be determined 
empirically.  Though, 10-20 minutes is a good approximation for the time it will take for 
a 200 µL stock dissolved with 200 µL of methanol.  Once dried, gently run a slow stream 
of nitrogen over the vial to evaporate any residual methanol.  Prepared samples can be 
capped and stored at -20°C until ready for use in crystallization experiments.  The 
protocol described by Caffrey and Cherezov (216) was used during sample preparation. 
Briefly, three parts melted cubic lipids (at 55°C) were mixed with two parts protein 
sample gently brought to room temperature. This was done by transferring the 
appropriate amount of cubic lipid to one gas-tight syringe attached to a custom coupler 
fitted with an 18-guage extrusion channel. The protein sample was transferred to a second 
gas-tight syringe.  Being sure to expunge both syringes of excess air, and using a wet 
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connection, both syringes were connected to the coupler and sample extruded until 
optically clear.  This process can be time consuming, but under the correct conditions, 
will most likely be obtained withing 100- to 200- manual cycles of extrusion.   Once in 
the mesophase, the sample can be dispended for crystallization trials using the Zinsser 
Xantus LCP robot. Excess sample, if stable, can be stored at 20°C and under 60% 
humidity to maintain the phase most amenable to crystallization. 
 
RhoGt Crystallization Trials 
Rhodopsin and transducin were extracted from bovine retinas as previously 
described. For crystallization, proteins were used as is or further purified to homogeneity 
by affinity chromatography and/or size exclusion chromatography to isolate homogenous 
populations of the receptor-G protein complex for crystallization.   
RhoGt complexes were reconstituted using 1) rhodopsin in urea-washed native 
ROS membranes or 2) ConA-purified, detergent-solublized rhodopsin extracted from 
urea-washed ROS membranes. Proteins where then mixed in stoichiometric ratios and 
incubated on ice for at least 30 minutes under dark-adapted conditions prior to light 
activation for inducing complex formation.  Both proteins were quantified by the 
bicinchoninic acid assay (BCA assay) to determine the precise amounts of each sample 
needed for either 1:1 or 2:1 Rho:Gt complex formation.  
For RhoGt complexes reconstituted using rhodopsin in native ROS membranes, 
dark-adapted membranes were first pelleted by centrifugation at 18,000 x g in a benchtop 
microcentrifuge for 30-45 minutes. Supernatant was discarded and membrane pellet 
resuspended in ROS buffer (50 mM Hepes pH 8.0, 100 mM NaCl, 1 mM MgCl2) and 
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subject to another round of centrifugation to remove any residual urea.  Rhodopsin in 
membranes resuspended in ROS buffer after the second round of centrifugation was 
quantified by determining absorbance at 500 nm, mixed in equimolar amounts with Gt to 
reconstitute the RhoGt complex, and samples immediately dispensed into crystallization 
trials following light activation by exposure to ambient light.   
For ConA-purified rhodopsin extracted from urea-washed ROS membranes 
(protocol as previously described), purified protein was quantified, mixed in equimolar 
amounts with Gt, light activated under ambient light, and immediately passed over a 
Superdex S200 10/300GL column equilibrated with a minimum of 2 column volumes of 
RhoGt buffer (50 mM Hepes pH 8.0, 100 mM NaCl, 1 mM MgCl2, 40 µM all-trans 
retinal (ATR)) supplemented with Anagrade quality detergent at a final concentration of 
1.5-2X over the CMC value. Protein was collected from peaks corresponding to 
homogeneous populations, concentrated in 30 kDa cutoff concentrations, and 
immediately used for crystallization trials in either phospholipid bicelles or by the in 
meso method using cubic lipids.  Concentrations of the purified complex used in 
crystallization trials varied between 2-10 mg/mL of total protein, as measured by the 
BCA assay.  
Crystallization screening was performed for purified RhoGt exchanged into a 
number of different bicelle compositions (Table 7) or LCP host lipids (Table 6). LCP 
host lipid compositions were prepared as previously described (216,223). Crystallization 
conditions for RhoGt in native membranes and bicelle-solubilized RhoGt were screened 
in duplicate at 4°C and 18-20°C.  LCP crystallization trials were all performed at 20°C.  
Purified samples of RhoGt were highly sensitive to freeze-thaw cycles, thus excess 
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amounts of the purified complex were discarded. Figure 23 summarizes the primary 
experimental approach used here for RhoGt structure determination.  
 
 
 
Figure 23. Experimental Approach for Crystallization and Structure Determination of the 
Rhodopsin-Transducin GPCR-G protein Complex.  A two-pronged approach was utilized for 
screening RhoGt crystallization conditions. First, 1) Endogenous rhodopsin and transducin 
extracted from bovine retinas were purified to homogeneity. 2) Dark-adapted rhodopsin was 
purified by Concanavalin A chromatography under dim red light. 3) Transducin was purified to 
homogeneity by a 2-step purification utilizing sucrose gradient centrifugation to separated G 
protein from the components of the ROS membranes harvested from bovine retina, followed by 
further separation of aggregate by size exclusion chromatography. 4) Separately purified proteins 
were mixed in vitro, light activated to form the high affinity complex, purified by a second size 
exclusion step, and either directly solubilized into phospholipid bicelles for 5) bicelle-mediated 
crystallization (Table 7) or 6) mixed with LCP host lipids (Table 6) for LCP crystallization.  
 
Table 7: Bicelle Compositions Screened for RhoGt Crystallization 
Bicelle Composition Temperature (°C) Drop Size (nL) 
2% PS+PA (70:30) 4, 18-20 400 + 400 
4% PS+PA (70:30) 4, 18-20 400 + 400 
8% PS+PA (70:30) 4, 18-20 400 + 400 
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Results 
Rhodopsin Monodispersity in Detergent Micelles 
A critical step in the primary experimental approach to crystallizing the RhoGt 
complex called for rhodopsin extraction from native urea-washed ROS membranes and 
solubilization in detergent. Membrane protein stability varies widely in the presence of 
different detergents, and identifying a suitable detergent system is an important 
component in membrane protein structural studies.  Thus, the stability of rhodopsin was 
screened in a number of common, nonionic detergents by monitoring changes in 
mondispersity using size exclusion chromatography. Monodispersity was assessed at 
three wavelengths corresponding to distinct activation states of the receptor: 280 nm 
(total protein), 340 nm (meta I), and 380 nm (meta II).  Of the five detergents screened, 
none appeared to produce a singular, Gaussian peak suggestive of a homogenous 
population of protein (Figure 24).  However, DDM and LDAO appeared promising, such 
that the peaks corresponding to meta II absorption constituted a majority of the the total 
populations observed. 
 
Meta II Stability in DDM and LDAO 
 The meta II assay was used to quantify the stability of rhodopsin in DDM and 
LDAO. In this assay, productive coupling between receptor and G protein reinforces the 
meta II state, which engages the G protein in a high affinity interaction.  Thus, the extent 
of meta II formation can be used to assess receptor and complex stability.  The meta II 
signal in the presence of DDM was nearly twice of that observed for LDAO-solubilized 
rhodopsin (Figure 25). 
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Figure 24. Rhodopsin Stability in Detergent Micelles.  A Superdex 200 10/300 GL column 
was equilibrated with two column volumes of RhoGt buffer containing A) 0.02% DDM, B) 
0.02% MNG-3, C) 1% OG, D) 0.2% DM, and E) 0.1% LDAO. Rhodopsin was extracted from 
native ROS membranes by incubating with a solution containing one of each of these detergents 
at a concentration 40-fold higher than their respective CMC values. This detergent-solubilized 
sample was then loaded onto the column and the elution profile monitored. The black trace 
corresponds to absorption at 280 nm (total protein). The blue trace corresponds to the 340 nm 
wavelength (meta I), and the red trace represents the 380 nm (meta II) wavelength. 
  
 The apparent stability of rhodopsin in the presence of DDM did not inform on the 
on the half-life of the complex, thus a multi-angle light scattering experiment coupled to 
size exclusion chromatography (SEC-MALS) was performed. This experiment revealed 
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that the majority of the complex, unsurprisingly, existed in its dissociated state, as shown 
by the presence of multiple peaks (Figure 26) eluted over the time course of the 
experiment.  The elution profiles of each of the peaks corresponded to a RhoGt complex 
(peak 1), free heterotrimer (peak 2), and free rhodopsin (peak 3).   
 
 
Figure 26. SEC-MALS Profile of DDM-solubilized RhoGt Complexes. DDM-solubilized 
rhodopsin was mixed with transudcin and loaded onto an Superdex S200 10/300 GL column 
equilibrated in RhoGt buffer containing 0.025 mM DDM. Each peak corresponds to a different 
population of protein.  Based on the elution volume and differential refractive index, which is a 
function of molecular size, peak 1 corresponds to RhoGt, peak 2 corresponds to free heterotrimer, 
and peak 3 corresponds to free rhodopsin. The majority of the complex eluted in its dissociated 
state. 
 
Figure 25. Comparison of Extra Meta II Signals in the Presence of DDM or LDAO.  Results 
shown represent the mean ± S.E.M. for three independent experiments performed on each 
sample. 
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RhoGt Crystallization in Phospholipid Bicelles 
 
The limited stability of rhodopsin-transducin complexes in detergent micelles 
presents a significant barrier to structural studies of the GPCR-G protein complex.  A 
number of factors likely contribute to the instability and range from unfavorable 
detergent-protein interactions resulting in precipitation, membrane-curvature induced 
destabilization of the protein-protein interaction, and even instability imposed by the loss 
of lateral pressure applied from a bilayer-like environment.  Fortunately, phospholipid 
bicelles represent a tractable membrane mimetic for stabilizing receptor-G protein 
complexes such as rhodopsin-transducin (211). Further, a number of membrane protein 
structures, including those of GPCRs (151,224), have been successfully determined in 
phospholipid bicelles Thus, attempts to crystallize the RhoGt complex were initially 
focused on bicelle-solubilized receptor.  Negatively-charged bicelles were shown to be 
especially amenable to RhoGt complex formation and could extend the half-life of the 
activated complex to nearly one week (211). Bicelle sample preparation is described in 
the Methods sections of Chapter II and in Chapter III.  Selection of the bicelle 
compositions used for crystallization was based on the results of a dynamic light 
scattering study characterizing the physical properties of each composition (211). In this 
study, the hydrodynamic radii were calculated as a function of the diffusion translation 
coefficient (Figure 27). Homogenous phospholipid structures with small variations in 
their average radii were selected for crystallization screening. Using two approaches for 
purifying the stable RhoGt complex (Figure 28), crystallization trials were then 
performed for bicelle-stabilized protein samples of the rhodopsin-transducin complex. 
The compositions screened are listed in Table 7. A number of promising preliminary 
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crystallization conditions were identified for RhoGt complexes solubilized in various 
negatively-charged bicelle compositions. A 70:30 mixture of neutral DMPC and the 
negatively charged DMPA and DMPS phospholipids (PS+PA(70:30)) was quite 
favorable for producing crystals.  Some of these conditions are shown in Figure 29. 
Although initial crystals were readily obtained, their overall quality was quite 
poor and attempts at reproduction and optimization were rather unsuccessful. The best 
attempt at optimization yielded broom-like crystals (Figure 29A) for which diffraction 
was limited to approximately 12 Å (Figure 29B, C).   
 
 
Figure 27: Phospholipid Composition Characterization by Dynamic Light Scattering. The 
hydrodynamic radii are plotted for neutral and negatively charged phospholipid compositions. 
Final concentrations of each composition in solution ranged from 2-8%. Results shown are the 
mean ± S.E.M. values of at least three independent experiments. 
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Figure 29. Preliminary Crystals of Bicelle-solubilized RhoGt.  The following crystals were 
obtained for protein samples mixed with A-B) 2% PS+PA (70:30) and C-D) 2% PS+PA (70:30) 
supplemented with ATR. 
 
Figure 28: Optimization of RhoGt Purification for Crystallization in Phospholipid Bicelles. 
The protocol outlined in Scheme 1 takes advantage of the resolving power of size exclusion 
chromatography and Superdex columns for isolating homogenous populations of protein for 
crystallization trials.  The protocol presented in Scheme 2 bypasses additional rhodopsin 
purification in order to take advantage of the stabilizing effects of native lipids on the rhodopsin-
transducin interaction for crystallization. 
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Figure 30. Sample Diffraction from Crystals Grown in the Presence of 2% PS+PA(70:30) 
Bicelles. Crystals were grown by the hanging drop method. Well solution (1 µL) containing 50 
mM Sodium Acetate pH 4.5, 1.26M (NH4)2SO4, and 200 mM NaCl was mixed with 1 µL of 5-7 
mg/mL protein in 50 mM HEPES pH 8.0, 100 mM NaCl, 1 mM MgCl2, 0.5 mM DDM, 40 µM 
all-trans retinal, and 2% PA+PS(70:30) bicelles. 
 
 
RhoGt Crystallization by the in meso Method 
 LCP crystallization, or the in meso method, has become an increasingly powerful 
tool for membrane protein crystallization (215). Like bicelles, this method also provides a 
lipid bilayer similar to the native cell membrane in which proteins are stabilized.  The 
added benefit of this approach is the bicontinuous nature of the membrane that facilitates 
classically difficult packing interactions between membrane proteins that promote 
diffraction to higher resolution than has been typically observed in macromolecular 
membrane protein crystallography (214). The high-throughput nature of the technique is 
especially attractive for systems limited by their expression or purification yields. Thus, 
crystallization of the RhoGt complex by the in meso method was attempted. Like 
phospholipid bicelles, LCP host lipids can be readily supplemented with additives that 
contribute properties of the native membrane environment, such as cholesterol and charge 
(223).  Given the influence of the electrostatic environment on RhoGt complex formation, 
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negatively charged phospholipids compatible with cubic host lipids were also screened in 
LCP crystallization trials (Table 6). 
 The chemical space sampled for LCP crystallization trials was much more defined 
than for other techniques. Volatiles that facilitate lipid solubilization were eliminated 
from all screens. This included most alcohols. Further, the PEG classes screened were 
limited to PEG400 and PEG4000. The former has been shown to stabilize the cubic phase 
and acts as a swelling agent to increase the size of the solvent channels permeating the 
bicontinuous membranes to facilitate protein diffusion, which is especially amenable to 
the crystallization of larger receptor complexes with soluble domains such as those of 
GPCR-G protein complexes (216).   
 The availability of a high-magnification microscope with the capacity to image 
UV fluorescence in addition to cross-polarized light greatly facilitated the screening 
process and allowed for the identification of microcrystal formation such as that shown in 
Figure 31. Under regular light, crystals appeared invisible to the naked eye (Figure 31A; 
left). The polarized image (Figure 31A; right), revealed the presence of microcrystals, 
which were subsequently successfully optimized and adopted a morphology that 
appeared quite promising (Figure 31B). 
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Figure 31. Microcrystals of RhoGt Obtained by the in meso Method. A) Initial morphology 
of RhoGt crystals obtained from 7.8 MAG + 5% DOPS.  RhoGt (4 mg/mL) was mixed in a 60:40 
v/v ratio with 7.8 MAG + 5% DOPS.  A 50 nL bolus of the lipid/protein mixture was bathed in a 
solution (500 nL) consisiting of 50 mM Acetate pH 4.5, 0.2 M CaCl2, and 15% PEG400. B) The 
optimized crystals were obtained 50 mM Acetate pH 4.5, 0.2 M CaCl2, and 35% PEG400. 
 
Despite the striking morphology of the optimized crystals, diffraction data proved 
that the quality of the crystals was worse than that observed for RhoGt crystallized in 
bicelles.  Even the use of a microfocus beam (GMCAT ID-21) was unsuccessful at 
producing isotropic data of sufficient quality and resolution for determining a structure.   
 
Conclusions 
 Phospholipid bicelles stabilization of RhoGt complexes was highly successful for 
in vitro biochemical characterizations and allowed for investigations of global features of 
the transient interaction between rhodopsin and transducin. Structural studies, however, 
were less successful in the presence of phospholipid bicelles.  Inspection of the crystals 
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and the conditions from which they were obtained revealed a propensity for the formation 
of bicelle crystals depleted of protein, or at the least, containing very little protein.  
Interestingly, the addition of ATR as a means for extending the half-life of the complex 
appeared to facilitate formation of empty bicelle crystals. This was deduced from a series 
of negative controls on a number of different phospholipid compositions. Because the 
biochemical properties suggest a favorable environment for the receptor, the inability to 
crystallize the complex is likely due to some inherent, endogenous feature of these 
proteins. 
 While the rhodopsin-transducin system is an attractive GPCR-G protein system 
for structural studies because of its ease of purification, abundance in native membranes, 
and the lack of basal activity in the receptor, other features of the native complex may 
just be the limiting factor in obtaining the crystal structure of this highly coveted G 
protein state.  Endogenous mammalian proteins such as rhodopsin and transducin come 
with post-translational modifications, which are very well characterized in both proteins.  
In this study, these modifications were left unaltered and crystallization trials were 
performed in their presence.  Crystallization of the transducin heterotrimer (43) required 
proteolytic digest of such moieties, as did the structure of β2AR-Gs (1).  Heterogeneous 
distribution of post-translational modifications, which actually facilitate purification of 
rhodopsin, may have formed a barrier to the reproduction and optimization of 
crystallization conditions. Future crystallization attempts might require that this feature of 
the native proteins be addressed.  
Biochemical studies were performed at concentrations significantly below those 
used for structural studies where G protein stability is likely uncompromised. Despite 
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being able to obtain highly pure, homogenous samples of activated RhoGt, the limited 
ability to concentrate RhoGt samples above 15 mg/mL is likely a deterrent to crystal 
formation in both bicelle crystallization and the LCP method of membrane protein 
crystallization.  Other GPCR crystals were grown using protein concentrations in excess 
of 50 mg/mL (225). While rhodopsin can be substantially concentrated in the absence of 
G protein, the addition of its cognate signaling partner caused significant precipitation at 
high concentrations of protein.  This is likely due to some instability imposed on the G 
protein by the protein or buffer environment. It is also possible that the post-translational 
modifications themselves are what limit transducin solubility.   
 Differential scanning fluorimetery for measuring protein thermostability would be 
a useful experiment for identifying conditions that contribute to transducin stability and 
those that contribute to its instability. In this way, one can contribute to the optimization 
of crystallization conditions by screening protein buffers. While extensive effort was 
placed on screening detergents, purification methods, crystallization temperatures, and 
bilayer properties, less attention was given to the effect of buffer composition in this 
study. This is a common technique used in macromolecular crystallography for 
improving the diffraction quality of crystals, and the RhoGt system would likely benefit 
from similar treatment (226). 
 While the current protocol for obtaining rhodopsin from retinas using urea 
washing is a highly efficient method for obtaining large quantities of >90% pure receptor, 
there is some concern that the presence of the urea negatively alters the receptor and 
contributes to its heterogeneity.  Further, any residual urea that may stick to the protein or 
the membranes could further disrupt the stability of the RhoGt interaction. A purification 
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protocol developed by Okada et al. utilizing Zn2+ precipitation of the receptor is a 
feasible alternative to the current protocol and has been shown to also be highly effective 
at isolating pure receptor (227).  Further, crystallization of rhodopsin purified in this 
manner improved the quality of rhodopsin crystals (3). Recently, both protocols were 
used to purify phosphorylated rhodopsin. Comparison of the results from each revealed a 
significant difference in the monodispersity of the receptor as assessed by size exclusion 
chromatography (unpublished data, Qiuyen Chen). The purity and monodispersity of the 
receptor was significantly improved for rhodopsin purified by Zn2+ precipitation.  Further, 
this alternative protocol eliminated the need for the time-consuming secondary ConA 
purification step, which significantly decreases the total handling time of the receptor and 
likely results in better quality protein for crystallization trials. Given this information, it 
would be worthwhile to revisit the method of rhodopsin purification from bovine retina. 
 Lastly, in light of recent structural and biophysical characterizations, we now 
know the extent to which the Gα helical domain facilitates receptor-mediated nucleotide 
exchange in G proteins. Computational, biophysical, and structural studies have revealed 
significant conformational changes that accompany receptor binding.  Flexible protein 
regions have often prevented crystallization of even polar soluble proteins. In the context 
of a large, hydrophobic, and unstable signaling complex, the dynamic nature of the 
helical domain most likely interferes with isotropic crystal packing that is necessary for 
x-ray diffraction. Indeed, a stabilizing “nanobody” used to determine the structure of the 
β2AR-Gs complex formed a plug between the GTPase and helical domains of the Gαs 
subunit in the structure.  A similar “antagonist” against G protein activation that stabilizes 
the receptor-bound conformation of Gαt and limits the flexibility of the helical domain 
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will most likely be extremely advantageous to structural studies of the rhodopsin-
transducin complex. 
 
 
This work was has been adapted with permission from: 
Thaker, T.M., Kaya A.I., Preininger, A.M., Hamm, H.E., Iverson, T.M.  (2012) 
Allosteric Mechanisms of G protein-Coupled Receptor Signaling: A Structural 
Perspective. Methods in Molecular Biology. 796: 133-74. 
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CHAPTER V 
 
CROSSTALK BETWEEN ALLOSTERIC NETWORKS INVOLVED IN THE 
ACTIVATION OF Gαi1 
 
Introduction 
Heterotrimeric G proteins, Gαβγ, function as molecular switches to elicit cellular 
responses (100).  In the Gα subunit, the signaling activity is regulated by the identity of 
bound guanine nucleotide. Structural studies demonstrated that in the Gα subunit, the 
nucleotide identity is encoded in the conformations of three distinct loops termed Switch 
I, Switch II, and Switch III adjacent to the nucleotide-binding site (4,13,43,55) (Figure 
32A). For example, crystal structures of the GDP-bound Gαi1 subunit in the absence of 
the Gβγ subunits lacked interpretable electron density in Switches II and III, suggesting 
that these are disordered (2,4). In contrast, crystal structures of Gαi1 bound to the GTP 
analogs, GDP-AlF4- and GTPγS, demonstrated that the Switch regions adopt ordered 
conformations (4,13,40,43,55) that are proposed to be important for mediating protein-
protein interactions with downstream effectors (17,228). Co-structures of Gα with 
adenylyl cyclase or GRK2 (53,229) have indeed revealed that Switch II composes a part 
of these effector-binding sites.  
G protein coupled receptor (GPCRs) are key for converting the Gα subunit from 
its GDP- to GTP-bound forms and thus activating it for interaction with effectors 
regulation, as first identified from investigations of β2-adrenergic receptor signaling in rat 
liver cells (19,20,23,28). Subsequent studies into photoreceptor activation and 
phosphodiesterase regulation in retinal disc membranes showed a direct interaction 
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between rhodopsin and its cognate G protein, transducin, catalyzed the exchange of GDP 
for GTP in the Gαt subunit (32,34,230). Receptor-mediated GDP release has since been 
demonstrated to be the rate-limiting step of G protein activation (22,231). Biochemical, 
kinetic, and structural characterizations of Gα have been used to identify the sequence 
and structural elements of Gα that interact with receptor in order to propose a mechanism 
for guanine nucleotide exchange in the Gα subunit. For example, the Gα N-terminus 
 
Figure 32: Overview of Structural and Functional Motifs of Gαi1. Functional elements of Gαi1 
are shown mapped onto the structure of GTPγS-bound K345L Gαi1. The GTPase and helical 
domains are labeled. The location of the K345L mutation on the α5 helix is highlighted with a 
blue circle. The N-terminus is truncated and only density following residue 32 is resolved in the 
structure shown. A) Conformations of the P-loop (purple) and Switch regions (SI, SII, SIII; gold) 
around the bound nucleotide. B) View rotated 180˚ to highlight the α1/α5 interaction and the β6-
α5 loop orientation relative to GTP.  
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(123-125,128,232), the α4-β6 loop (118-120,233-235), the α3-β5 loop (121), and the C-
terminus of Gα (128) have all been shown to mediate receptor-G protein interactions. 
Crystal structures of heterotrimeric G protein complexes have revealed that these regions 
formed a contiguous surface approximately 30 Å from the nucleotide-binding site 
(1,2,46,52).  
Of the many receptor-interacting elements of Gα, perhaps the best studied is the 
Gα C-terminus. The importance of this Gα region in receptor-mediated nucleotide 
exchange was first revealed through interaction mapping using peptide mimetics of 
various regions of the G protein (128). In this study, changes in metarhodopsin II (meta 
II) formation upon binding of either transducin or a peptide derived from residues 340-
350 of the Gαt C-terminus were monitored to determine the relative receptor affinities 
(128). Meta II is one of the activated states of rhodopsin and when in the meta II state, 
rhodopsin has high affinity for cognate G protein. Interestingly, competent G protein can 
stabilize the meta II state and conversely, meta II bound to G protein can stabilize the 
nucleotide-free state of Gα. The peptide corresponding to the C-terminus of Gα competed 
with transducin in binding rhodopsin and contributed to the stability of meta II (128) 
suggesting that C-terminal peptides of Gα could act as mimetics of the intact protein for 
stabilizing activated GPCRs. Further investigation using combinatorial libraries of 
peptide mimetics of the Gαt C-terminus containing systematic sequence substitutions 
identified mutations that resulted in peptides with improved affinity for rhodopsin over 
the parent sequence (236). Indeed a near 300-fold improvement in affinity was associated 
with a substitution in the peptide equivalent to a lysine to leucine substitution in the intact 
protein (K341L) (236). Similarly, the peptide mimetic of the Gαi1 C-terminus containing 
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the equivalent K345L mutation exhibited nearly two orders of magnitude improvement in 
affinity over peptide with the wild-type sequence (222).  This enhanced affinity was 
important for stabilization of opsin and rhodopsin in activated forms for structure 
determination (80-82,237). Herrmann et al. examined the effects of a subset of the 
affinity-enhancing mutations in intact G proteins comprised of Gβ1γ1 and recombinant 
Gαi1 engineered to express the C-terminal sequence of Gαt (238). Surprisingly, the 
K341L mutation on the chimeric Gαt/αi1 protein background did not significantly improve 
the affinity for receptor as compared to the wild-type Gαt sequence (238). One possibility 
that was not considered at the time is the potential influence such a mutation may have on 
the assembly of allosteric networks within Gα that communicate receptor recognition 
events into a nucleotide exchange response. 
Complementary biophysical and structural experiments strongly suggest that the 
C terminus of the Gα subunit drives allosteric guanine nucleotide exchange in the Gα 
subunit. Specifically, these studies have focused on the α5 helix, an extension of the Gα 
C-terminus that forms a direct connection from the receptor-binding surface of the G 
protein to its nucleotide-binding pocket. For example, site-directed spin labeling (SDSL) 
combined with electron paramagnetic resonance (EPR) spectroscopy measurements 
(131,239) revealed unique changes in both mobility and solvent accessibility of various 
spin label modifications along the α5 helix upon receptor activation (131). These changes 
were attributed to a rigid-body rotation and translation motion adopted by the helix. 
Uncoupling of this motion from receptor interactions by the insertion of a glycine linker 
into the α5 helix abolished nucleotide exchange within Gαi1 (131,240). In complementary 
studies, cysteine mutagenesis stabilizing the position of the α5 helix in an activated 
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conformation demonstrated a dramatic increase in nucleotide exchange in the absence of 
receptor and suggested that the α5 helix dipole could contribute to GDP release (15). Van 
Eps et al. expanded upon these studies and again used SDSL and double electron-electron 
paramagnetic resonance to show that receptor interactions with the Gα C-terminus 
facilitated separation of the GTPase and helical domains (136). Crosslinking of the 
GTPase and helical domains by engineering cysteine disulfides further established that 
the domain separation was a necessary component of receptor-enhanced nucleotide 
exchange (136). The recent crystal structure of the β2-adrenergic-Gαs has since 
corroborated the presence of extensive receptor-α5 helix interactions, as well as the 
presence of a significant reorientation of the helical domain (1).  
While the α5 helix is a major determinant of Gα activation, a number of 
additional studies using mutagenesis (241,242), biophysical (131,136), and computational 
approaches (243,244) have identified conformational changes that accompany those 
exhibited by the α5 helix during G protein activation. Molecular dynamics simulations 
have proposed models that suggest receptor recognition stabilizes the αN-β1 junction and 
the β2-β3 hairpin, in addition to the α5 helix, in Gα proteins to relay receptor interactions 
into a GDP dissociation response (243,244). Fluorescently labeled Gαi1 exhibited 
receptor-dependent changes in the environments of Switch I and Switch II, supporting a 
global effect of receptor binding on the structural organization of Gα proteins (137). 
Similarly, EPR studies revealed receptor-mediated changes in the mobility of spin labels 
on the β1, β2, and β6 strands of Gαi1 (109,131). These strands form extensions of Switch 
I, the P-loop, and the α5-β6 loop, all of which are active site elements that have also been 
shown by EPR to exhibit conformational variability (131,136). Biochemical and 
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structural studies on the Gαi1 variants altering the P-loop (5,27) and α5-β6 loop 
(15,25,29) and linker (29) have revealed the importance of protein-nucleotide interactions 
(Figure 32B) mediated by residues of these structural elements in facilitating nucleotide 
exchange. These findings suggest that the allosteric mechanism of Gα activation likely 
involves precise coordination between each of the aforementioned components.  
Despite these significant efforts, the mechanism of receptor-mediated allosteric 
activation of Gα subunits is not fully understood. Based upon the previous findings that 
the K341L mutation of Gαt displays substantially different biochemical behavior in the 
intact protein than it does in a peptide, we hypothesized that this mutation altered the 
allosteric activation network. Accordingly, we used the equivalent K345L variant of Gαi1 
as a tool to probe transient allosteric properties of receptor-mediated guanine nucleotide 
exchange. Our results combine receptor-binding studies, high-resolution crystallographic 
studies, and stability measurements to demonstrate how the presence of the K345L 
mutation alters the allosteric network in the Gαi1 subunit. These results allow us to 
propose a mechanism for how various structural elements within Gα proteins likely 
coordinate to facilitate allosteric G protein activation.  
 
Methods 
Experimental methods for ROS membrane preparation, rhodopsin purification, 
transducin purification, nucleotide exchange assay, and the rhodopsing binding assay 
(extra meta II stabilization assay) are described in the Methods section of Chapter II.  
Assays and methods unique to the subject matter presented in this chapter are described 
below. 
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Expression and Purification of Ga Subunits 
Gαi1 was expressed as a fusion protein from a single colony of transformed E. coli 
BL21-Gold (DE3). Transformed E. coli was grown in a 2mL starter culture of 2X YT 
media with 50 µg/mL at 37 °C for 8 hours. The culture was then transferred to 150 mL of 
2X YT media with 50 µg/mL kanamycin A and grown at 37 °C overnight. Large-scale 
cultures (980 mL of 2X YT media with 50 µg/mL kanamycin A) were inoculated with 20 
mL of the overnight culture and grown at 37˚C until the cells reached an OD600 of 
approximately 0.6. Expression was induced with 30-60 µM of IPTG for 18 hrs at 22°C.  
After induction, the cells were harvested by centrifugation and frozen at -80°C. 
Prior to purification, cell pellets were thawed and resuspended in ice-cold Lysis 
Buffer (50 mM NaHPO4, 300 mM NaCl, 2 mM MgCl2, 5 mM βME, 20 µM GDP, pH 
8.0) supplemented with 0.1 mM PMSF or 1 mM pefabloc (Lysis Plus Buffer) and 1 
µg/mL aprotinin, leupeptin, and pepstatin.  The resuspended cells were disrupted by 
sonication and the lysate clarified by centrifugation for 1 hr at 220,000 × g. The 
supernatant was treated with 10 µg/mL DNase and RNase, filtered, and added in batch to 
a 50% slurry of TALON Cobalt affinity resin equilibrated in Lysis Plus Buffer. 
Supernatant was bound to resin by rotating for 1 hour at 4°C. Protein-loaded resin was 
transferred to a gravity flow column and the column washed with 20 column volumes of 
Lysis Plus Buffer, then 6 column volumes of Lysis Plus Buffer supplemented with 5 mM 
imidazole pH 8.0, The protein was eluted with 5 column volumes of Lysis Plus Buffer 
supplemented with 100 mM imidazole pH 8.0. The eluted protein was concentrated using 
an Amicon 10 kDa MWCO centrifugal concentrator at 2,000 × g. The concentrated 
sample was then diluted 20-fold with Lysis Buffer, and thrombin was added at a 
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concentration of 1 U per 1 mg of purified protein. The sample was then incubated 
overnight on ice at 4°C to allow for cleavage of the N-terminal affinity tag.  The protein 
sample was further purified by passing over a column of TALON Cobalt affinity resin 
equilibrated in Lysis Buffer to trap uncleaved product, and by size exclusion 
chromatography on a Superdex S200 10/300GL column equilibrated in Storage Buffer 
(50 mM Tris-Cl, 200 mM NaCl, 2 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol (DTT), 
20 µM GDP, pH 8.0) to remove aggregate. The cleaved protein contains two additional 
N-terminal residues (Gly-Ser) derived from the thrombin recognition sequence. Purified 
Gαi1 was concentrated to 10 mg/mL and glycerol added to 10% (v/v) prior to storage at -
80°C. Gα concentrations were determined by the BCA assay (245) for all crystallization 
and biochemical characterizations.  
 
Rhodopsin and Transducin Purification 
Endogenous rhodopsin and transducin were purified as previously described 
(220). Briefly, dark-adapted rhodopsin was stored as aliquots of urea-washed rod outer 
segment (ROS) membranes, which were prepared by washing retinas twice with EDTA 
Buffer (10 mM Tris-Cl, 1 mM EDTA, 1 mM DTT, ph 7.5) and once with Urea Buffer 
(10 mM Tris-Cl, 1 mM EDTA, 1 mM DTT, 7 M urea, pH 7.5). Pelleted membranes were 
then resuspended in 10 mM MOPS, 200 mM NaCl, 2 mM MgCl2, 1 mM DTT, 100 µM 
PMSF, pH 7.5 and aliquots stored at -80°C.  
The rhodopsin-transducin complex was purified from light-adapted bovine ROS 
membranes. Membranes were washed four times with Isotonic Buffer (5 mM Tris-Cl, 
130 mM KCl, 0.6 mM MgCl2, 1 mM EDTA, 1 mM DTT, pH 8.0) and two times with 
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Hypotonic Buffer (5 mM Tris-Cl, 0.6 mM MgCl2, 1 mM EDTA, 1 mM DTT, pH 8.0). 
Transducin was then released into the supernatant by resuspending ROS membrane 
pellets with Hypotonic Buffer containing 0.1 mM GTP. The membranes were pelleted by 
centrifugation and the supernatant containing transducin was dialyzed against Transducin 
Storage Buffer (20 mM Tris-Cl, 200 mM NaCl, 10 µM GDP, 5 mM β-ME, 10% glycerol, 
pH 7.5).  Purified transducin was stored at -80°C. 
 
Basal and Receptor-mediated Nucleotide Exchange 
The rate of GDP exchange for GTPγS in Gαi1 was determined by monitoring the 
increase in intrinsic tryptophan fluorescence (λex= 290 nm, λem= 340 nm) using a Varian 
Cary Eclipse fluorescence spectrometer. The fluorescence signal from basal nucleotide 
exchange was measured at 21°C for 90 min after addition of 10 µM GTPγS to 500 nM 
wild-type or mutant Gαi1 in 50 mM Tris-Cl, 200 mM NaCl, 2 mM MgCl2, 1 mM DTT, 
pH 7.5. Receptor-mediated nucleotide exchange was monitored for heterotrimeric G 
protein, Gαi1β1γ1, reconstituted by incubating wild-type or mutant Gαi1 with Gβ1γ1 
purified from endogenous transducin in a 1:1 molar ratio. 2 µM of dark rhodopsin in 
urea-washed rod outer segment (ROS) membranes was added to 500 nM heterotrimeric G 
protein sample prepared in assay buffer and incubated in the dark. Immediately upon the 
addition of 10 µM GTPγS, samples were light activated and mixed by pipetting. The 
fluorescence signal from receptor-mediated nucleotide exchange was monitored for 60 
min at 21°C. Nucleotide exchange rates were calculated from data for 3 independent 
experiments with 4 replicates per experiment and fit using a one-site exponential 
association equation in Prism. 
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Rhodopsin Binding Assay 
Wild-type and K345L Gαi1 binding to rhodopsin in urea-washed ROS membranes 
was measured as previously described (15). Gαi1 (5 µM) was incubated with Gβγ (10 
µM) and rhodopsin (50 µM) in binding buffer (50 mM Tris-Cl, 100 mM NaCl, 2 mM 
MgCl2, pH 8.0) for 30 min at 4°C and assessed under three different conditions: dark-
adapted, after light activation, and after light activation with the addition of GTPγS (100 
µM).  Supernatants were separated from membranes by centrifugation at 200,000 × g for 
1 hr. Dark-adapted fractions were protected from light during centrifugation and 
supernatants removed under dim red light.  Isolated fractions were boiled, visualized by 
Coomasie-stained SDS-PAGE gel, and quantified by densitometery using a Bio-Rad 
Multimager. Quantities of 37 kDa Gαi1 in either the soluble or insoluble fraction are 
expressed as a percentage of the total protein in both. Data reported are the average of at 
least three independent experiments. 
 
Extra Metarhodopsin II Formation 
The formation of meta II in ROS membranes was measured on an Aminco 
DW2000 spectrophotometer in the presence of increasing concentrations of G protein as 
previously described (123). Heterotrimeric G protein was reconstituted from purified 
wild-type or K345L Gαi1 in the same manner as used for receptor-mediated nucleotide 
exchange measurements. Rhodopsin (2 µM) in dark-adapted urea-washed ROS 
membranes were incubated with varying concentrations of wild-type or K345L Gαi1β1γ1 
in meta II buffer (50 mM HEPES, 100 mM NaCl, 1 mM MgCl2, 1 mM DTT, pH 8.0) on 
ice for approximately 10 min. Absorption spectra for both dark and light-adapted samples 
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were then collected at 4°C. Following collection of a dark-adapted spectrum, samples 
were exposed to 2 quick flashes of light approximately 30 s apart. The light-adapted 
spectrum was then immediately collected. The extra meta II signal was calculated as the 
change in meta II formation (difference between absorption at 390 nm and 440 nm) upon 
light activation. Dose response curves were generated by nonlinear regression using a 
sigmoidal dose-response (variable slope) equation as previously described (222). 
 
Differential Scanning Fluorimetry (DSF) 
DSF was performed as described (226). Protein samples were diluted to a final 
concentration of 5 µM in assay buffer containing 5× SYPRO Orange (BioRad) and 50 
µM GDP or GTPγS. Thermostability was screened in both the extra meta II (EMB) assay 
buffer and nucleotide exchange (NEB) assay buffer. Triplicate samples were prepared in 
20 µL volumes and transferred to a clear low-profile 96-well PCR plate (BioRad) and 
equilibrated at 25 ˚C for 2 min in a BioRad CFX96 Real-time system (C1000 Thermal 
Cycler) prior to a temperature ramp from 25˚C to 95˚C in 0.2˚C increments at a rate of 
1˚C/min. Data were analyzed using DSF analysis tools version 3.0.2 (226).  
 
Crystallization, Data Collection, Structure Determination and Refinement 
Crystals of GDP- and GTPγS-bound forms of the K345L Gαi1 variant protein 
were grown by hanging-drop vapor diffusion using previously reported conditions (10). 
Prior to crystallization, purified protein was diluted into 80 mM HEPES, 120 mM 
succinic acid, 8 mM DTT, pH 8.0 and concentrated to 11 mg/mL in an Amicon 10 kDa 
MWCO centrifugal concentrator. Protein was incubated with 1 mM GTPγS for at least 1 
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hour or briefly with 20 µM GDP, 40 µM AlCl3, and 16 mM NaF. Crystals were grown 
from hanging drops consisting of 4.8 µL protein (10 mg/mL) and 1.2 µL reservoir 
solution (2.0 – 2.2 M ammonium sulfite pH 8.0, 5 – 20 mM MgSO4) equilibrated against 
1 mL of reservoir solution at 20°C. Crystals were cryo-protected by briefly soaking in 
reservoir solution containing glycerol at a final concentration of 17.5% and flash-cooled 
by plunging in liquid nitrogen.  
Diffraction data were collected at the Advanced Photon Source (APS) beamlines 
21-ID-D and 21-ID-G. All data were collected at 100 K and recorded on a Mar 300 
detector. Crystals formed in two different space groups: P3221 for GTPγS-bound K345L 
Gαi1 and I4 GDP-bound K345L Gαi1. All data were indexed, integrated, and scaled using 
HKL2000 (246). Crystallographic data processing and refinement statistics are reported 
in Table 8.  
The structure of GTPγS-bound K345L Gαi1 was determined by molecular 
replacement in Phaser (247) using the structure of K349P Gαi1 as a search model (PDB 
ID: 2ZJY) (10). The structure of GDP-bound K345L Gαi1 was determined by molecular 
replacement in Phaser using the GTPγS-bound K345L Gαi1 structure as a search model. 
Iterative rounds of refinement in Phenix (248) and model building in Coot (249) were 
performed to improve model quality. Geometry was assessed in Procheck (250) and 
Molprobity (251). Figures 1, 3, 4, 5, 6 and 7 were prepared using PyMOL (247). 
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Table 8. K345L Gαi1 Crystallographic Data Collection and Refinement statistics 
    GDP-bound   GTPγS-bound 
Data collection 
Beamline   21-ID-D   21-ID-G 
Wavelength   1.078 Å   0.979 Å 
Space group   I 4    P 32 2 1  
Unit cell dimensions  a=121.5 Å   a=79.6 Å 
    b=121.5 Å   b=79.6 Å 
    c=68.2 Å   c=104.8 Å 
    α=β=γ=90°   α=β=90°, γ=120° 
Resolution Range  50 - 2.10 Å (2.18 - 2.10 Å)a 50 - 1.55 Å (1.61 - 1.55 Å) 
Number of reflections  143,580   419,345 
Unique reflections  29,073    55,216 
Rsymb    5.3% (35.0%)   6.9% (38.6%) 
<I>/<σ>c   24.0 (5.0)   22.8 (3.7) 
Completeness   99.7% (100%)   97.7% (92.0%) 
 
Refinement 
Rcrystd    17.9%    15.6% 
Rfreee    21.5%    18.7% 
aValues in parentheses are for the highest resolution shell. 
bRsym= , where j is the jth measurement and <I> is the weighted mean of I. c<I>/<σ> is the mean intensity divided by the mean error. 
dRcryst= , where Fo and Fc are the observed and calculated structure 
factor amplitudes, and k is a weighting factor. 
eRfree is the same as Rcryst calculated on 5% of the reflections in GDP-bound K345L Gαi1 (1507 
reflections) and GTPγS-bound K345L Gαi1 (2806 reflections). 
fRamachandran analysis from PROCHECK (250). 
 
 
Results 
Basal and Receptor-mediated Nucleotide Exchange 
Basal and receptor-mediated nucleotide exchange rates were measured for 
recombinant Gαi1 as a function of the increase in intrinsic tryptophan fluorescence upon 
the addition of the nonhydrolyzeable GTP analog, GTPγS. The K345L Gαi1 exchange 
rates were approximately 30% and 20% slower under basal and receptor-mediated 
conditions, respectively, than wild-type Gαi1 (Figure 33A; Table 9).  
! 
"hkl " j | I j # $I % | /"hkl " I j
! 
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Binding and Activation of Rhodopsin by the K345L Gαi1β1γ1 
Reconstituted Gαi1β1γ1 binding to rhodopsin in ROS membranes was used to 
assess the effect of the K345L mutation on the ability of Gαi1 to bind activated receptor 
(Figure 33B,C). Quantifying the percent recovery of Gαi1 protein in the pellet fraction or 
the soluble fraction revealed that the amount of K345L Gαi1 bound upon light activation 
(LP) was decreased compared to wild-type Gαi1. Conversely, the quantity of Gαi1 
released into the soluble fraction upon light activation was greater for K345L Gαi1. This 
suggests that the presence of the K345L mutation alters the receptor-binding site in Gαi1. 
The extra meta II assay was used to quantify the affinity between receptor and 
wild-type or K345L Gαi1β1γ1 (Figure 33C; Table 9). Using this method, the affinity 
measured between rhodopsin and wild-type Gαi1β1γ1 (EC50 = 0.89 ± 0.02 µM) was found 
to be comparable to that determined by kinetic light scattering (EC50 = 0.72 ± 0.05 
µM)(238). However, the K345L Gai1b1g1 (EC50 = 2.03 ± 0.05 µM) had a modestly 
reduced affinity. In silico modeling of the K345L Gαi1 bound to rhodopsin was based 
upon the Gαs- β2 adrendergic receptor costructure (1) and did not offer a trivial 
explanation for this reduction in affinity (not shown). 
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Figure 33: Biochemical Properties of Gαi1 Variants. Data for wild-type ( ) and K345L ( ) 
Gαi1. A) Basal and receptor-mediated nucleotide exchange rates measured as a function of 
intrinsic fluorescence (λex = 280 nm, λem = 340 nm). The change in fluorescence was monitored at 
21 °C for 500 nM wild-type and  K345L Gαi1β1γ1 upon the addition of 10 µM GTPγS. Samples 
for determining receptor-mediated nucleotide exchange rates were additionally incubated with 2 
µM rhodopsin. Data were fit with an equation for pseudo-first order association kinetics. Data 
presented here are relative to wild-type Gαi1, which was normalized to 100%. B) SDS-PAGE gels 
of wild-type and K345L Gαi1 proteins reconstituted with Gβγ prior to binding ROS membranes in 
the dark, in the light, and after light activation, following the addition of GTPγS. Abbreviations 
are: DS, supernatant from the dark-adapted sample; DP, pellet fraction from the dark-adapted 
sample; LS, light supernatant; LP, light pellet; GS, supernatant from light activated sample with 
GTPγS; GP, pellet from light activated sample with GTPγS. C) Results from densitometery 
quantitaiton of SDS-PAGE gels in C). D) Rhodopsin affinity for Gαi1β1γ1 determined by the extra 
meta II assay. Rhodopsin (2 µM) was incubated with varying concentrations (0-15 µM) of wild-
type ( ) and K345L ( ) Gαi1β1γ1 and the change in meta II determined by monitoring the 
absorbance before and after light activation at 4°C. Data were plotted as a function of the Gαi1β1γ1 
concentration and fit to a 4-paramater, variable slope equation to calculate the EC50 values. E-F) 
Fluorescence analysis of heat-induced melting of wild-type and K345L Gαi1. Protein sample (5 
µM) in NEB or EMB buffer was incubated with 10X E) GDP or F) GTPγS and SYPRO orange 
dye prior to melting. Changes in the fluorescence signal were monitored upon a temperature ramp 
from 25 °C to 95 °C. Sigmoidal regions of the data were fit with the Boltzmann equation to 
determine the Tm values, which are plotted here as the average of three independent trials per 
sample. Results shown are the mean ± S.E.M. of three independent experiments (* p < 0.05; ** p 
< 0.01; **** p < 0.0001).  
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Table 9.  Results from Biochemical Characterizations of Gαi1 Proteins. 
 Wild-type K345L E43A 
Nucleotide Exchange Rates    
Basal (min-1) 0.0180 ± 0.0006 0.0126 ± 0.0007 0.0176 ± 0.0005 
Δ rates (basal)  -30% -2% 
    
Receptor-mediated (min-1) 0.20 ± 0.01 0.164 ± 0.005 0.131 ± 0.005 
Δ rates (receptor-mediated)  -19% -35% 
    
Rhodopsin binding affinity    
Affinity (mM) 0.89 ± 0.02 2.03 ± 0.05 0.77 ± 0.06 
Δ affinity  -2.3-fold +0.9-fold  
    
Thermostability    
GDP-bound    
Tm (˚C) (NEB) 46.08 ± 0.02 43.19 ± 0.04 44.59 ± 0.01 
ΔTm  -2.89 -1.49 
Tm (˚C) (EMB) 46.79 ± 0.03 44.00 ± 0.07 44.77 ± 0.03 
ΔTm  -2.83 -2.01 
    
GTPγS-bound    
Tm (˚C) (NEB) 67.65 ± 0.03 67.90 ± 0.02 66.01 ± 0.04 
ΔTm  0.25 -1.63 
Tm (˚C) (EMB) 69.11 ± 0.03 69.20 ± 0.02 66.80 ± 0.04 
ΔTm  0.09 -2.30 
 
 
 
Thermostability of the K345L Gai1 Variant 
To identify how the K345L Gαi1 mutant influences the stability of the nucleotide 
binding states of Gαi1, we measured the thermostability of the wild-type and the K345L 
variant in the presence of GDP (Figure 33E; Table 9) or GTPγS (Figure 33F; Table 9). 
Consistent with previous studies, both wild-type and K345L Gαi1 are more stable when 
bound to GTPγS than GDP (13,40,43). The Tm values for GTPγS-bound wild-type and 
K345L Gαi1 were statistically identical. In comparison, the Tm of the GDP-bound K345L 
Gαi1 variant decreased by 2.8 °C as compared to wild-type Gαi1. 
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Structures of the GTPγS- and GDP-bound K345L Gαi1 Subunit 
To examine the architectural changes in the K345L Gαi1 variant, crystal structures 
in the GDP (Figure 34A) and GTPγS-bound (Figure 34B) states were determined to 1.5 
Å and 2.1 Å resolution, respectively (Table 8). The resolution of these structures is 
among the highest observed for any Gα protein with each respective guanine nucleotide. 
Superposition of corresponding backbone Cα atoms of GTPγS-bound K345L Gαi1 and 
GTPγS-bound wild-type Gαi1 (PDBID: 1GIA (13)) resulted in an r.m.s. deviation of 
0.299 Å (310 Cα atoms aligned out of 321 total)  suggesting little conformational change 
accompanied the mutation. However, it is noted that residues at the N- and C-termini that 
have not previously been resolved in crystal structures of GTPγS-bound Gαi1 proteins 
were clearly observed in the electron density. At this time, it is unclear whether the 
observation of the residues at the termini is a direct result of the mutation or is simply a 
crystal-to-crystal variation. 
In contrast, superposition of GDP-bound K345L Gαi1 and GDP-bound wild-type 
Gαi1 (PDBID: 1GDD (4)) resulted in a r.m.s. deviation of 0.452 Å between Cα  atoms 
(324 aligned out of 335 total). The statistically significant conformational difference of 
the GDP-bound form is consistent with the biochemical assessment that the GDP-bound 
state of Gαi1 has been altered by the K345L mutation. The majority of the structural 
differences observed in the GDP-bound K345L Gαi1 structure occurred within 
functionally important motifs of the guanine nucleotide binding site located at the 
interface of the GTPase and helical domains of the protein. The Switch regions in the 
GDP-bound K345L Gαi1 structure displayed the most significant conformational changes. 
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The Switch I position was marked by an inward shift (Figure 35A) as compared to wild-
type. This reorientation positioned Switch I in closer proximity to the α and β- phosphates 
of the bound GDP. Accompanying the new position of Switch I in the K345L Gαi1 
structure was the formation of a salt-bridge (2.3 Å) between Arg178 and Glu43 of the P-
loop (Figure 35B). In previous studies, enhanced interactions between Switch I residues 
and bound nucleotide are correlated with reduced nucleotide exchange in Gα (46,239), 
 
Figure 34: Structural Overview of A) GDP-bound and B) GTPγS-bound K345L Gαi1. 
Structures are colored by the Cα RMS deviation calculated for K345L Gαi1 and wild-type Gαi1 
(PDB IDs: 1GDD (GDP-bound) and 1GIA (GTPγS-bound)). Scale bars corresponding to the 
range in RMS deviation values are shown below. 
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suggesting that GDP is more tightly bound. Conversely, reduction of the number of 
Switch I interactions with bound nucleotide are correlated with an increase in the rate of 
nucleotide exchange in Gα subunits (6,29).  
In GDP-bound K345L Gαi1, Switch II and III differed in both structure and 
orientation as compared to wild-type Gαi1. Five of the 17 Switch II residues (Figure 
 
Figure 35: Switch I Conformational Changes in GDP-bound K345L Gαi1. A) Relative 
orientation of Switch I (SI) observed in the structure of GDP-bound K345L Gαi1 (yellow) 
compared to GDP-bound wild-type (PDBID: 1GDD; red), GTPγS-bound wild-type (PDBID: 
1GIA; blue), and GDP-AlF--bound Gαi1 (PDBID: 1GFI; orange). B) The conformation of SI in 
the GDP-bound K345L Gαi1 structure promotes the formation of an ionic interaction (2.3 Å) 
between Glu43 from the P-loop and Arg178 from SI. 
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36A) and two of the six Switch III residues (Figure 36B) that were not observed in wild-
type Gαi1 bound to GDP (Figure 36C) were clearly resolved, albeit in a conformation 
that differed from GDP-bound Gαt (42) (Figure 36D), GDP-AlF4-bound Gαi1 or GTPγS 
Gαi1. The change in Switch II may be physically propagated to the adjacent β2-β3 hairpin 
loop, which exhibits a 0.5 Å inward shift in the GDP-bound K345L Gαi1 and a 0.5 Å 
outward shift in the GTPγS-bound K345L Gαi1 as compared to wild-type.  
 
Validation of the Conformational Changes as a Part of the Signaling Pathway Using 
Site-directed Mutagenesis 
 
Many of the residues in regions that undergo conformational changes in the 
K345L Gαi1 structure have been mutagenized and the altered signaling characteristics 
reported in the literature (6,25,29,109,131,239). To validate that the observed 
conformational changes are indeed important for allosteric signaling, we selected Glu43 
as a target. In the GDP-bound K345L Gαi1 structure, Glu43 forms a salt bridge to Arg178 
that links Switch I and the P-loop.  If this salt bridge is transiently formed during 
allosteric signaling, we anticipate that loss of the negative charge of Glu43 would result 
in a change in receptor-mediated nucleotide exchange rates. Biochemical analysis (Table 
9) indeed shows a 35% reduction in receptor-mediated nucleotide exchange while basal 
nucleotide exchange was unaffected. The binding between the E43A Gαi1 variant and 
rhodopsin was not affected as assessed by the meta II assay (EC50 = 0.77 ± 0.06 mM). In 
addition, the Tm in GDP was statistically identical to that of wild-type, but decreased 
from 69.11 ± 0.03 °C (wild-type Gαi1) Tm) to 66.80 ± 0.04 °C) in the presence of GTPγS.  
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Figure 36: Conformational Variability of Switch II and III in GDP-bound Gα. A) Difference 
(Fo-Fc) electron density for Switch II and B) Switch III in GDP-bound K345L Gαi1 contoured to 
2σ. Relevant structural elements are labeled as such. Comparison of Switch II (SII) and Switch III 
(SIII) conformations in C) GDP-bound K345L Gαi1 (yellow) and D) wild-type Gαt (green). 
 
That this mutation affects receptor-mediated activation but not basal nucleotide 
exchange or receptor binding strongly indicates that Glu43 contributes to allosteric 
signaling as predicted.  
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Discussion 
The K345L Gαi1 Shifts the Equilibrium between Nucleotide Bound States by Altering the 
Allosteric Network Between Receptor and Guanine Nucleotide 
 
The majority of published Gα mutations proposed to alter allosteric signaling are 
associated with an increase in both intrinsic and receptor-mediated nucleotide exchange 
(6,25,29). This is consistent with the global destabilization of structure often associated 
with site-directed mutants. In contrast, a reduction in both basal and receptor mediated 
nucleotide exchange was observed in K345L Gαi1. The mechanistic basis for this unusual 
reduction in nucleotide exchange could potentially be attributed to one of many physical 
changes. For example, K345L Gαi1 might have an increase in the affinity for bound GDP, 
or the nucleotide-free state of K345L Gαi1 that binds receptor might be destabilized, or 
the allosteric connection between receptor-binding and nucleotide release might be 
disrupted in K345L Gαi1. To distinguish between these possibilities and determine 
whether focused study of this mutation would provide insight into the function of Gα 
proteins, we assessed additional biochemical properties of K345L Gαi1. The modest loss 
of binding and receptor activation is in contrast to the previously reported 200-fold 
increase in the affinity for the Gαi1 peptide containing the K345L mutation (222), but in 
agreement with studies of Gαt demonstrating similar receptor affinity as wild-type when 
this mutation was placed in the context of the intact protein (238).  
To identify if this loss in affinity had a trivial explanation, we compared the 
structures of meta II (81) bound to a peptide mimetic of Gαi1 to that of the β2-adrendergic 
receptor bound to intact Gαs (1) and used in silico modeling to qualitatively assess the 
influence of sequence on binding in each case. It is notable for this analysis that the 
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peptide costructure shows a different binding mode than the C-terminus of Gαs. This 
difference in conformation has previously motivated a proposal that the peptide 
costructure represents a pre-docked state for the C-terminus of Gα. Examination of the 
structure of opsin or meta II bound to peptide does not demonstrate an obvious reason 
why the K345L mutation would have increased affinity in the context of a peptide and 
decreased affinity in the context of the intact Gα.  
  An alternative mechanism that would result in the K345L mutation having 
increased receptor affinity in a peptide but reduced affinity in the context of the intact 
protein would be if the mutation altered the allosteric equilibrium between the nucleotide-
bound states of Gα. The lack of immediate physical phenomena, such as steric clash, that 
would explain a lowering of receptor affinity in the presence of the intact protein supports 
destabilization of the nucleotide-free state of K345L Gαi1. In addition, we measured a 
lowered Tm of the GDP-bound state of Gα. This state first associates with activated 
receptor in a low affinity complex, and the lowered Tm of this state in particular is 
consistent with a shifted nucleotide binding equilibrium in K345L Gαi1.  
 
Structural Changes in GDP-bound K345L Gαi1 Localize within Functional Regions of the 
Gα Subunit 
 
It is reasonable to speculate the role of the β1-strand and the β2-β3 hairpin as 
additional sensors for receptor binding in addition to their role as triggers for inducing 
receptor-mediated conformational changes in Gα. Structural, computational, and 
dynamics studies have long supported the role of the β2-β3 hairpin in receptor-mediated 
Gα activation. Consistent with this hypothesis, the residues Val34, Leu194, and Leu348 
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mediating the interactions between the β1-strand, the β2-β3 hairpin, and the α5 helix are 
highly conserved in Gα subunits with the exception of a histidine residue replacing Val34 
in Gαs. Biochemical studies on the Gαo/i2 chimeras suggest that α5 helix interactions with 
the β2-β3 hairpin are important to subunit activation (252), and that the β2-β3 hairpin 
formed the relay in the gear-shift model for receptor-mediated nucleotide exchange (134). 
Parallel molecular dynamics simulations and EPR characterizations corroborated the role 
of the β2-β3 hairpin as a dynamic component during G protein activation (131,243). 
However, these studies did not offer a specific mechanism for how the β2-β3 hairpin 
conformational switch facilitates nucleotide exchange or how this conformational switch 
is even initiated. Most recently, the β2-adrenergic-Gαs complex structure revealed a major 
receptor-G protein interaction with the β2-β3 hairpin loop mediated by the conserved 
intracellular loop 2 residue, Phe139. This residue was in close proximity to the Gαs 
residue homologous to the Leu194, which resides in the β2-β3 hairpin loop in Gαi1 (1).  
Investigations into the relevance of this interaction using fluorescent probes showed that 
mutation of Leu194 to a cysteine uncoupled receptor interactions from G protein 
activation (137). In the latter, it was suggested that the Phe139-Leu194 interaction is part 
of a larger network completed by interactions with the α5 helix residue Phe336 for 
transducing receptor-interactions into conformational changes within Switches I and II 
during Gα activation. The results presented here elaborate on this specific mechanism by 
which the β2-β3 strand facilities Gα activation and subsequent conformational changes in 
Switch regions. The presence of the membrane-proximal hydrophobic network in which 
the β2-β3 hairpin takes part in likely represents one architectural aspect of the Gα state 
preceding the state sampled by the formation of the Phe139-Leu194 interaction.  
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Much less is known about the precise role of the β1-strand in facilitating Gα 
activation. Previously determined structures have revealed only minor differences that 
did not offer any conclusive insight into its functional role. Even in the K345L Gαi1 
variant structures, this region does not exhibit much if any conformational variability 
with the exception of Val34 participating in the membrane-proximal hydrophobic 
network identified here. Hydrogen-deuterium exchange experiments, on the other hand, 
have provided compelling evidence for the N-terminal motif as a dynamic element 
facilitating GDP release in Gαs proteins (253). One interpretation as to how this is 
mediated involves destabilization of the active site P-loop, an extension of the β1-strand, 
upon receptor binding and induction of β1-strand conformational changes. Thus, the 
integrity of these hydrophobic interactions forming the membrane-proximal network at 
the receptor-binding interface is likely one determinant for maintaining the Gα subunit in 
a state such as that observed in GDP-bound wild-type Gαi1 proteins and here in the 
K345L variant. In the absence of receptor, formation of the hydrophobic interaction 
likely limits spontaneous Gα activation. 
Productive coupling of receptors and G proteins is the physiological event that 
catalyzes the rate-limiting step of GDP release in Gα activation, and general consensus 
exists over the importance of Switch I in facilitating this event. Crystal structures of wild-
type Gα proteins (13,40) showed that Switch I, which forms an extension of the β2-β3 
hairpin, adopts among the most dramatic conformational changes in the various Gα 
activation states, and a number of studies on Gα Switch I mutants underscore the 
importance of this region for nucleotide release. One such study investigating the effects 
of the K180P mutant on the kinetics of GTP hydrolysis inadvertently revealed the 
 119 
importance of the wild-type lysine residue in maintaining Gαi1 in the ground state (14). In 
the presence of this mutation and GppNHp, Gαi1 assumed an autoinhibited conformation 
marked by increased interactions between Switch I and the active site P-loop. Similar 
interactions between Switch I and the P-loop residues were also observed in the 
autoinhibited GppNHp-bound wild-type Gαi1 structure (9) and in the GDP-bound K345L 
Gαi1 structure. In contrast, in the T329A Gαi1 variant Switch I is displaced outward to 
increase the active site volume, disrupt the Mg2+ ion coordination sphere and Switch I 
interactions with the P-loop, and destabilize the GDP-bound ground state (6). 
Consequently, nucleotide exchange rates were significantly elevated in the T329A Gαi1 
variant compared to those observed in wild-type and K345L Gαi1. In light of these 
observations, the structure of the GDP-bound K345L Gαi1 variant also represents a 
ground state that is marked by not only the membrane proximal hydrophobic network, 
but also a Switch I conformation engaged in a stabilizing interaction with the P-loop. 
 
Disruption of an Active Site Salt-bridge between the P-loop Residue Glu43 and Switch I 
Residue Arg178 is Required for Facilitating G protein Activation 
 
One particularly subtle hallmark of the heterotrimeric G protein is the formation 
of a salt bridge between the P-loop residue, Glu43, and the Switch I residue, Arg178, in 
the Gα subunit, such that it is observed in both the Gαt (2) and the Gαi1 (46) 
heterotrimeric complex and appears to be reinforced by the presence of the Gβγ subunits.  
Surprisingly, of the ten available GDP-bound, five GDP-AlF4--bound, seven GTPγS-
bound, and two GppNHp-bound Gαi1 structures, only three unambiguously possessed this 
interaction. All three of these structures (GDP-bound K345L Gαi1, GppNHp-bound wild-
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type Gαi1, and GppNHp-bound K180P Gαi1) exhibited decreased capacity to transition to 
the activated state, and thus appear to be auto-inhibited to some extent much like 
heterotrimeric G protein complexes in the absence of receptor-mediated activation 
(9,14,46). Nucleotide-release is similarly inhibited in the Gαi1 bound to the GoLoco motif 
of RGS14, where upon further analysis of the structure of the complex, it was revealed 
that the Glu43-Arg178 interaction was also conserved here (254).  While Arg178 has 
been extensively characterized in the literature and is known to be required for stabilizing 
the γ-phosphate leaving group of GTP during hydrolysis, less is know about Glu43 in 
contrast (13,40,255). One study suggests a role for the amide atoms of the P-loop residue 
in facilitating Arg178 in stabilizing dissociative transition states (11,256), however, the 
evidence presented here suggests that the salt-bridge hinders transitions to the activated 
state.  
Substantial deuterium exchange at the interface of the GTPase and helical 
domains of Gαs upon receptor-mediated activation has been attributed to conformational 
changes in the P-loop (253). Mutation of the Glu43-adjacent P-loop residue, Gly42, in 
Gαi1 to an arginine has been previously shown to diminish Gα transitions to the activated 
state and nucleotide exchange rates (27). This biochemical phenotype was attributed to 
the inability of Arg42 to promote the active site conformational changes accompanying G 
protein activation. Thus, such concomitant conformational changes described for Switch I 
and the P-loop likely represent a driving force behind GDP release, and we speculate that 
the Glu43-Arg178 salt bridge observed in the GDP-bound K345L Gαi1 structure acts a 
sensor for Gαi1 interactions with activated receptor to facilitate these conformational 
changes. The uncoupling of receptor-binding and nucleotide exchange in the E43A Gαi1 
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mutant shown here supports the role of the active salt bridge and the P-loop residue in the 
process of Gα activation.  
 
A Model for Receptor-mediated G protein Activation 
By placing the newly observed conformational intermediates and functional 
regions identified here within the context of known conformations of the Gα subunit, we 
propose a network for allosteric receptor-mediated nucleotide exchange in Gαi1.  
The C-terminal α5 helix has long been known to be of primary importance for 
communicating receptor binding to the guanine nucleotide-binding site. While 
speculative, it is possible that the well-characterized receptor-initiated α5 roto-translation 
further introduces conformational strain in elements of the GTPase fold itself for 
mediating GDP release. Indeed a twist in the central β-sheet is observed in the β2-
adrenergic-Gαs complex structure. Structural changes in Switch I and the P-loop are 
likely the result of this strain. Specifically, the α5 helix together with the β1-strand, and 
the β2-β3 hairpin loop, each constituting various dynamic elements of the receptor-
binding site, likely contribute to the conformational strain. A route by which receptor 
binding could promote nucleotide exchange in Gα subunits is illustrated in Fig. 36, and 
utilizes the β1-strand and the α1 helix to communicate receptor-interactions with the β2-
β3-hairpin and the α5 helix into structural changes in the active site Switch I and P-loop 
during Gα activation.  
An ionic interaction between a glutamine residue in the base of the α1 helix and a 
threonine at the base of the α5 helix link the two structural elements to the P-loop. Such 
an interaction can be thought to limit the conformational flexibity of either structural 
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element. Site-directed mutagenesis to disrupt this interaction previously was shown to 
dramatically enhance the rate of uncatalyzed nucleotide exchange in Gαi1 (6). Roto-
translation of the α5 helix upon receptor binding would be expected to similarly break the 
ionic interaction and remove the constraints on the P-loop flexibility imposed by the α5-
α1 interaction. 
In addition to the α5 helix, the β1-strand in Gαs has been shown by hydrogen-
deuterium exchange to represent a highly dynamic element of the Gα protein during 
receptor-mediated activation (253). The β1-strand precedes the P-loop connected to the 
α1 helix.  It is possible that α5-mediated release of the α1 helix, and subsequent 
flexibility in the P-loop, contributes to the dynamic behavior of the β1-strand. Because of 
the intimate interactions between the β-strands of the GTPase fold, conformational 
changes in β1 can be thought to propagate to the adjacent β2-β3 hairpin, which acts as a 
conduit from the receptor-binding site to the active site Switch I loop. Indeed, 
conformational changes in the β2-β3 interactions with the α5 have been shown by SDSL 
and EPR to be important for facilitating receptor-mediated nucleotide exchange (239).  
The tightly coupled nature of the interactions between the β1-α5-α1-P-loop 
network (Figure 37A) and the β2-β3-Switch I network (Figure 37B) suggests extensive 
crosstalk between the two, and the resultant conformational changes are likely occurring 
in concert to facilitate nucleotide exchange in the presence of receptor-stimulation 
(Figure 37C). Additional investigations of these membrane proximal elements are 
necessary for validating their individual contributions in the mechanism. However, the 
data presented here presents a framework for which such future experiments can be 
designed to further probe allostery in G protein signaling. 
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Figure 37: An Allosteric Model for Gα Activation. Gα is shown in the absence of Gβγ. A) The 
β1-P-loop-α1 helix (network 1) form a network of interactions with the α5 helix, which hold these 
elements in their constrained conformations in the absence of receptor binding.  B) An adjacent 
motif formed by the β2-β3 hairpin-Switch I (network 2) form an additional network that is also 
static in the absence of receptor-coupling. C) Upon receptor binding to the Gα subunit, and the α5 
helix, rearrangements in the interactions among elements of network 1 are communicated to 
network 2, and concomitant conformational changes in the P-loop (purple) and Switch I (gold) 
result to facilitate GDP release. 
 
 
Conclusions 
This study reveals the importance of subtle conformational changes in receptor-
mediated G protein activation. Investigations into the well-studied C-terminal mutation, 
K345L (K341L in Gαt), and a novel active site mutation, E43A, in the full-length Gαi1 
subunit contribute to our understanding of how N- and C-terminal motifs in Gα proteins 
facilitate crosstalk between allosteric networks during heterotrimeric G protein activation.  
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Accession Numbers 
Atomic coordinates and structure factors have been deposited into the RCSB 
Protein Data Bank with accession codes 4NOD and 4NOE. 
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CHAPTER VI 
 
SYNOPSIS AND CONCLUSIONS 
 
 The goals of this work were to gain insight into the allosteric mechanisms of 
receptor-mediated G protein activation. The results presented contribute novel 
information on three distinct aspects of this mechanism. The first part addresses 
molecular determinants of complex formation and stabilization.  The second part applies 
the findings from the first part to the structural study of the rhodopsin-transducin 
complex, which revealed molecular determinants of complex disassembly. In the last part 
of this work, structural and biochemical investigations into the local environment of the 
Gαi1 subunit in the presence of a mutation destabilizing receptor-G protein interactions 
reveal the allosteric connections that likely convey receptor binding into a signal 
facilitating nucleotide release during G protein activation. 
 In the first part of this study, model membrane systems were investigated to 
overcome challenges of studying transient GPCR-G protein complexes, and to better 
understand the determinants of GPCR-G protein complex formation preceding the G 
protein activation step. A novel technique utilizing dynamic light scattering was 
developed to characterize the physical properties of phospholipid bicelles of varying 
compositions.  Biochemical results reporting the effects of various bicelle compositions 
on GPCR-G protein complex formation, stabilization, and subsequent receptor-mediated 
G protein activation were put into the context of membrane morphology. These results 
underscored the importance of membrane structure in facilitating productive receptor-G 
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protein interactions, and offered insights into the mechanism by which detergent micelles 
destabilize such protein-protein interactions. In addition, the dependence on nonspecific 
negative charge for complex stabilization highlighted the extent to which electrostatic 
interactions at the membrane interface facilitate GPCR-G protein coupling. Surprisingly, 
the presence of the negative charge enhanced both the affinity of receptor for G protein 
and the rate of G protein activation. These findings, taken together, offer a rationalization 
for the inherent instability of such complexes in vivo, such that weak interactions are 
likely necessary for efficient G protein turnover in response to extracellular stimuli. 
 In the second part of this study, the findings from the first part were exploited for 
structural studies performed on the rhodopsin-transducin complex to gain insight into the 
structure of the nucleotide-free state of the G protein.  Negatively charged bicelles and 
lipidic cubic phase phospholipids were investigated as a medium for crystallization.  The 
results of these studies revealed that the physical properties of GPCRs and G proteins that 
are stabilizing in vivo are actually destabilizing for protein crystallization. Successful 
structural studies will most likely require the manipulation of protein systems with 
engineered stability. 
 Lastly, in the third part of this study, structure function investigations of the 
K345L Gαi1 revealed how modest changes in allosteric networks can have dramatic 
effects on G protein activation. Further, this study reinforced the importance of 
productive receptor-G protein interactions for facilitating conformational changes in 
allosteric sites of the G protein during activation.  Destabilization of the GDP-bound state 
in the presence of the K345L mutation revealed novel interactions between the well-
characterized receptor-binding element, the α5 helix, and proximal structural elements of 
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the GTPase fold that represent a conduit between the receptor and nucleotide binding site. 
These included the β1, β2, and β3 strands, and minor changes in their membrane 
proximal environment dramatically effected the conformation of the active site Switch I 
loop. These findings unveil a novel mechanism for conveying receptor interactions into a 
signal facilitating nucleotide release. 
While one of the goals of this work was to characterize the global architecture of 
the GPCR-G protein complex to better understand the nucleotide-free state of the G 
protein, indirect investigations in the absence of the crystal structure were able to offer 
equally valuable insight into the transient G protein activation state. Thus, continued 
efforts towards identifying and characterizing various Gα intermediates will be necessary 
for painting a complete picture of the allosteric landscape in G proteins as was attempted 
here. These results hopefully provide a framework for additional investigations into 
allosteric mechanisms of G protein regulation. 
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Appendix A 
 
SUBSTRATE SPECIFICITY IN ACETATE KINASE ENZYMES FROM THE 
DOMAIN EUKARYEA 
 
Introduction 
Enzyme-catalyzed phosphoryl transfer reactions are important for a range of 
biological activities. Acetate kinases (ACKs) transfer a phosphoryl group to and from 
acetate, thus promoting the interconversion of acetate and acetyl phosphate. With this 
transformation, ACKs play a role in multiple, distinct bioenergetic pathways (257-259). 
For example, in fermentative bacteria, the ACK-catalyzed dephosphorylation of acetyl 
phosphate has been demonstrated to be essential for the ACK- phosphotransacetylase 
(ACK-PTA) bioenergetic pathway, which utilizes energy stored in acetyl-CoA (257). 
Similarly, ACK-dependent dephosphorylation of acetyl phosphate facilitates ATP 
synthesis via the pentose phosphoketolase pathway in fungi (258).  Conversely, in the 
methanoarchaeon Methanosarcina, ACK activates acetate for its conversion to acetyl-
CoA in the first step of acetioclastic methanogenesis (259).  While the investigations into 
ACK enzymes have focused on bacterial and archaeal systems, ACK was identified in the 
eukaroyote Entamoeba histolytica in the early 1960s (260) and was first biochemically 
characterized in the 1970s (261). Genes encoding putative ACKs have since been 
identified within the genomes of other eukaryotic pathogens, including the basidomycete 
Cryptococcus neoformans (258). At least in E. histolytica, the organism does not appear 
to have homologs for other proteins required for the known bioenergetic pathways that 
use ACK (262). This suggests that the biological function of the E. histolytica ACK may 
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be different from that demonstrated in prokaryotes, but at present, that function remains 
unknown.  
 ACKs belong to the acetate and sugar kinase/hsp70/actin (ASKHA) superfamily 
(263). Members of this family use tandem RNase-H like folds as a scaffold for the 
optimal positioning of five signature sequence motifs, three of which (termed 
ADENOSINE, PHOSPHATE 1, and PHOSPHATE 2) form the ATP binding pocket 
(Figure 38A, B) (264). While the oligomeric states of ASKHA superfamily members can 
differ, each protomer fully houses a complete active site.   
 
 
 
Figure 38: Conserved motifs of the ASKHA superfamily.  A) Location of the ASKHA 
superfamily sequence motifs shown in a protomer of C. neoformans ACK. B) A structure-based 
sequence alignment of each motif shown with secondary structure elements labeled. Fully 
conserved residues are shaded grey and strongly conserved residues are outlined in blue. 
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Biochemical and structural investigations of ACK from the methanogenic 
archaeon Methanosarcina thermophila have been key in developing a mechanistic 
proposal for ACKs (265-271). It is now generally accepted that phosphoryl transfer 
between the nucleotide and the substrate occurs directly via an in-line mechanism. This is 
supported by a crystal structure of the M. thermophila ACK in complex with acetate and 
the nucleotide transition state analog ADP-AlF3 (271), which showed the two 
cosubstrates bound within the active site in a linear array. The structural evidence for the 
in-line transfer mechanism effectively ended a long-standing debate on the role of ACK 
phosphoenzyme, which had originally been proposed as a catalytic intermediate. 
Domain motions are proposed to facilitate catalysis in M. thermophila ACK by 
closing around the cosubstrates, which correctly aligns the g-phosphate of ATP (or 
pyrophosphate (PPi)) with the phosphoryl acceptor (271). Fluorescence quenching 
experiments demonstrated that the differences in interdomain angle observed in the 
crystal structures of numerous ASKHA enzymes indeed convert to interdomain 
movement (264,272). 
Mirroring the state of knowledge on the biological function of eukaryotic ACKs, 
few direct studies on the enzymatic mechanism of eukaryotic enzymes have been 
performed and it is not clear how (or if) the mechanism is modified with respect to the 
mechanism proposed for the M. thermophila enzyme (271). Interestingly, the E. 
histolytica ACK has been shown to use Pi/PPi, rather than ADP/ATP, as the phosphoryl 
acceptor/donor pair for phosphoryl transfer (261,262). Further, this enzyme has a strong 
kinetic advantage for catalyzing the dephosphorylation of acetyl phosphate (261,262). 
Although a kinetic characterization has not yet been reported in the literature, C. 
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neoformans ACK has also been shown to kinetically favor acetate formation (Ingram-
Smith, C., personal communication). Here, we report the crystal structures of the E. 
histolytica and C. neoformans ACKs at 2.4 Å and 1.9 Å resolution, respectively. These 
provide a structural basis for catalysis in the eukaryotic ACKs. 
 
Materials and Methods 
Protein Expression and Purification 
The E. histolytica ACK gene cloned into the pQE30 plasmid was co-transformed 
with the lacI-containing plasmid pREP-4 into Escherichia coli YBS121 (a generous gift 
of George Bennett, Rice University). The C. neoformans ACK gene was cloned into the 
pET21b plasmid and transformed into E. coli Rosetta2 (DE3). Both were expressed and 
purified using similar methods to those described for E. histolytica ACK (262).  Briefly, 
expression cultures were grown in LB broth containing the appropriate antibiotic at 37°C 
with shaking until the OD600 reached 0.9. Expression was induced with the addition of 
IPTG to a final concentration of 1 mM. Cultures were shaken overnight at ambient 
temperature. 
Cells were harvested by centrifugation and resuspended in purification buffer (25 
mM Tris, 150 mM NaCl, 20 mM imidazole, and 10% glycerol, pH 7.4). Cells were lysed 
using a French pressure cell and the cellular debris removed by centrifugation at 100,000 
x g for 1 hour. ACK was purified from clarified lysate using a 5 mL HisTrap Ni-affinity 
column and eluted with a linear gradient from 20 mM to 500 mM imidazole in 
purification buffer. Each protein was pooled and dialyzed against buffer containing 25 
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mM Tris, 150 mM NaCl, and 10% glycerol, pH 7.4 and further purified by size exclusion 
chromatography using a Superdex S200 10/300GL column. 
 
Crystallization, Data Collection, Structure Determination and Refinement 
 E. histolytica ACK was crystallized using the hanging drop vapor diffusion 
method by mixing 1 µL protein (8 mg/mL in 25 mM HEPES, pH 7.5) with 1 µL reservoir 
solution (50 mM ADA, 0.6 M potassium-sodium tartrate, 10 mM FeCl3, pH 6.6) and 
equilibrating against 1 mL reservoir solution at 20°C. Crystals formed within 3 days and 
were cryo-protected in a solution containing all of the crystallization components and 
30% ethylene glycol prior to flash cooling in liquid nitrogen. 
 C. neoformans ACK was crystallized by the hanging drop vapor diffusion method 
by mixing 1 µL protein (3 mg/mL in 25 mM Tris, pH 7.4) with 1 µL reservoir solution 
(50 mM ADA, 100 mM sodium tartrate, 18.5% PEG 2000, pH 6.2) and equilibrated 
against 1 mL reservoir solution at 4°C for 4 days. Crystals were cryo-protected by 
soaking in a solution containing all of the components of the crystallization reaction, but 
with the PEG 2000 concentration increased to 30% and then flash cooled in liquid 
nitrogen. 
 Crystallographic data were collected at the Advanced Photon Source LS-CAT 
beamlines (Table 10) and processed using HKL2000 (246).  The structures of both 
eukaryotic ACKs were determined by molecular replacement using the program 
PHASER (247) and a polyalanine model of the M. thermophila ACK structure (PDB 
entry 1G99; (266)) as the search model.  Preliminary phases for the C. neoformans ACK 
model were calculated in DM (273) and improved by solvent-flattening and two-fold 
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non-crystallographic symmetry (NCS) averaging.  Manual model building was performed 
in COOT (249) and refinement was performed in CNS (274) and REFMAC (275). Tight 
NCS restraints applied to individual domains of the C. neoformans ACK model were 
reduced as the model quality improved. Final model quality was assessed with 
PROCHECK (250). Figures were prepared with PyMOL (276).  
 
Table 10: ACK Crystallographic Data Collection and Refinement Statistics 
 E. histolytica ACK  C. neoformans ACK 
Data collection   
APS Beamline  21-ID-G 21-ID-D 
Wavelength 0.979 Å 1.127 Å 
Space group I222  P21 
Unit cell dimensions a=98.8 Å a=51.4 Å 
 b=126.9 Å b=107.6 Å 
 c=145.6 Å c=79.1 Å 
 β=90 b=99.8° 
Resolution Range 44 - 2.4 Å (2.46 - 2.4 Å)a 39 - 1.9 Å (1.97 - 1.9 Å) 
Number of reflections 273,804 224,881 
Unique reflections 35,682 64,297 
Rsymb 13.8% (44.0%) 5.8% (30.9%) 
<I>/<σ>c 15.6 (3.0) 27.0 (5.2) 
Redundancy 7.7 (5.8) 3.5 (3.0) 
Completeness  99.3% (93.7%) 95.7% (89.8%) 
   
Refinement   
Rcrystd 21.0% 17.8% 
Rfreee 23.1% 21.9% 
   
Rms deviation   
Bond Length 0.004 0.01 
Bond Angle 0.93 1.2 
aValues in parentheses are for the highest resolution shell. 
bRsym= , where j is the jth measurement and <I> is the weighted mean of I. c<I>/<σ> is the mean intensity divided by the mean error. 
dRcryst= , where Fo and Fc are the observed and calculated structure 
factor amplitudes, and k is a weighting factor. 
eRfree is the same as Rcryst calculated on 5% of the reflections in E. histolytica ACK (1999 
reflections) and C. neoformans ACK (3188 reflections). 
 
! 
"hkl " j | I j # $I % | /"hkl " I j
! 
"hkl || Fo | #k | Fc || /"hkl | Fo |
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Results and Discussion 
Overall Structures 
 On a global level, the structures of both eukaryotic ACKs (Figure 39A, B) are 
similar to that of the previously reported M. thermophila ACK. This dimer has been 
described as resembling a bird with wings spread (266). The ‘body’ of the bird contains 
the C-terminal RNase-H like domain and mediates dimerization, while the ‘wing’ is 
organized around the N-terminal RNase-H like domain.   
 
 
Figure 39: Structures of the eukaryotic ACKs. A) E. histolytica ACK with the N-terminal 
wing domain colored green and the C-terminal body domain colored cyan. B) C. neoformans 
ACK with the wing domain colored purple and the body domain colored grey. The putative 
acetate and nucleotide binding sites are highlighted with a triangle and a circle, respectively. The 
rotation axes relating each domain of the dimer are highlighted with a line colored similarly to the 
corresponding domain.  
 
Superposition of each protomer of the E. histolytica and C. neoformans ACKs 
revealed that while each domain is folded similarly, there is a difference in the 
interdomain angle between the body and wing domains. This gives rise to unique rotation 
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axes that superimpose the body and wing domains in both structures (Figure 39A, B). 
The difference in angle was calculated using DynDom (277) and revealed a difference in 
interdomain angle of 9° between the two protomers of E. histolytica ACK and 14° 
between the two protomers of the C. neoformans ACK.  
 
Active Site Architecture 
The M. thermophila ACK is the closest structurally characterized homolog of the 
eukaryotic ACKs, and will be used for comparisons in this report. Comparison of each 
eukaryotic ACK to M. thermophila ACK determined in the presence of acetate, ADP-
AlF3, and thiopyrophosphate (PPS) (271) supports the assignment of the active site at the 
interface of the body and wing domains and suggests a binding site for the phosphoryl 
donor (ATP or PPi) and acetate. The three signature motifs that mediate ATP binding in 
the ASKHA superfamily, termed ADENOSINE, PHOSPHATE 1, and PHOSPHATE 2 
(278), surround the putative phosphoryl donor binding pocket in both of the eukaryotic 
ACKs (Figure 38A). Co-crystallization of the E. histolytica and C. neoformans ACKs 
with either PPi or nucleotide analogs, respectively, did not result in the appearance of 
new electron density corresponding to a bound phosphoryl donor in this site. Instead, 
superpositions with the structure of acetate and ADP-AlF3 bound M. thermophila ACK 
(Figure 40A, D) were used to evaluate whether the phosphoryl donor could reasonably 
be accommodated in a similar location within the eukaryotic ACKs. Manual modeling of 
ADP-AlF3 into the structure of the C. neoformans ACK (Figure 40B, E) and PPS into 
the structure of the E. histolytica ACK (Figure 40C, F) resulted in reasonable contacts 
between protein and the respective nucleotide analogs. 
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Figure 40: Active site architecture.  A) A surface representation of the M. thermophila ACK 
(PDB ID 1TUY) with the N-terminal wing domain colored dark blue and the C-terminal body 
domain colored light blue. B) A surface representation of the C. neoformans ACK colored as in 
Figure 2. ADP-AlF3 and acetate are modeled into putative binding sites. C) A surface 
representation of the E. histolytica ACK colored as in Figure 2 with PPS and acetate modeled 
into putative binding sites. D-F) Close up views of the nucleotide or PPi binding sites in ACKs. 
D) M. thermophila ACK, E) C. neoformans ACK, and F) E. histolytica ACK. In panels E) and F), 
the position is modeled according to methods listed in the text.  G-I) Close up views of the 
substrate binding site. G) M. thermophila ACK H) C. neoformans ACK, and I) E. histolytica 
ACK. The acetate is modeled in panels H) and I). 
 
The ADENOSINE motif normally positions the protein side chains into 
conformations that promote the interaction between protein and the adenosine base of 
ATP in ASKHA superfamily enzymes (278). Interestingly, both the sequence and the 
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backbone structure of the ADENOSINE motif are conserved in the E. histolytica ACK 
(Figure 38A, 40F), which has been demonstrated to use PPi, and not ATP, as a 
phosphoryl donor (Fowler et al., 2012). Inspection of the E. histolytica ACK structure 
shows that substitution of a conserved glycine to glutamine and isoleucine to methionine 
(Gln-323 and Met-324 on a2A’) sterically occludes the ATP-binding cleft (Figure 40C, 
F). Additionally, a salt bridge between Asp-272 and Arg-274 on ag stabilizes an alternate 
conformation of Arg-274 which positions its guanidino group into the ATP-binding cleft 
further contributing to the occlusion. These features may be important in the conversion 
of phosphoryl donor selectivity from ATP to PPi.   
 The structure of the M. thermophila ACK in complex with its substrate acetate 
(Figure 49A, G) revealed a hydrophobic substrate-binding pocket between the wing and 
body domains (271).  Manual modeling of acetate into both the C. neoformans  (Figure 
40B, H) and E. histolytica ACKs (Figure 40C, I) again resulted in reasonable contacts 
between protein and substrate. Indeed, the residues surrounding the acetate-binding 
pocket are almost completely conserved in the eukaryotic ACKs with the exception of a 
proline to threonine substitution at position 223 in the E. histolytica enzyme (Figure 40I). 
However, site-directed mutagenesis studies of Thr-223 in E. histolytica ACK did not 
reveal a specific role for this side chain (262). 
 
Mechanistic Implications 
 Given the similarities observed within the active sites of the M. thermophila, C. 
neoformans, and E. histolytica ACKs, it is reasonable to use the mechanism proposed for 
the M. thermophila enzyme as a starting proposal for eukaryotic ACKs. Each of the 
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enzymes has an active site that would support binding of the acetate and the phosphoryl 
donor (either ATP or PPi) in a linear arrangement (Figure 40A-C). This binding mode is 
consistent with the in-line transfer mechanism proposed for M. thermophila ACK, where 
the phosphoryl transfer occurs directly between the two properly aligned cosubstrates 
(271). 
The biological role of ACK in M. thermophila is to produce acetyl phosphate (and 
ADP) from acetate and ATP during methanogenesis (266). The reaction is therefore 
commonly discussed in the acetyl phosphate forming direction, although in vitro, the M. 
thermophila enzyme catalyzes the reverse reaction at a similar rate (262,269). In contrast, 
kinetic characterization of both the E. histolytica ACK (261,262) and the C. neoformans 
ACK (Ingram-Smith, C. and Smith, K.S., manuscript in preparation) revealed faster 
turnover in the acetate-forming direction. It is unclear from the structures why the 
reaction is favored in one direction while the M. thermophila enzyme appears to catalyze 
the same reaction bidirectionally with comparable efficiency (269).  Nevertheless, it is 
conceivable that the in-line transfer could work in reverse. In this scenario, acetyl 
phosphate and Pi/ADP would bind in a linear array within the active site, and the 
phosphoryl group would be transferred from the acetyl phosphate to the Pi/ADP.  
 The difference in interdomain angle observed in both the E. histolytica and C. 
neoformans ACKs mirrors that observed in other ASKHA superfamily members (264). 
Enzymes with a global architecture similar to ACKs commonly employ domain closure 
to facilitate catalysis (for example, see (279)). The ability to adopt multiple interdomain 
angles in the eukaryotic ACKs suggests that interdomain motions could similarly 
contribute to catalysis, as has been shown for the M. thermophila enzyme (272).  
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Accession Numbers 
Coordinates and structure factors have been deposited with the RCSB Protein 
Data Bank with accession numbers 4H0O (E. histolytica ACK) and 4H0P (C. neoformans 
ACK). 
 
 
This work was has been reprinted with permission from: 
Thaker, T.M., Tanabe, M., Ingram-Smith, C., Fowler, M., Smith K.S., Preininger, A.M., 
and Iverson, T.M. (2013) Crystal Structures of Acetate Kinases from the Eukaryotic 
Pathogens Entamoeba histolytica and Cryptococcus neoformans. Journal of Structural 
Biology. 181(2): 185-189.  
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